A genome-scale investigation of clavulanic acid biosynthesis by Streptomyces clavuligerus in batch and chemostat cultures using transcriptomic and fluxomic analysis. by Mercier, Claire J.M.
©8319179
UNIVERSITY OF SURREY LIBRARY
ProQuest Number: 10130281
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com plete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uesL
ProQuest 10130281
Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States Code
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
- r  UNIVERSITY OFm  SURREY
A Genome-Scale Investigation of 
Ciavuianic Acid Biosynthesis by 
Streptomyces davuUgerus in Batch and 
Chemostat Cultures Using Transcriptomic 
and Fiuxomic Analysis
by Claire 3M Mercier
Submitted for the Degree of Doctor of Philosophy
April 2007
School of Biomedical and Molecular Sciences 
University of Surrey
®  Claire JM Mercier
A bstract
Streptomyces davuUgerus produces the potent /^lactamase inhibitor ciavuianic acid, 
which is used in conjunction with other /^lactam antibiotics. Although the genome of 5. 
davuUgerus has not yet been sequenced, tools were developed to study the metabolic 
flux distribution (fluxomics) and gene expression (transcriptomics) at genome scale. A 
Streptomyces clavuligerus-spec\f\c genome-scale metabolic network was derived from 
the network reconstructed for the close relative 5. coelicolor (Borodina et al., 2005), 
removing reactions unique to 5. coelicolor and adding the ones known to take place in 
S. davuUgerus. This metabolic network was then used to perform Flux Balance Analysis. 
Genome-scale transcription analysis was also made possible by customising S. coelicolor 
DNA microarrays thanks to the addition of 80 5. clavuligerus-s'peQ\f\c probes, 
corresponding to most of the sequenced 5. davuUgerus genes, to the 8,000 5. coelicolor 
probes, including probes for the genes of the ciavuianic acid cluster. These genome- 
scale methodologies were applied to 5. davuUgerus grown in chemostat and batch 
cultures. Macromolecuiar compositions at two dilution rates (0..02h‘  ^and O.OSh"^ ) and in 
different growth phases were analysed in order to obtain reliable flux data. Flux 
distribution was simulated accurately and predicted supplements such as threonine, 
ma late, pyruvate or citrate that might lead to increased antibiotic production.
The customised DNA microarrays demonstrated that the genes of the ciavuianic acid 
cluster are regulated differently in batch and in chemostat culture. The analysis of the 
transcription data also predicted that the use of supplements such as glycine or 
thymidine could lead to increased ciavuianic acid production. Finally, the gene 
expression patterns showed that S. davuUgerus might be using an alternative pathway 
to metabolise glycerol during ciavuianic acid production.
In batch culture, the fiuxomic and transcriptomic data showed no correlation, while 
some correlation was observed In chemostat culture. This demonstrated that chemostat 
culture is more useful than batch culture when performing genome-scale analysis. 
However, batch culture remains a valuable tool to assess gene co-expression or to study 
a switch between two phases of growth.
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EDTA ethylenediaminetetraacetic acid
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GMP guanosine 5'-monophosphate
GTP guanosine 5'-triphosphate
HPLC High Performance Liquid Chromatography
HSP heat-shock protein
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IMP inosine 5'-monophosphate
P growth rate
MAL malate
Mb megabase (10®)
Mmax maximum growth rate
mRNA messenger RNA
NADH nicotinamide adenine dinucleotide (reduced form)
L is t  of  A b b r e v ia t io n s XIV
NADP nicotinamide adenine dinucleotide phosphate (oxidized
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sue succinate
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tRNA transfer RNA
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1.1. The S treptom yces qm us
Streptomyces davuUgerus is a member of the Streptomyces genus. The Streptomyces genus 
is the most widely studied genus of the Actinomycetales order, which also includes 
Mycobacterium, Corynebacterium and Micrococcus. The suffix 'myced or ^myceted comes 
from the Greek ^mykes', fungus, indicating that these microorganisms were first classified as 
fungi.
Streptomycetes are gram-positive aerobic filamentous bacteria. They usually inhabit soil, 
where they are able to metabolise a wide range of compounds (amino acids, aromatic 
compounds, alcohols...) thanks to the production of extracellular enzymes (amylases, 
cellulases, xylanases, phosphatases, lipases, proteinases and nucleases). They are therefore 
important decomposers (Piret and Demain, 1988). They are also largely responsible for the 
earthy smell of the soil as a result of the secretion of chemicals called geosmens or 
geosmins. A function of these chemicals is thought to be the attraction of animals such as 
camels to the water nearby, which could be a way for streptomycetes to get dispersed.
Streptomycetes also produce a large variety of compounds useful to mankind, including anti­
tumour agents, immuno-suppressants, insecticides, and half of the world's antibiotics. Some 
well-known antibiotics produced by the genus include neomycin, produced by Streptomyces 
fradiae, or streptomycin, produced by Streptomyces griseus.
Streptomycetes show some peculiar genetic characteristics. They possess unusually large 
genomes with high G+C content (>70%) which exist as linear chromosomes. For instance, 
5. avermitiiis linear chromosome presents 9 Mb (7,577 protein-coding genes), and S. 
coeiicoior qeno\x\e presents 8.7 Mb (and 7,825 protein-coding genes), compared to 4.6 Mb 
for E. co iior 2.2 Mb for Neisseria meningitidis.
Most streptomycetes also contain plasmids, both linear and circular (Kieser e t ai., 2000). For 
instance, Streptomyces coeiicoior contains a linear plasmid, SCPl, as well as a circular 
plasmid, SCP2.
So far, two species have been sequenced: Streptomyces coeiicoior in 2002 (Bentley e t ai., 
2002), and Streptomyces avermitiiis in 2003 (Ikeda et ai., 2003; Omura et ai., 2001) but 
some more are in progress.
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Streptomycetes exhibit on solid media a complex life cycle similar to that of fungi; as 
illustrated in Figure 1.1.
Single spore
Spore chain ^
o
Vegetative
mycelium
Aerial mycelium
Antibiotic production
Figure 1.1. Streptomycetes' life cycle on solid media
Streptomycetes, because of their filamentous structure, face a dispersal problem, which they 
can solve thanks to the formation of spores (cf. Figure 1.2.). They achieve this by sending up 
aerial hyphae, which will eventually change into spore chains (Chater e t a!., 2002). The 
formation of this aerial mycelium is triggered by external factors such as starvation or drying 
out. This coincides with the production of secondary metabolites such as antibiotics, which 
might confer them an advantage to compete against other microorganisms when the 
external conditions become more difficult, as in the case of drought or lack of nutrients 
(Chater etaL, 2002).
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Figure 1.2. Sporuiating colony of S. davuUgerus {^kS)
Their complex life cycle, as well as the difficult and competitive environment in which they 
live, can explain their unusually large genome. Indeed, a large number of genes need to be 
dedicated to extracellular biology, to cell growth and division, and to regulation of 
morphological differentiation (Chater eta!., 2002).
1.2. Production of secondary metabolites
The term 'secondary metabolite' was first introduced by Bu'lock (1961). Secondary 
metabolites, or idiolites, are metabolites that are usually being produced after the organism 
has achieved growth, although growth phase (trophophase) and production phase 
(idiophase) can overlap when the medium supports slow growth (Piret and Demain, 1988). 
They play a role in the organism's life but are not essential for growth, unlike primary 
metabolites. On solid media, production of secondary metabolites usually starts with the 
formation of aerial mycelium. In a batch culture, this will often take place after the 
exponential phase (Kieser et a!., 2000). Secondary metabolites derive from a small number 
of different precursors, such as amino acids, small fatty acids, sugars and nucleic acids.
Antibiotic-producing species are often sensitive to their own antibiotic during growth phase. 
This sensitivity is usually lower in stationary phase. Mechanisms used to avoid suicide 
because of their own antibiotic include: 1) enzymatic modification of the antibiotic, 2) 
alteration of the antibiotic target in the cell, 3) decreased uptake of the antibiotic after its 
excretion (Piret and Demain, 1988; Hopwood, 2007).
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It has been proposed that secondary metabolites are produced in order to improve the 
survival of their producer (Chater et aL, 2002; Demain and Fang, 2000). The arguments 
advanced to support this view include (Demain and Fang, 2000):
- Most of these metabolites are produced thanks to clusters of biosynthetic genes, which also 
contain resistance and regulatory genes.
- These compounds have complex structures and pathways and are energetically expensive 
to produce.
- Non-producers also present clusters of resistance genes to these compounds.
- Antibiotic production and sporulation, which is a stage at which the organism is particularly 
vulnerable and the nutrients run out, are usually temporally related.
Challis and Hopwood (2003) suggested that many secondary metabolites work synergistically 
(where they present together a greater biological activity than the sum of their individual 
activities) or contingently (where multiple metabolites acting on the same target prevent 
biological competition). For instance, 5. davuUgerus produces both p-lactam antibiotics (such 
as cephamycin C) and |3-lactamase inhibitors (such as ciavuianic acid). This can not be a 
simple coincidence, as there are no known ciavuianic acid producers that do not also produce 
cephamycins. The facts that ciavuianic acid and cephamycin C genes occur as a 'supercluster' 
on the chromosome and have a common regulator {ccaR) corroborate with the idea that the 
two antibiotics act synergistically, with ciavuianic acid protecting cephamycin C from 13- 
lactamases.
An example of secondary metabolites being produced contingently are siderophores. 5. 
coelicolor possesses two independent pathways for the production of siderophores. One 
leads to the production of desferrioxamines and the other one to the production of 
coelichelins. These pathways are coregulated, and their activity is maximal under iron- 
deficient conditions and abolished under iron-sufficient conditions. This allows S. coelicolor X.o 
survive in environments inhabited by competitors that have the ability to take up 
ferrioxamines (the iron-desferrioxamine complexes) produced by other organisms.
It is difficult, however, to comprehend what advantage a saprophytic soil microorganisms 
would have to produce a metabolite such as an immunosuppressant that only seems to be 
active on the vertebrate immune system, for instance (Challis and Hopwood, 2003).
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1.3. S treptom yces davuUgerus ciavuianic acid
5. davuUgerus ATCC 27064 (NRRL 3585, DSM 738) was first described by Higgens and 
Kastner (1971), who isolated it from a South American soil sample. Its name refers to the 
shape of its spore-bearing hyphal branches: ^davulaf in Latin means 'little club' and the suffix 
^-igeruë means 'bearing'. Its spores are gray to grayish green (Higgens and Kastner, 1971).
5. davuUgerus produces over 20 secondary metabolites, including many (3-lactam antibiotics 
such as ciavuianic acid, cephamycin C, deacetoxycephaiosporin C, penicillin N (an 
intermediate in cephamycin C pathway) and at least four other clavams (Nabais and 
Dafonseca, 1995; Tahlan et aL, 2004a). Non-|3-lactam antibiotics include holomycin and an 
antibiotic complex, MM 19290, related to tunicamycin (Baggaley et aL, 1997). Doran e t aL 
(1990) also described a p-lactamase-inhibitory protein (BLIP).
Another important characteristic of 5. davuUgerus is that it is not able to use glucose as a 
carbon source, because it lacks a glucose transport system (Aharonowitz and Demain, 
1978a; Garcia-Dominguez etaL, 1989).
It also possesses all the enzymes of the urea cycle, which is unusual for a prokaryote, 
although it is not clear if the urea cycle is functional (Kirk etaL, 2000).
1.3.1. p-lactam antibiotics and p-iactamases
There are four different classes of p-lactam antibiotics: the clavams, the carbapenems, the 
monobactams and the 'sulphur-containing', which include the penicillins and the cephamycins 
and cephalosporins (cf. Figure 1.3.). Each class is defined by the composition, or absence, of 
a five- or six-membered ring that is fused to a common, four-membered lactam ring 
(McGowan etaL, 1998).
Penicillins, cephamycins and cephalosporins all contain a sulphur atom in the fused ring and 
have a common biosynthetic pathway, whereas the other p-lactams are characterised by the 
presence in the fused ring of an oxygen atom (clavams), or of carbon atoms (carbapenems), 
or by the absence of a fused ring (monobactams).
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‘Sulphur-containing’
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Penicillins Cepiiamycins and 
cephalosporins
Figure 1.3. Structure of the four classes of p-lactams (McGowan etaL , 1998)
This family of antibiotics is sensitive to the enzyme p-lactamase produced by some 
pathogens such as Staphylococcus aureus or E coii, p-lactamase is an enzyme that 
hydrolyses the p-lactam bond, rendering antibiotics such as penicillins, cephalosporins or 
carbapanems inactive (cf. Figure 1.4.). The production of p-lactamase is the most important 
mechanism for bacterial resistance to p-lactam antibiotics (Lee eta!., 2002).
OH
HgN"
0
OH
p-lactamase
enzyme
COjH
H,N'
0  0 ^ \  HN
OH
s. R
COjH
Active amoxicillin Inactive amoxicillin
Figure 1.4. Action of p-lactamase enzyme on amoxicillin (penicillin)
p-lactamase inhibitors were discovered in both the clavams (clavulanic acid, produced by 5. 
ciavuiigerus) and the carbapenems (olivanic acids, produced by 5. oHvaceus and 5. 
fulvovirldls) families.
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1.3.2. Clavulanic acid
1.3.2.1. Overview
Clavulanic add was first Isolated and described In 1976 by Brown et al. Its systematic name 
is z-(2R,5R)-3-(y0-hydroxyethylldene)-7-oxo-4-oxa-l-azablcyclo-[3.2.O]-heptane-2-carboxyllc 
add (cf. Figure 1.5.).
|3-lactam ring oxazolidine ring
Figure 1.5. Molecule of clavulanic acid
Clavulanic add Is a fused p-lactam antibiotic structurally distinct from the penicillins, 
cephalosporins and cephamyclns In that It has an oxygen atom In place of sulphur and no 
side chain at C-6. It Is therefore classified as a clavam.
It shows a broad antibacterial spectrum but at a relatively low level of activity (Brown et a!., 
1976; Lee eta!., 2002). It was the first naturally-occurring p-lactamase potent Inhibitor to be 
fully characterised. Clavulanic add effectively Inhibits the p-lactamases produced by many 
Gram-posltlve and Gram-negative bacteria such as Staphylococcus aureus, Escherichia coH, 
Klebsiella, Proteus, Shigella, Pseudomonas and Haemophilus influenzae (Brown et a i, 1976; 
Haglnaka etaL, 1981). Thanks to the presence of 10 pg/ml clavulanic add, many of these p- 
lactamase producing organisms are rendered almost as sensitive to penicillins and 
cephalosporins than other non-/3-lactamase producing bacteria (Brown etaL, 1976).
Clavulanic acid's p-lactamase Inhibition activity is thought to be linked to Its unique 5R 
stereochemistry (Liras and Rodrlguez-Garcia, 2000). Clavulanic add Irreversibly binds to the 
hydroxyl group of serine at the active centre of yg-lactamases to produce a sTable acylated 
Intermediate, leading to the Inactivation of the p-lactamase, as Illustrated In Figure 1.6. 
(Chen et aL, 2003; Haglnaka e t aL, 1981). This Is similar to the reaction between p-
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lactamases and penicillin but the acyl enzyme formed here is hydrolysed very slowly, thus 
Inhibiting the enzyme (Rolinson, 1991).
clavulanic acid
‘CO2H 0 ^  CO 2 Ho
OH ÇH2
ÇH2  CH—
N H -C H — CO' 
p-lactamase acyl enzyme complex
Figure 1.6. Mode of action of clavulanic acid (Rolinson, 1991)
Clavulanic acid is currently used in combination with amoxicillin under the trade name 
Augmentin® and with ticarcillin under the trade name Timentin®. These products have made 
clavulanic acid a highly valuable product. It is therefore subject to a lot of research, 
especially since its patent expired in 2 0 0 2 .
I.3.2.2. Clavulanic acid biosynthesis
- Origin o f the carix)ns
The identification of the Cg-precursor of clavulanic acid has remained a problem for many 
years because interconversions among the glycolysis intermediates are very easy in vivo 
(Elson, 1981; Townsend, 2002). It was only proven recently that glyceraldehyde-3- 
phosphate is the actual precursor (Khaleeli et a!., 1999; Thirkettle et a!., 1997), together with 
the Cg-precursor arginine (Townsend and Ho, 1985; Valentine etaL, 1993).
- Biosynthesis
The early steps of clavulanic acid and S. ciavuiigerus' c l a v a m  metabolites biosynthesis 
are common (Jensen et a!., 2000).
The overall reaction of clavulanic acid formation can be summarised as (Roubos, 2002):
3 oKG + ARG + ATP + GAP + 2 NADPH + 4 0% ^  AMP + CA + 3 CO2 + 3 HzO + 2 NADP + 
NH4 + 3 Pi + 3 sue + UREA
As illustrated in Figure 1.7., glyceraldehyde-3-phosphate and arginine are condensed into N^ - 
(2-carboxyethyl)-arginine (CEA, a member of the opine family) by the enzyme CEA synthase
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(CEAS, encoded by ceaS2). A (3-lactam synthase ((3-LS, encoded by b!s2) then catalyses the 
formation of the (3-lactam ring, generating deoxyguanidino proclavaminic acid (Townsend, 
2002). This molecule is then converted into guaninidoproclavaminic acid via hydroxylation by 
clavaminate synthase (CAS, encoded by cas2) (McGowan et aL, 1998). Next, 
guanidinoproclavaminic acid is converted into proclavaminic acid by proclavaminic amidino 
hydrolase (PAH, encoded by pahZ), which hydrolyses the guanidine side-chain (Liras and 
Rodriguez-Garcia, 2000). CAS subsequently catalyses two further oxidations to transform 
proclavaminic acid into dihydroclavaminic acid, and then dihydroclavaminic acid Into 
clavaminic acid, the branch point between production of clavulanic acid and other clavams 
(Egan et aL, 1997; Townsend, 2002). Further on, clavaminic acid is converted via a yet 
unknown process into clavaldehyde, which already possesses the 5/? stereochemistry 
required for reaction with penicillin-binding proteins and (3-lactamases but is much less 
sTable than clavulanic acid (Arulanantham etaL, 2006).
Disruption of o rfl5  {oppA2) and o rfl6  result in an accumulation of N-acetyl-glycyl-clavaminic 
acid and N-glycyl-clavaminic acid, suggesting that these two compounds are intermediates 
between clavaminic acid and clavaldehyde (Arulanantham et aL, 2006). Arulanantham et aL 
(2006) recently discovered that o rfl7  encodes an N-glycyl-clavaminic acid synthase (GCAS) 
that converts clavaminic acid into N-glycyl-clavaminic acid. The exact roles of orflS  and 
orfl6 , as well as the steps between N-glycyl-clavaminic acid and clavaldehyde, still need to 
be elucidated. Li et aL (2000) showed that cyp, fd  and o rfl2  are also required for the 
biosynthesis of clavulanic acid. The protein encoded by cyp is a cytochrome P-450, the one 
encoded by ^  is a ferredoxin enzyme and could not be identified. They suggested that 
the cytochrome P-450 as well as the ferredoxin mediate the oxidative deamination that takes 
place between clavaminic acid and clavaldehyde.
Finally, clavulanate-9-aldehyde reductase (CAR, encoded by cat) catalyses the last reduction 
leading to clavulanic acid (Liras and Rodriguez-Garcia, 2000).
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Figure 1.7. Clavulanic acid biosynthesis 
Adapted from Aruiananttiam etaL  (2006)
All the genes involved in clavulanic acid synthesis are organised within a cluster around cas2 
on a 12-kb EcoRI fragment of the 5. ciavuiigerus chromosome (McGowan et aL, 1998). This
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cluster is adjacent to a large cluster responsible for cephamycin, penicillin and cephalosporin 
production (McGowan et aL, 1998; Townsend, 2002). They form together the p-lactam 
'supercluster' (Perez-Llarena et aL, 1997; Roubos, 2002b). It Is interesting to note the 
positional link between the production of a p-lactam antibiotic (cephamycin) and the 
production of a p-lactamase inhibitor (clavulanic acid).
It has also been shown that all the genes encoding enzymes of the early steps of clavulanic 
synthesis {ceas, bis, pah), as well as oat, are present as two sets of paralogous genes 
(Jensen et aL, 2000; Tahlan et aL, 2004c). It is still unknown where the second set is 
located, and why these genes are duplicated in S. ciavuiigerus genome, although it is 
believed that the paralogous cluster could be involved specifically with the production of S. 
ciavuiigerus other clavams. The paralogous cluster is distinct from the clavulanic acid cluster 
and from the clavam cluster (where a second cas gene, casl, is also located) and their genes 
are regulated differently (Jensen e t aL, 2000; Tahlan et aL, 2004a; Tahlan et ai., 2004c). 
For instance, Tahlan etaL (2004a) showed that the transcription of ceas2\s greatly affected 
in a ccaR defective mutant while the transcription of ceasl remains the same. Paradkar and 
Jensen (1995) also showed that, in Acas2 mutants, casl can only be expressed, and 
clavulanic acid can still be produced, in soy medium, but not in starch-asparagine medium, 
suggesting that both Casl and Cas2 can contribute to clavulanic acid production, but they 
are regulated differently.
The other clavams produced by 5. ciavuiigerus do not possess the typical 5/? stereochemistry 
of clavulanic acid but a more common 55 stereochemistry. Therefore, they do not present a 
p-lactamase inhibition activity (Baggaley etaL, 1997).
The cephamycin-clavulanic acid cluster, the clavam cluster and the paralogous cluster, 
although all involved in clavams synthesis, are physically unlinked on the chromosome 
(Tahlan etaL, 2004b).
The gene clusters involved in clavulanic acid synthesis, transport or regulation are 
represented on Figure 1.8.
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Figure 1.8. Details of the genes of the three clusters Involved In clavulanic acid production, 
transport and regulation. Note that the size of the boxes is not an Indication of the length of the genes. A Table 
explaining what the genes are can be found In appendix 1.
I.3.2.3. Clavulanic acid regulation
There is no universally accepted theory as to how secondary metabolism is controlled. Most 
antibiotics are produced through complex biosynthetic pathways, which are themselves 
encoded by clusters of genes (Bibb, 1996). These clusters typically contain pathway-specific 
regulatory genes, controlled by pleiotropic regulatory genes (Bibb, 1996; Kieser et aL, 2000; 
Perez-Llarena etaL, 1997).
Antibiotic production and morphological differentiation are usually simultaneous. However, 
some asporogenous mutants have been shown to produce secondary metabolites, while it is 
common for non-producers to remain able to sporulate (Bate et aL, 2002). This indicates 
that there are different levels of regulation, some high ones regulating both morphogenesis 
and antibiotic production, some lower ones regulating either one or the other, and some 
even lower levels, regulating smaller groups of genes (Demain, 1998).
Various factors have been shown to play a role in the regulation of clavulanic acid production 
and are discussed below.
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1.3.2.3.1. Nutritional regulation
Some nutrients, mainly carbon, nitrogen and phosphate, have been shown to have an effect 
on regulation of secondary metabolism in two different ways:
- Nutrient limitation leads to a decrease in protein synthesis, triggering the stringent 
response (Wilson and Bushell, 1995);
- Nutrients are also able to repress or inhibit some enzymes of the secondary metabolism, 
therefore regulating it.
- Carbon regulation
Rapidly utilisable carbon sources often repress synthesis and inhibit activity of antibiotics 
synthases (Piret and Demain, 1988). For instance, glucose interferes with many secondary 
metabolites production such as actinomycin, cephalosporins, and tylosin by targeting some 
enzymes involved in their biosynthesis.
The regulatory effect exerted by carbon sources is called carbon catabolite regulation (CCR) 
and is widely distributed among microbial systems to assure a sequential utilisation of carbon 
sources, when more than one is present, so that the best carbon source is catabolised first. 
Simultaneously, enzymes using other substrates are being repressed.
Several groups have reported the isolation of Streptomyces mutants showing a total lack or 
significant decrease in glucose kinase activity. These mutants were not sensitive to glucose 
repression, or repression by other carbon sources such as galactose, glutamate or citrate, 
suggesting a link between CCR and glucose kinase (Mahr et ai., 2000; Sanchez and Demain, 
2002).
- Nitrogen regulation
It has been suggested that ammonium repression of some secondary metabolites could be 
explained by the ammonium inhibition of some enzymes involved in amino acids catabolism. 
Indeed amino acids catabolism supplies many precursors of secondary metabolites, such as 
lower fatty acids in polyketide biosynthesis (Omura and Tanaka, 1986). For instance, 
tetracycline production is decreased by high concentrations of nitrogen. One of the 
mechanisms is that nitrogen decreases the activity of anhydrotetracycline oxygenase, the last 
enzyme of the tetracycline pathway (Behai et ai., 1983). Cephamycin C production is also 
decreased by high levels of nitrogen in Streptomyces ciavuiigerus (Aharonowitz and Demain,
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1978b), which can be explained by the repression of enzymes of its biosynthetic pathway 
(cyclase and expandase) (Brana etaL, 1985b).
- Phosphate regulation
In many cases, phosphate has also been shown to have an effect on secondary metabolism. 
It is often the major growth-limiting nutrient in natural environments, so microorganisms 
have developed regulation mechanisms of their phosphate requirements. The finding that 
phosphate concentrations over lOmM often suppress biosynthesis of antibiotics in 
streptomycetes (Martin, 1977) can be explained by several mechanisms: 1) Phosphate 
represses and/or inhibits phosphatases involved in antibiotic pathways including 
phosphorylated intermediates. 2) Phosphate is thought to repress or inhibit other synthases 
as well (Martin, 1977; Piret and Demain, 1988; Sanchez and Demain, 2002). 3) Phosphate 
favours primary metabolism as an effector of a large number of enzymatic reactions of 
primary metabolism. 4) For some unknown reasons, a high phosphate concentration favours 
glycolysis over the pentose phosphate pathway, making NADPH the limiting factor for 
antibiotic production (Martin, 1977).
For instance, Gil and Campelo-Diez (2003) found that phosphate repressed the expression of 
genes involved in candicidin biosynthesis by Streptomyces griseus. Similarly, Streptomyces 
rimosus can only produce the antibiotic oxytetracycline at very low phosphate 
concentrations. This control has been shown to be exerted, at least in part, at the 
transcription level (McDowall etaL, 1999).
- In 5. ciavuiigerus
Several authors have noted the inhibiting effect of concentrations of phosphate on clavulanic 
acid production, whereas cephamycin C biosynthesis does not appear to be as sensitive to 
phosphate regulation (Jones etaL, 1996; Romero etaL, 1984).
Kirk etaL (2000) tested the effect of the nature of the growth-limiting substrate of clavulanic 
acid production, using Metabolic Flux Analysis. They found that the availability of the Cg 
precursor (arginine) was primarily affected by a change in the nutrient limitation. The flux to 
arginine was indeed the greatest under P-limitation, slightly lower under N-limitation, and 10 
times lower under C-limitation. Clavulanic acid production was also the highest by far under 
P-limited conditions, and nil under C-limitation. C-limiting conditions appear to restrict 
capacity for anaplerotic metabolism, therefore minimising TCA cycle derived biosynthesis
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such as arginine, whereas N-limiting conditions seem to restrict the availability of nitrogen 
for amino acid synthesis, including arginine. Ives and Bushell (1997) also showed that under 
P-limitation, clavulanic acid production is limited by the availability of the C3 precursor 
(glyceraldehyde-3-phosphate).
As mentioned above, Paradkar and Jensen (1995) also showed that casl is expressed in soy 
medium, but not in starch-asparagine medium. Wang eta l. (2005) further tried to design an 
optimised medium for clavulanic acid production and found that soy meal powder, 
FeS0 4 .7 H20  and ornithine had the most positive effect on clavulanic acid production. 
Ornithine is a precursor of arginine, and Fe is required in clavulanic acid production, so it is 
not surprising to find that they enhance clavulanic acid production. It Is unclear though what 
nutrient in soy meal has a positive effect on the antibiotic production.
I.3.2.3.2. The stringent response
The 'stringent response' can be described as the reaction of bacterial cells to starvation by 
quickly stopping further growth and performing the necessary adjustments to their 
metabolism. The stringent response is thought to enhance viability thanks to energy 
conservation, and to enable quick recovery when the conditions improve. Most secondary 
metabolites are produced once the growth rate decreases, and the stringent response 
mechanism is believed to provoke the simultaneous secondary metabolite production, and 
morphological differentiation.
Rates of RNA accumulation, DNA replication, and carbohydrates, lipids, nucleotides, and 
glycolytic intermediates biosynthesis are reduced by the stringent control, while proteolysis, 
nucleotide repair, and antibiotic production, are all activated (Lamond and Travers, 1985).
When amino acids become depleted, deacylated (uncharged) tRNA accumulates (Jain et aL, 
2006). Cells consequently have a high ratio of uncharged tRNAs relative to aminoacylated 
(charged) tRNAs. The Elongation Factor Tu (EF-Tu) carries these deacylated tRNAs to the 
ribosome, thus aborting the translation. The ribosome-bound RelA protein detects uncharged 
tRNAs on the ribosome, and forms a highly phosphorylated guanine nucleotide, (p)ppGpp, 
also known as stringent factor. (p)ppGpp is a GDP/GTP with a pyrophosphate attached to its 
3' hydroxyl group. This reaction fails to occur when EF-Tu brings a charged tRNA to the 
ribosome.
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(p)ppGpp is eventually hydrolyzed to GDP and phosphates by SpoT (which can also 
synthesize (p)ppGpp), releasing the cell from the stringent response.
In E coH, (p)ppGpp is synthesized by RelA on nitrogen or amino acid starvation and by SpoT 
on carbon or phosphate starvation in a ribosome-independent manner.
Similarly, S. coelicoloTs relA mutants fail to produce antibiotics under nitrogen limitation but 
are not affected under phosphate limitation (Sun et aL, 2001). S. coelicofor's genome also 
contains a second member of the relA/spoT family, rsM  RshA also seems to have an 
hydrolase activity, like SpoT (Sun et aL, 2001). However, the production of antibiotics by 
rshA mutants does not seem to be affected and no RshA-dependent (p)ppGpp synthesis 
could be observed in the relA mutant.
It is not really known yet how (p)ppGpp controls the transcription of genes, but the affected 
genes present unusual promoters, showing conserved features. It is possible that (p)ppGpp 
alters RNA polymerase's recognition of these promoters (Lamond and Travers, 1985). Some 
mutations occurring in the |3 subunit of RNA polymerase that confer rifampicin resistance 
simultaneously abolish the ppGpp requirement for antibiotic production. It has been argued 
that these mutations might mimic the effect of ppGpp binding to the RNA polymerase (Bibb, 
2005).
(p)ppGpp does not seem to be required and/or to be sufficient to produce all antibiotics. For 
instance, the production of ppGpp in 5. coelicolor has been shown to provoke the 
transcription of the gene for the actinorhodin pathway-specific activator actII-ORF4, but no 
effect was observed on the corresponding gene for undecylprodigiosin production, 5 . 
coelicolofs other main antibiotic (Hesketh et aL, 2001). This shows that there is no 
compulsory link between the initiation of antibiotic production and the stringent response.
Two genes involved in ppGpp synthesis and/or degradation were discovered in 5. 
ciavuiigerus, relA and rsh (Jin et ai., 2004). Jin et ai. (2004) showed that (p)ppGpp synthesis 
begins immediately after depletion of casamino acids, with pppGpp peaking after 5 minutes 
and ppGpp after 10 minutes. The level of both compounds became undetecTable after just 
an hour. No ppGpp or pppGpp was produced by reiA defective mutants, but rsh defective 
mutants only showed a decrease in the levels of ppGpp and pppGpp. The reiA mutants also 
failed to produce aerial mycelium and spores on solid medium and showed retarded growth, 
whereas rsh defective mutants did not exhibit retarded growth and displayed a morphology
Ch a pter  1 . I n t r o d u c t io n  17
similar to the wild type organism. Both the relA and the rsh mutants presented significantly 
reduced levels of both cephamycin C and clavulanic acid.
Another study by Jones eta!. (1997) showed that ppGpp accumulated before clavulanic acid 
biosynthesis to high levels in phosphate-limited conditions. However, it only accumulated to 
low levels in glycerol-limited conditions, where clavulanic acid production is much lower. In 
carbon-limiting conditions, the transcript for the enzyme CAS appeared two hours before 
ppGpp, suggesting that ppGpp does not act as a signalling molecule initiating transcription of 
cas2. However, under phosphate limitation, ppGpp appeared one hour before the cas2 
transcript peak.
The effect of the rsh knock-out on antibiotic production in S. ciavuiigerus is quite different 
from the effect of the rshA knock-out in S. coeiicoior, in which the production of the 
pigmented antibiotics actinorhodin and undecylprodigiosin remains unaffected by the 
mutation. It  may be that 5. ciavuiigerus is more sensitive to small changes to (p)ppGpp 
concentration. It is therefore thought that reiA plays an essential role in (p)ppGpp synthesis, 
while the role of rsh might be somehow obscured by its predominant degradative activity.
The link between secondary metabolism and stringent response in 5. ciavuiigerus is still 
unclear and appears to be complex.
13.2.3.3. y-butyroiactones
Many streptomycetes produce small diffusible molecules called y-butyrolactones or 
butanolides (Demain, 1998). These 'microbial hormones' are effective in the nano Molar 
concentrations, play a role in the onset of secondary metabolite production, and sometimes 
also regulate morphological differentiation (Bibb, 1996; Takano et ai., 2001; Takano, 2006).
The most widely studied of these y-butyrolactones is Streptomyces griseus'MacXor. It was 
shown by Hara and Beppu (1982) that mutants of Streptomyces griseus that were not able 
to sporulate or produce streptomycin, did not produce any A-factor either. Furthermore, the 
addition of exogenous A-factor was able to restore both sporulation and antibiotic 
production. However, the presence of A-factor alone is not sufficient to initiate secondary 
metabolism or sporulation.
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The whole cascade of events from A-factor to streptomycin production has now been 
elucidated. afsA encodes a key enzyme for A-factor biosynthesis. ArpA, the A-factor receptor 
protein, binds to a 22bp palindrome called ARE (autoregulatory response element) box in the 
promoter region of adpA (A-factor-responsive transcriptional activator) until the presence of 
A-factor enables its dissociation. adpA is then able to be transcribed and its product binds to 
the promoter of strR, a pathway-specific regulatory gene responsible for transcription of 
other streptomycin genes, which triggers streptomycin biosynthesis (Aharonowitz and
Demain, 1978b; Ohnishi et aL, 1999; Onaka et aL, 1995).
ARE boxes for binding of y-butyrolactone receptor proteins are found upstream of several 
genes encoding SARP {Streptomyces antibiotic regulatory proteins, cf. I.3.2.3.5. Regulatory 
genes).
Streptomyces coelicolor also produces several y-butyrolactones, such as S. coeiicoior 
butanolide 1 or SCBl, reported to stimulate production of actinorhodin and
undecylprodigiosin. However, they have not been studied as deeply as A-factor and their
synthesis seems to Involve a complex regulatory mechanism (Takano etaL, 2001). The three 
identified SCBs are produced at late transition phase when scbA, the afsA homologue, is 
Induced, whereas the A-factor accumulates in early exponential phase (Takano, 2006). ScbR, 
an arpA homologue has also been identified, which encodes a protein that binds to its own 
promoter and to that of the adjacent scbA, thus regulating production of SCBs (Takano et 
aL, 2001).
Ohnishi et ai. (1999) argued that streptomycetes species have developed through evolution 
y-butyrolactones acting in different fashions on their specific pathways. Hence, some of them 
are produced in a growth-dependent manner while some others are produced just before 
antibiotic production.
Kim et ai. (2004) have recently identified scaR, a gene encoding a y-butyrolactone
autoregulator receptor in S. ciavuiigerus. A recombinant ScaR, rScaR, expressed in E. coli, 
showed high affinity towards the y-butyrolactone SCBl from 5. coeiicoior.
Santamarta et ai. (2005) Identified an ARE box upstream of ccaR and showed that AscaR 
mutants exhibited normal morphology and a higher production of both clavulanic acid and 
cephamycin C, suggesting that ScaR acts as a repressor protein, and that the deletion of 
scaR might result in higher ccaR levels. They also discovered that ScaR also binds to a region
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upstream of scaR, suggesting It Is self-regulatory, as it is the case in 5. virginiae. Finally, an 
interesting finding was that at least one additional protein, different from ScaR, also binds to 
the ARE sequence upstream of ccaR, which would suggest an alternative modulation of ccaR 
expression due to the binding to the ARE motif of two proteins, a repressor and a possible 
activator.
1.3.2.3A. Pleiotropic genes
The 6 /c/ genes are an example of pleiotropic genes. Mutations of bidA in 5. coeiicoior resuWs 
in loss of both morphological and physiological differentiation (Leskiw et ai., 1991a; Leskiw 
et ai., 1991b). Leskiw et ai. (1991b) showed that this phenomenon was explained by the fact 
that bidA encodes the only tRNA that can translate the rare UUA leucine codon. This codon is 
found in many genes involved in morphological and physiological differentiation, suggesting 
that the pleiotropic gene bidA regulates antibiotic production and sporulation by allowing the 
translation of mRNA containing the rare UUA codon only under certain conditions (Leskiw et 
ai., 1991a).
The cephamycin cluster of 5. ciavuiigerus, which is itself a part of the 'p-lactam supercluster', 
contains a positive regulatory gene, ccaR, required for both cephamycin and clavulanic acid 
production (Liras, 1999). Transcription of ccaR precedes cephamycin and clavulanic acid 
production (Perez-Llarena et ai., 1997). Its amplification results in a two- and three-fold 
increase in the production of cephamycin C and clavulanic acid, respectively, although they 
are produced by two completely different pathways (Liras and Rodriguez-Garcia, 2000). The 
product of this gene belongs to the group of Streptomyces antibiotic regulatory proteins 
(SARP) (Liras and Rodriguez-Garcia, 2000). Mutants disrupted in ccaR can not transcribe 
cephamycin C and clavulanic acid structural genes, although some genes, such as bia in the 
cephamycin C cluster, are not regulated by ccaR (Liras, 1999).
Some research has been performed to reveal how ccaR regulates cephamycin C production 
(Kyung et ai., 2001; Santamarta et ai., 2002). Kyung et ai. (2001) showed that CcaR 
specifically binds to the promoter of the M  gene, the gene responsible for the first step of 
the cephamycin C biosynthesis. Santamarta et ai. further found that Gear also binds to the 
promoter of the bidirectional cefD-cmcI gene of the cephamycin cluster. Hence CcaR also 
controls expression of the middle {cefD) and late {cmcl) steps of cephamycin C synthesis.
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CcaR has also been shown to bind to its own promoter (Santamarta e t aL, 2002). It is 
therefore autoregulatory.
It has been found that ccaR contains a leucine from a rare TTA codon, similarly to A ctll- 
0RF4 in S. coelicolor (Perez-Llarena et ai., 1997). ActII-0RF4 has been reported to be a 
transcriptional activator of the actinorhodin genes, and the TTA codon has been shown to be 
involved in the mechanism. As mentioned earlier, TTA codons are recognised in 5. coeiicoior 
by a rare tRNA encoded by the bidA gene. S. coeiicoior bidA mutants, which are therefore 
unable to recognise TTA codons, are also unable to produce actinorhodin or to sporulate 
(Leskiw et ai., 1991a).
A gene highly similar to S. coeiicoior bidA was found in S. ciavuiigerus, and was therefore 
thought to have the same role. However, Trepanier et ai. (2002) showed that S. ciavuiigerus 
bidA mutants did produce antibiotics, although they were unable to sporulate. It was 
therefore suggested that the TTA codon in ccaR is mistranslated efficiently in S. ciavuiigerus 
bidA mutants. This could be linked to the fact that all TTA codons in streptomycetes are 
followed by C or T apart from the one contained in the 6/o(4-independent gene ccaR, which is 
followed by a G. This particularity could make an in-frame mistranslation compulsory 
because the +1 reading frame in the sequence would be the TAG amber stop codon. The 
sequence TTA could therefore be mistranslated by imperfect pairing with another tRNA such 
as the leucyl tRNAcAA (Trepanier et ai., 2002).
Another difference between 5. coeiicoior ActII-0RF4 and 5. ciavuiigerus CcaR is that the 
stimulatory effect of CcaR on cephamycin C and clavulanic acid production is less important 
than that of ActII-0RF4 on actinorhodin, hinting that there must be some other genes 
involved in cephamycin C and clavulanic acid regulation (Perez-Llarena et ai., 1997).
CcaR is believed to act indirectly on clavulanic acid production through ClaR (cf. 1.3.2.3.5. 
Regulatory genes). Thalan e t ai. (2004a) also showed that CcaR somehow controls the 
expression of the ceas2 promoter, yielding a polycistronic transcript composed of the genes 
involved in the early stages of clavulanic acid production {ceas2- b is2 - pah2- casl).
Bignell et ai. (2005) recently reported that the 5. ciavuiigerus bidG regulated the expression 
of ccaR itself. BIdG is an anti-anti-sigma factor. Anti-anti-sigma factors allow sigma factors to 
direct transcription. The S. ciavuiigerus' bidG is required for antibiotic production and
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morphological differentiation. A downstream transcriptionally-linked open reading frame 
{orf3) encoding a putative anti-sigma factor protein was also identified. b!dG\s expressed as 
both a monocistronic and a polycistronic transcript, the latter including orf3. AbldG mutants 
did not produce any clavulanic acid, cephamycin or 55 clavams, and did not undergo 
morphological differentiation because of the absence of CcaR.
We mentioned earlier that CcaR binds to its own promoter and is therefore auto-regulatory. 
In Streptomyces virginiae, the transcriptional activator BarA binds to its own promoter in the 
absence of butyrolactones, but not in their presence. As suggested earlier, the recent 
identification of a y-butyrolactone autoregulator receptor protein in 5. ciavuiigerus (Kim et 
ai., 2004) and the discovery of a potential autoregulatory response element (ARE) sequence 
motif in the region upstream on ccaR strongly support the idea that expression of ccaR may 
be regulated by a y-butyrolactone-based quorum-sensing system (Santamarta et ai., 2005; 
Wang e t ai., 2004).
I.3.2.3.5. Reguiatory genes
A novel class of proteins have been described in streptomycetes: the Streptomyces aritMddc 
regulatory proteins or SARP (Wietzorrek and Bibb, 1997). They are now considered as the 
prominent family of regulatory proteins in streptomycetes. ActII-0RF4 and RedD, controlling 
respectively the production of actinorhodin and undeceylprodigiosin in 5 . coeiicoior, and 
DnrI, controlling the biosynthesis of the polyketide antitumour antibiotics daunorubicin and 
doxorubicin in S. peucetius, are the most studied and stereotyped SARPs (Bate et ai., 2002; 
Sheldon et ai., 2002). They appear to play a role at the bottom of the regulatory cascade. 
They bind to genes in the antibiotic cluster thanks to DNA-binding domain and act as 
transcriptional activator for the genes of this cluster (Wietzorrek and Bibb, 1997). Their 
overexpression often induces antibiotic overproduction (Sheldon et ai., 2002).
Some antibiotic clusters, such as the tylosin one, are more complex in that they possess 
more than one regulatory gene. S. fradiads tylosin cluster actually contains at least five 
regulatory genes, including two SARP-encoding genes: tyiS and tyiT. TylS controls the 
expression of another regulatory gene, tyiR, while TylT does not appear to be essential for 
tylosin production (Bate eta!., 2002).
Another regulatory gene named ciaR is located in the clavulanic acid cluster of 5. 
ciavuiigerus. Its amplification increases clavulanic acid production but strongly represses
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cephamycin C production. Its disruption leads to a higher production of cephamycin C and no 
clavulanic add production. The mutants accumulate clavaminic acid, indicating that daR 
controls genes involved in the late steps of the clavulanic acid pathway (Liras and Rodriguez- 
Garcia, 2000). Paradkar et aL (1998) showed that c/^/?-disrupted mutants lack transcription 
of the genes 0RF7 {oppAl), ORFIO {cyp) and car of the clavulanic acid cluster, whilst the 
early genes ceas2, b!s2, pah2, cas23nà oat2are transcribed independently.
The daR transcript can not be found in cca/?-disrupted mutants, which is consistent with a 
role of CcaR as an activator protein (Liras, 1999). There might be other proteins involved in 
the regulatory cascade between daR and ccaR (Liras and Rodriguez-Garcia, 2000).
The gene oat2 of the clavulanic acid cluster is similar to argJ of the arginine pathway. When 
oat2 \s disrupted, clavulanic acid production is halted in starch-asparagine medium, while it is 
reduced to 40% of the wild-type in soy-based medium (Kershaw etaL, 2002). This is due to 
the presence of the second set of paralogous genes, which cannot be expressed in starch- 
asparagine based medium (Jensen etaL, 2000b).
de la Fuente e t aL (2004) found that both Oat2 and ArgJ present ornithine acetyltransferase 
(OAT) activity, although deletion of oat2 does not affect the total OAT activity in the cell, but 
reduces the production of clavulanic acid under standard culture conditions. They showed 
that Oat2  has a regulatory role that modulates clavulanic acid production in response to 
arginine levels thanks to the ARG box present in oat2. In the wild-type, low arginine 
concentrations (below ImM) stimulated clavulanic acid biosynthesis while high arginine 
concentrations (2.5 to 20mM) resulted in a 2 fold reduction in the production compared to 
the addition of ImM. ûoat2 mutants were not as strongly affected by high arginine 
concentrations and therefore the yields were higher than in the wild-type in the presence of 
high levels of arginine, although they were much lower than in the wild type when no 
arginine is added.
The negative regulation at high levels of arginine could be mediated by a reaction product of 
Oat2 such as N-acetylarginine, which might inhibit carboxyethylarginine utilisation by p-LS 
(cf. Figure 1.9.).
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Figure l.Q.The role of ArgJ In the biosynthesis of arginine.
Adapted from Kershaw e ta l. (2002).
1.3.2.3.6. Cross-regulation
Clavulanic acid biosynthesis can also be increased by abolishing the biosynthesis of other 
secondary metabolites. Paradkar et ai. (2001) managed to increase the clavulanic acid 
production by 2- to 2.5-fold by disrupting the gene of the cephamycin C pathway. Since 
the two pathways are biochemically distinct, the effect could be due to the metabolic 
resources normally used to make lysine, cysteine and valine for cephamycin C biosynthesis 
being spared and redirected towards the production of arginine and 3- 
phosphoglyceraldehyde. It could also be explained by an effect on ccaR of the elimination of 
the metabolites arising from cephamycin C synthesis. Paradkar and his co-workers also 
obtained an increase in clavulanic acid titer by deleting both ia t and cvml, a gene in the 
clavam cluster. Since the production of clavams competes with the production of clavulanic 
acid up to the clavaminic acid stage, it is much easier to understand why preventing S. 
ciavuiigerus fxoxx\ synthesising clavams would be advantageous.
1.3.2.3.7. Conclusion
All the parameters mentioned above are likely to be part of a complex regulatory network 
(Bibb, 1996), but intensive research on antibiotic biosynthesis regulation is still needed in 
order to understand the relationship between the various factors involved.
1.3.2.4. Process conditions
- Inoculum
Like in most organisms, the state of the inoculum is very important for the subsequent 
fermentation. Neves et ai. (2001) demonstrated that inoculating a bioreactor with an
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Inoculum that was still in exponential phase resulted in a shorter lag phase and a higher 
productivity (in pg.mL'\h'^) compared to older inoculums.
- Medium composition
Production of secondary metabolites in streptomycetes is triggered by a decrease in growth 
rate due to exhaustion of one of the nutrients (typically carbon, phosphate or nitrogen). This 
is also the case with S. ciavuiigerus in which clavulanic acid production has been shown to be 
initiated by nutrient limitation and medium composition (cf. 1.3.2.3. Clavulanic acid 
regulation). It was found that the most efficient type of limitation for clavulanic acid 
production was phosphate limitation (Kirk et ai., 2000).
High levels of secondary metabolites production have been obtained using complex media 
with substrates such as soy meal, but it is necessary to use defined medium while studying 
Flux Analysis. In that case, glycerol is usually used as the carbon source, because, as 
discussed before, S. ciavuiigerus is not able to metabolise glucose (Aharonowitz and Demain, 
1978a).
- Effect o f external conditions on clavulanic acid stability
Clavulanic acid is an unsTable compound (Kirk, 2000; Mayer and Deckwer, 1996; Roubos, 
2002). Both temperature and pH seem to have an effect on the extent of this instability. 
Clavulanic acid is more sTable at lower temperature and pH 6.4, getting more and more 
degraded towards acidic and basic conditions (Bersanetti et ai., 2004; Mayer and Deckwer, 
1996; Roubos et ai., 2002). Roubos (2002) found that ammonium and magnesium were the 
medium components that demonstrated the most negative influence on clavulanic acid, while 
Mayer and Deckwer (1996) showed that soy meal seemed to be able to protect clavulanic 
acid, possibly by a physical means.
The degradation has also been shown to occur faster in presence of living cells, implying that 
it is not only degraded by acid-catalysed hydrolysis but also by enzymatic activity (Mayer and 
Deckwer, 1996). Mayer and Decker (1996) suggested that degradation could be partly due to 
the production of p-lactamase by 5. ciavuiigerus as a protection from its own antibiotics.
The exact mechanism of degradation is not yet understood, and this remains a problem for 
the pharmaceutical industry.
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1.4. Metabolic engineering
Westerhoff and Kholodenko (2004) defined metabolic engineering as "the science-based 
alteration of the molecules in and around the living organism with the aim of optimizing both 
its metabolic productivity and its functioning".
The keyword here is 'science-based', involving that the modifications are the results of some 
scientific experiments, unlike the classic random mutations experiments.
Metabolic engineering has successfully been applied to 1) optimise the production of 
metabolites, 2) extend the range of substrates, 3) synthesise novel products, and 4) improve 
an organism's properties such as its capacity to tolerate certain inhibitory substances 
(Stephanopoulos, 1998).
It is important to get a good understanding of the microorganism's metabolism as a whole in 
order to know which pathways, and therefore which genes, to target. Two of the tools that 
can be used for this purpose are Flux Analysis and DNA microarrays. They will be described 
in depth in Chapter 4 and Chapter 5, respectively.
1.5. Aims and objectives of this study
The overall aim of this project was to reach a better understanding of clavulanic acid 
production in Streptomyces ciavuiigerus. In otder to achieve this, two genome-scale 
methods, fluxomics and transcriptomics, were used to study clavulanic acid production both 
in batch and chemostat cultures. Custom microarrays containing about 80 S. ciavuiigerus- 
specific probes, as well as a metabolic network with reactions and biomass composition 
specific to 5. ciavuiigerus, were used in order to obtain relevant data. The advantages and 
drawbacks of fluxomics and transcriptomics will be discussed in the context of this study, and 
the results from batch and chemostat cultures will be compared.
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2.1. Introduction
Microbial cell cultures are often carried out in bioreactors in which the organism of interest is 
given the nutrients necessary for growth and product formation and some parameters such 
as the temperature, the pH and the stirring rate are monitored and controlied. Because of 
the control possible in bioreactors, they represent an ideal environment to study a 
microorganism's physiology and metabolism, unlike flasks or solid medium experiments.
Bioreactors enable the study of an organism's response to changes such as medium 
composition, growth rate, or gene deletion while keeping all the other parameters (pH, 
temperature, dissolved oxygen etc.) constant.
Other advantages of bioreactors include the fact that they allow a much higher culture-to- 
cuiture reproducibility and their automation.
In this study, bioreactors were used in order to study the growth and antibiotic production of 
S. ciavuiigerus in both batch and continuous cultures using Flux Balance Analysis (FBA) and 
DNA microarrays. Batch cultivations were first performed in order to examine the transition 
between the growth phase and the production phase. Continuous cultivations were then 
carried out at two different dilution rates, one supporting high antibiotic production, the 
other supporting low antibiotic production.
2.1.1. Batch culture
Batch culture is a closed culture system in which an initial, limited amount of nutrient is 
available.
The typical growth curve obtained during a batch culture is represented In Figure 2.1.
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Figure 2.1. Typical microbial growth curve in batch culture
The first phase is the lag phase where the organism adapts to its new environment (pH, 
redox, etc.), synthesizes new enzymes to cope with the new nutrients, etc. The growth rate 
is close to zero. Then the exponential, or log, phase starts, where the biomass grows 
exponentially at a constant maximum growth rate (pmax) because there is an excess of 
nutrients.
The exponential phase can be mathematically described by the equation (Stanbury et aL, 
1999):
where x is the concentration of microbial biomass, 
t is time, in hours, 
and pmax is the specific growth rate, in hours ^
The integration of (1) gives:
X, = (2)
where Xo is the original biomass concentration,
and Xt is the biomass concentration after the time interval, t hours.
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On taking natural logarithms, (2) becomes:
In X, = \nxQ + jut (3)
Equation 3 shows that a plot of the natural logarithm of biomass concentration against time 
would yield a straight line, with a slope equal Pmax-
During deceleration phase, the growth rate decreases because the nutrients become 
exhausted and/or the accumulation of waste becomes toxic to the microorganisms. The 
culture then reaches the stationary phase, where growth is even more hindered. The rate of 
growth equals the rate of death and the biomass concentration remains constant (p = 0 ). 
The term 'stationary' is misleading as the culture is only macroscopically stationary. Part of it 
is actually still metabolically active and can produce products called secondary metabolites, 
which are not produced during the exponential phase.
Finally the death phase occurs, effected by complete depletion of nutrients and/or continued 
accumulation of waste products.
2.1.2. Chemostat culture
Chemostat culture is a type of continuous culture characterised by constant and equal 
nutrient feeding and spent medium removal, and in which the concentration of a growth- 
limiting nutrient determines the biomass concentration (cf. Figure 2.2). This technique 
enables the achievement of a steady-state, at which biomass and product concentrations are 
constant. It is therefore possible to set a chosen growth rate.
Chemostat culture is used for processes such as waste-water processing for instance. Apart 
from single-cell protein production, this method is not widely used in the bioindustry but it is 
used in research to study microbial physiology for instance, because it can give a "snapshot" 
of a particular stage of growth of an organism.
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Figure 2.2. Schematic representation of a chemostat
The system and the term chemostat were proposed by Novick and Szilard (1950) while 
Monod (1950) developed simultaneously a virtually identical device that he called 
'bactogène'.
In a chemostat, the flow rate (f, in dm^.h'^) of the media can be set to give the desired 
dilution rate (D, in h'^) such that:
(4)
with V = culture volume, in dm-
C h a p te r  2 . C u lt iv a t io n  o f  S t r e p t o m y c e s c l a  vuLiG ERUsm  B a tch  and  30
C h em o sta t
The change in the culture population is equal to the growth of the microorganisms minus the 
output of microorganisms, which can be mathematically expressed as:
—  = fÀX — Dx (5) dt
or
—  ~ x { fÀ -D )  (6 ) dt
Following the above equation, if the culture's specific growth rate p is higher than the 
dilution rate D, the population will increase until the limiting substrate runs out.
But if p is lower than D, cell density will decrease because the microorganisms are being 
washed out faster than they can grow.
When a dilution rate is first set, the cells will initially grow exponentially as in a batch culture 
at their maximum growth rate Pmax until the limiting substrate runs out, unless the dilution 
rate at which the chemostat has been set is higher than the critical value Dc (where p = 
Pmax). In all other cases, the cells will eventually adjust to the rate of nutrient supply so that 
their specific growth rate is equal to the dilution rate i.e. p = D. Such a balanced growth is 
known as a steady state and dx/dt = 0 .
Monod and his contemporaries (Monod, 1950; Novick and Szilard, 1950) developed the 
mathematical models for microbial growth in continuous culture in the 1940's and 1950%. 
The basic hypothesis of that model is that the specific growth rate is dependent on S, the 
concentration of the growth limiting nutrient, according to the Michaeiis-Menten kinetics 
equation (7).
Ks +S (7)
where Ks is a saturation constant equal to the concentration of the growth limiting nutrient 
when p = 1/2 Pmax.
So when a chemostat is at steady state and p = D:
D - f i
V y
(8)
where Sr is the limiting substrate concentration in the inflowing medium.
C h a p te r 2 . C u lt iv a t io n  o f  S t r e p t o m y c e s c l a v u l ig e r u s ih  B atch  and  31
C h em o sta t
The relation between growth (dx) and substrate utilisation (dS) is (Harder et ai, 1976):
dx weight of organisms formed
dS weight o f substrate consumed 
where Y is the growth yield coefficient.
= r  (9)
The change of substrate concentration dS/dt can be written as:
change = input -  output -  consumption
or, mathematically:
^  = = (10)dt yield Y
where Ss is the steady state concentration of the substrate.
By substituting (7) in (10):
dt = D { S , - S s ) - ^ ^ ^ . (11)
and, by substituting (7) in (6 ):
dx 
dt =  X /^max - D (12)
Since in a steady state, not only dx/dt = 0, but also dS/dt = 0, it is possible to express the 
steady state concentration of the substrate Ss from equation (11 ) and (12):
(13)
and in the same way, the steady state concentration of ceils Xgcan be written from (10) and 
(13):
S r - K ^  . D
Mmax ^  y
(14)
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Figure 2.3. Cell concentration, output of bacteria, doubling time, 
and steady state substrate concentration as a function of the dilution rate
Figure 2.3. shows that the microorganisms concentration is maximal when the dilution rate 
equals 0 and the substrate concentration Ss is also 0. As the dilution rate increases, the cell 
density decreases and the substrate concentration increases. At the critical dilution rate, 
which is about the same at Pmax/ the concentration of organisms becomes 0  and the 
substrate concentration in the chemostat equals the inflowing substrate concentration Sr.
It also shows that chemostat cultivation is only suiTable in the range of dilution rates where 
a small change in D only causes a small change in Xr and Sr.
Monod's model has actually been proven to be in agreement with the majority of 
experimental data (Hoskisson and Hobbs, 2005).
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2.1.3. Continuous culture vs. batch culture
2.1.3.1. Advantages and drawbacks of batch cultivations
First of all, batch cultivations are easy to set up and to perform. They are also the basis of 
most industrial processes (together with fed-batch cultivations). It is therefore interesting to 
study the microorganisms' physiology in these conditions.
The growth cycle in batch cultivation is very well known, making it possible to study the 
microorganism at different growth stages. In continuous culture systems, the terms lag 
phase, exponential phase, stationary phase and death phase have no meaning.
Batch experiments can also be used to explore the timing of gene expression in relation to 
physicochemical changes in the environment for instance. The analysis of the level of gene 
expression at different time points and/or after different environmental changes allows to 
study which genes are involved in the response to the change encountered, which genes are 
co-regulated etc.
However, the growth rate and the environment in batch cultivation are constantly changing, 
making it difficult to study the microorganisms at a very specific stage. Even in the stationary 
phase, the culture is in a highly variable state, and multiple sub-populations can be found, 
some of them dying, some of them growing, and some of them in stasis. This can affect 
experimental reproducibility as a sample taken after the same time from two different batch 
cultivations might not be in the exact same state.
In a transcriptomic study performed in batch culture, it is impossible to isolate the effects of 
the studied parameter from secondary effects such as growth-rate dependent factors (Hayes 
2002).
Finally, adaptation of microorganisms to a change in their environment is not always 
instantaneous. Consequently, a physiological change observed in a batch culture can reflect 
a change in the environment which took place some significant time before the change was 
observed. It can therefore be difficult to relate cause and effect (Stanbury eta!., 1999).
2.1.3.2. Advantages and drawbacks of chemostat cultivations
The main advantage of chemostats is that they allow the study of microorganisms in highly 
defined conditions. As we have seen in 2.1.2., the growth rate and the substrate
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concentration remain constant in a chemostat, and the growth rate can be fixed. This 
enables more statistically significant and more reproducible results, and the possibility to 
differentiate between the physiological and/or transcriptional effects due to the growth rate 
or the stress and the effects due to the studied change (mutation, medium etc.).
Chemostats are also very versatile and allow the study of many variables one after the other. 
Neither batch nor chemostat culture can represent exactly what happens to microorganisms 
in nature but it has been argued (Kovarova-Kovar and Egli, 1998) that chemostat culture in a 
carbon-limited medium may be more relevant for modelling organisms than batch cultivation. 
According to Hoskisson and Hobbs (2005), some natural microbial systems such as the gut 
or the mouth can be considered as similar to chemostats.
Finally, as explained in more details in Chapter 4, flux analysis is facilitated in steady-state 
conditions, which can only be obtained in a chemostat.
On the other hand, it has been demonstrated (Notley-McRobb et al., 2002) that chemostats 
are prone to mutations because they run for much longer than batch culture and apply a 
strong selective pressure on microorganisms by offering an essential nutrient in limiting 
quantity. A spontaneous mutant with a selective advantage over the wild type organism can 
quickly become predominant as the wild type will be washed out. Chemostats are even often 
used to select for higher-production or faster-growing mutants.
Cultures must be closely monitored by microscopy, agar plate culture, cell dry weight 
measurement and assay of the product of interest in order to detect mutations. It is also 
good practice to keep the number of generations to a maximum of 50 (Avignone-Rossa, 
personal communication).
2.1.4. Growth in bioreactors in streptomycetes research
Bioreactors are an invaluable tool for the study of streptomycetes. As explained in Chapter 1, 
streptomycetes undergo many physiological and morphological changes during growth. 
Secondary metabolites are usually produced only In stationary phase or when one of the 
major nutrients has become exhausted. Both batch and continuous cultures have been 
successfully used for the study of different aspects of Streptomycetes physiology.
Kirk et ai. (2000), Avignone-Rossa et ai. (2002) and Bushell et ai. (2006) have all used 
chemostat culture to perform metabolic flux analysis with Streptomyces davuiigerus (Kirk et
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aL and Bushell et al.) and Streptomyces Hvidans (Avignone-Rossa et al.). Kirk et al. 
investigated the effect of the nature of the growth limiting substrate (carbon, phosphate or 
nitrogen), while Avignone-Rossa et al. studied the carbon fluxes in three different strains of 
5. Hvidans at four different growth rates and with two different carbon sources, and Bushell 
et aL used metabolic flux analysis to design a feeding strategy aimed at improving clavulanic 
acid production. However, chemostats do not seem to have been extensively used to study 
transcriptomics in streptomycetes.
Batch cultures have often been used for both flux analysis and gene expression analysis. For 
example, Jonsbu et al. (2001) studied the production of nystatin by Streptomyces noursei in 
batch culture using ^^C-labeling and metabolic flux analysis, and Bum Kim et aL (2004) 
applied metabolic flux analysis to the production of calcium-dependent antibiotic (CDA) by 
Streptomyces coellcolor. Some genome-scale transcriptomic studies were also performed in 
batch culture, such as the study of growth phase-responsive gene expression of antibiotic 
synthetic pathways in Streptomyces coellcolor by Huang et aL (2001) or the comparison of 
gene expression between the wild type and the ùiabsAl mutant of Streptomyces coellcolor b^ / 
Mehra et aL (2006).
Both batch and continuous cultures have their advantages for genome-scale studies. Batch 
cultivation is important because antibiotics are industrially produced that way (Jonsbu et aL, 
2001; Mcdermott etaL, 1993). They also allow the observation of the transition between the 
growth phase and the antibiotic production phase. However, it may be difficult, as it was 
noted above, to differentiate between the effects of the environmental changes independent 
from the antibiotic production and the effects solely due to antibiotic production.
On the other hand, it can be argued that chemostat cultivation is the best way to perform 
flux analysis, as a steady-state is desired. However, pseudo-steady-state can sometimes be 
assumed on batch culture.
Both methods can therefore yield interesting and complementary data, and the use and 
comparison of both of them to perform genome-scale transcriptomic and fluxomic analysis 
can be very useful.
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2,2. Materials and methods
2.2.1. Media composition
Media used in this study were formulated as described in Tables 2.1. to 2.4.
SV2 (per litre)
Glycerol 15g
Glucose 15g
Soya peptone 15g
Calcium carbonate ig
The pH was adjusted to pH 7.0 and the medium was autoclaved
at 121° for 15 minutes.
Table 2.1.: Composition of the SV2 medium
Phosphate-limited medium (per litre)
Glycerol 60g
NH4CI 7g
KH2PO4 0.25g
MOPS 2 lg
The pH was adjusted to pH 6 .8  and the medium was autoclaved 
at 121° for 15 minutes. 10mL/L of filter-sterilised trace 
elements solution were then added.
Trace elements solution (per litre)
MgS04.7H20 25g
FeS04.7H20 2.5g
C0 CI2 0.055g
CUCI2 0.053g
CaCl2.2 H2 0 1.38g
ZnCl2 1.04g
MnClz 0.62g
Na2MoÜ4 0.03g
Table 2.2.: Composition of the phosphate-limited medium
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M5D+ (per iitre)
Dextrin lOg
Yeast extract 2 g
Peptone 2.5g
K2HPO4 ig
MgS0 4 .6 H20 ig
NaCI ig
CaCOs 4g
(NH4)zS04 Ig
The pH was adjusted to pH 7.4 and the medium was autoclaved
at 121° for 15 minutes. ImL/L of filter-sterilised trace elements 
solution was then added.
Trace elements solution (per litre)
MnClz^HzO ig
FeS04.7H20 ig
ZnS04 ig
Table 2.3.: Composition of the M5D+ medium
M5D- (per iitre)
Dextrin lOg
K2HPO4 Ig
MgS0 4 .6 H20 Ig
NaCI ig
CaCOs 4g
(NH4)2S04 ig
Oxoid agar n°3 2 0 g
The pH was adjusted to pH 7.4 and the medium was autoclaved
at 121° for 15 minutes. ImL/L of filter-sterilised trace elements 
solution was then added.
Trace elements solution (per litre)
MnCl2.4H20 ig
FeS04.7H20 ig
ZnS04 ig
Table 2.4.: Composition of the M5D- medium
2.2.2. Culture maintenance
The organism used was Streptomyces davuHgerus KYCC 27064 NRRL 35851. It was obtained 
from SmithKline Beecham (now GlaxoSmithKline).
Spores of S. davuHgerus from a frozen stock were first revived in 25 m l of SV2 broth in a 
250 m l baffled flask placed at 30°C on an orbital shaker at 250 rpm for 24 hours. 2 mL of 
this culture were transferred to 25 mL of M5D+ broth in a 250 mL baffled flask under the 
same conditions. After 24 hours, 100 pL of this culture were spread on M5D- agar plates.
C h a p te r 2 . C u lt iv a t io n  o f  S t r e p t o m y c e s c l a v u l ig e r u s ih  B atch  and  38
Ch em o sta t
These plates were left at 30°C for two to three weeks or until sporulation occurred. 5 m l of 
20 % glycerol + 0.01 % Tween 80 were then pipetted on the plate, and spores were 
scratched using a plastic spreader in order to resuspend them into the glycerol solution. The 
spore suspension was then pipetted into 1.5 mL vials and placed at -80°C.
2.2.3. Inoculum preparation
To eliminate nutrient carry-over into nutrient-limited media, a two-stage inoculation 
procedure was followed. First, the content of one vial of Streptomyces davuHgerus spores 
was thawed at room temperature and inoculated into 25 mL of SV2 broth in a 250 mL 
baffled flask. The flask was placed at 30°C on an orbital shaker at 250 rpm for 24 hours to 
allow the spores to be revived. 4 mL of this culture were then transferred into a 250 mL 
baffled flask containing 50 mL of the cultivation medium, placed in the same conditions. 
After 24 hours, according to previous experiments, the inoculum was assumed to be in 
exponential phase and therefore ready for subculture.
2.2.4. Bioreactor set-up
The bioreactor used in most of this study was a two-litre Discoverer bioreactor (Adaptive 
Biosystems, UK) (cf. Figure 2.4.). The third batch culture (TS3) was run in a 7000 Series 
five-litre bioreactor in order to be able to take more samples (Adaptive Biosystems, UK).
Figure 2.4. Adaptive Biosystems Bioreactor used in this study
The bioreactor settings were monitored and controlled through a computer by the software 
BioDirector by Adaptive Biosystems (UK) (cf. Figure 2.5.).
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Figure 2.5. BioDirector, the software controlling the bioreactor's settings
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Figure 2.6. Set-up of the bioreactor running a batch culture
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Sterile air was supplied to the culture through a sparger placed directly below the impeller. 
The air flow was maintained at 0.25 L.min  ^ in batch (starting volume of 1.8 L) and at 0.18 
L.min'  ^ in chemostat (working volume of 1.13 L) throughout the culture using a MassFlow 
unit (Adaptive Biosystems, UK). The batch culture run in the five-litre vessel was set up with 
a starting volume of 4 L and an air flow of 0.48 L.min \
Dissolved oxygen was monitored with a D140 OxyProbe® oxygen sensor (Broadley James, 
UK).
Mixing was achieved in the two-litre vessel with a Rushton turbine placed close to the bottom 
of the bioreactor (cf. Figures 2.6. and 2.7.). The five-litre bioreactor was set up with one 
Rushton turbine at the bottom and a pitch-blade impeller in the middle of the vessel. In 
batch culture, the stirring rate was initially set at 700 rpm, and increased to a maximum of 
900 rpm during the cultivation in order to keep the dOz over 70%. In continuous culture, the 
stiring speed was kept at 900 rpm throughout the cultivation.
Figure 2.7. Rushton turbine 
Post Mixing WebSite ( http://www.postmixing.com/)
The inlet and oulet gas composition was monitored thanks to a Tandem Dual Gas Sensor unit 
(Adaptive Biosystems, UK). The oxygen sensor was based on electrochemical galvanic action, 
while the carbon dioxide sensor used infrared absorption. The temperature was monitored 
with a temperature probe and regulated at 28°C thanks to a heating device in the vessel. 
The pH was monitored with a Fermprobe® pH electrode (Broadley James, UK) and adjusted 
to pH 6 .8  by automatic additions of 0.5M HCI and 0.5M KOH. A 10% Breox FMT 30 
(International Specialty Chemicals, UK) antifoam solution was manually added on demand to 
the culture in case of excessive foaming.
The bioreactor was autoclaved filled with water for 30 minutes at 121°C. The P-limited 
medium was prepared with 0 .0 1 % antifoam, autoclaved separately and transferred to the 
bioreactor after checking its operational functioning. The medium was inoculated at 5% 
volume and operated as a batch either until clavulanic acid concentration started to decrease 
(when run as a batch culture) or switched to continuous culture after reaching exponential 
phase (cf. 2.1.2. Chemostat culture).
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2.2.5. Biomass dry weight determination
Dry weight determination was carried out in triplicate using 5 mL samples collected on ice. 
Gelman 0.45 pm filters were pre-dried twice five minutes in a microwave oven at 650W 
before being placed in a vacuum desiccator. The filters were then weighed on a precision 
scale and placed on filter paper pads in Petri dishes.
The filter to be used was first soaked with 0.01% Tween 80 to decrease its hydrophobicity 
before being placed on a vacuum filtration device. The filter was initially rinsed with 2x10 mL 
reverse osmosis water before passing the 5 mL sample. The filter was then rinsed with 3x10 
mL reverse osmosis water to remove any soluble medium constituents and placed on the 
filter paper pad back in the Petri dish. The filter was dried again in the microwave oven (2 x 
5 minutes at 650W) before being placed in a vacuum desiccator. It was finally weighed a 
second time and the biomass dry weight was calculated as an average of the three replicates 
and expressed in g.L'\
2.2.6. Substrates and products analysis
5 mL of culture were taken on ice and were immediately filtered through a Sartorius Minisart 
0.2 pm filter. 200 pL of each sample were immediately used for clavulanic acid assay (cf.
2.2.6 .2.) while the remainder was placed in microcentrifuge tubes and kept at -20°C for 
substrates and products analysis.
2.2.6.1. Substrates analysis
2.2.6.1.1. Glycerol
This glycerol assay was adapted from McGowan etaL (1983). It was based on an enzymatic 
reaction.
Glycerol + A T P  Giycerokijmse  ^Glyccrol -3-phosphate + AD?
Glycerol 3-phosphate + oxidase  ^p>jhy(ji.Qxyacetone Phosphate + H jO j
H jO j + 4-aminoantipyrine+p-chlorophenol Pgrpxidase  ^ HjO-t-Quinonimine
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The increase in absorbance at 510 nm due to quinonimine production is directly proportional 
to the amount of glycerol present.
Glycerol standards were prepared at 0, 0.1, 0.25, 0.5, and 1 g.L'\ The samples were diluted 
in reverse osmosis water in order to reach glycerol concentrations no higher than 1 g.L'\
The enzyme mixture composition is shown in Table 2.5.
Tris-HCI pH 7.4 50 mM
Glycerokinase (Sigma) 500 U.L^
Glycerol-P oxidase (Sigma) 1500 U.L*'
Peroxidase (Sigma) 1000  U.L'^
4-aminoantipyrine 0.2 mM
ATP 0.75 mM
MgClz 3.75 mM
Triton X-100 2  pL.L-'
p-chlorophenol 2.11 mM
Table 2.5. Composition of the enzyme mix for glycerol analysis
1 mL of the enzyme reagent was mixed with 10 pL of the sample/standard and incubated for 
10 minutes at 30°C. The absorbance was read at 510 nm and the glycerol concentration in 
g.L  ^was calculated from a glycerol standard curve.
2.2.6.1.2. Ammonia
This ammonia assay was adapted from Mondzac etaL (1965). It was based on the following 
enzymatic reaction:
2-Oxoglutarate +  N H , +  N A D H  Dehydrogenase > Glutamate +  N A D
The oxidation of NADH into NAD causes a decrease in absorbance at 340 nm that Is directly 
proportional to the sample ammonia concentration.
Samples were diluted in order to contain a maximum of 300 pM NH4CI.
The reagent was prepared as shown in Table 2.6.
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Tris buffer pH 8 , 0.5 M 200 pL
2-oxoglutarate 0.1 M 100 pL
NADH 8  mM 30 pL
Sample (max 300 pM NH4CI) /  Standard (0, 
100, 200 and 300 pM NH4CI) 500 pL
RO water 150 pL
Table 2.6. Composition of the reagent mix for ammonium analysis (per cuvette)
The absorbance at 340 nm was recorded before adding 20 pL L-Glutamate Dehydrogenase 
(>900 U/mL, Sigma). The absorbance at 340 nm was recorded again after 90 minutes. The 
increase in absorbance was calculated and used to determine the concentration of 
ammonium in g.L"^  using an ammonium chloride standard curve.
2.2.6.1.3. Phosphate
The phosphate assay was adapted from Rouser et aL (1970). It was based on the following 
chemical reactions;
Phosphate + Ammonium Molybdate + Antimony Potassium Tartrate 
4gf4Condition_s  ^Antimony-phosphomolybdate complex > Blue Complex
The antimony-phosphomolybdate complex is reduced by ascorbic acid to form an intensely 
blue complex with a maximum absorbance at 880 nm. The absorbance at 880 nm is directly 
proportional to the concentration of phosphate in the sample.
The reagent was prepared as detailed in Table 2.7.
0.1 M ammonium molybdate 3 mL
5 N sulphuric acid 10 mL
0.1 M ascorbic acid 6  mL
0.0084 M potassium antimonyl tartrate 1 mL
Table 2.7.: Composition of the reagent mix for phosphate analysis
This reagent was sTable for 4 hours. Standards of KH2PO4 at 0, 0.75, 1 and 1.5 mg.L'^ were 
prepared. If required, samples were diluted to reach a maximum concentration of 1.5 mg.L'^
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KH2PO4. 800 pL of the standard/sample were mixed with 200 pL reagent, and the 
absorbance at 880 nm was read after 10 minutes at room temperature. The phosphate 
concentration was then calculated in g.L'\
2.2.6 .2. Clavulanic acid analysis
Clavulanic acid concentration was determined using a spectrophotometric assay based on the 
derivatisation reaction with imidazole (Bird etaL, 1982).
Standards of clavulanic acid at 0, 10, 25 and 50 mg.L'  ^ were prepared using potassium 
clavulanate provided by Fermic (Mexico). The samples were diluted with reverse osmosis 
water when necessary to obtain a maximum clavulanic acid concentration of 50 mg/L. 
Clavulanic acid was derivatised using a 10% (W/V) solution of imidazole pH 6 .8 . The 
compound formed (l-(4-aza-8-hydroxy-6-oxo)-oct-2-en-l-oylimidazole) has a maximum 
absorbance at 311 nm that is proportional to the amount of clavulanic acid in the sample.
Two cuvettes were prepared for each sample/standard:
- A: 200 pL sample/standard + 800 pL imidazole
- B (sample blank): 200 pL sample/standard + 800 pL water
The cuvettes were mixed by inversion and incubated at 30°C for 12 minutes. The 
absorbance was read at 311 nm and clavulanic acid concentration in mg.L'^ was calculated 
based on the difference between the absorbance of A and B for each sample/standard.
2.2.7, Rates calculation
p and production and consumption rates in the batch cultures were calculated by performing 
curve fitting on the data sets (with the amounts of products and substrates in mmol.L'^) and 
then computing the first derivative of the curve's equation at the different time-points, giving 
a production/consumption rate in m m o l .L ' \hus ing  the software TableCurve2D (Systat 
Software Inc.). The production/consumption rates could then be divided by the biomass dry 
weight at that particular time point in order to yield a specific production/consumption rate in 
mmol.h'\g biomass'^
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In chemostats, |j was equal to the dilution rate, as explained above. To obtain the production 
and consumption rates of the different substrates and products, the amount produced or 
consumed in mmol.L'^ was simply multiplied by the dilution rate, giving a 
production/consumption rate in mmol.L'\h' \  which could then be divided by the biomass dry 
weight in order to yield a specific production/consumption rate in mmol.h'\g biomass \
2.3. Results and discussion
2.3.1. Medium development
The medium used initially was the one previously developed in this laboratory to give the 
best clavulanic acid production (Kirk, 2000). This phosphate-limited medium had the same 
composition as the one described in 2 .2 .1 ., but contained only 0 .1  g.L^ instead of 0.25 g.L^ 
KH2PO4. The growth curve observed using this medium is shown in Figure 2.8.
Cell dry weight, clavulanic acid and substrates concentration
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Figure 2.8. Biomass, clavulanic acid and substrates concentration in phosphate-limited medium before 
optimisation. The error bars represent + /-  standard deviation of three replicates.
Figure 2.8. shows that this medium was phosphate-limited because phosphate became 
depleted after only 40 hours while not even half of the glycerol and the ammonium had been 
used by the culture when death phase was reached. The growth profile was very similar to 
the one obtained by Kirk (2000) using the same medium and the same strain. Kirk reported a
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maximum biomass concentration of 1.5 g.L'  ^and a maximum clavulanic acid concentration of 
30 mg.L \
However, the biomass dry weight (maximum of 1.4 g.L'^) and the clavulanic acid 
concentration (maximum of 35 mg.L'^) were quite low, which made it difficult to assay them 
precisely and would have made it necessary to take large samples for microarray or biomass 
composition analysis. Therefore, a higher phosphate concentration was necessary in order to 
obtain higher biomass and clavulanic acid concentrations, while remaining under phosphate 
limitation as this is the condition under which clavulanic acid is best produced.
In this medium, glycerol and ammonium were in large excess. Between 0 and 140 h, their 
consumption remained fairly linear, enabling us to calculate how much of each substrate was 
consumed per unit of time. Assuming linearity of consumption, glycerol was consumed at a 
rate of about 0.1 g.L'\ NH4CI was consumed at a rate of about 0.012 g.L'\ and KH2PO4 was 
consumed at a rate of about 0.02g.L'\ Only 35% of the glycerol and 30% of the ammonium 
were consumed over the 240h of culture whereas all the phosphate was consumed within 40 
hours, indicating that the medium is truly phosphate-limited and that both the glycerol and 
the ammonium are in large excess. It was therefore decided to increase the phosphate 
concentration to 0.25 g.L^ KH2PO4, which would yield sufficient biomass and clavulanic acid 
for the different assays, if biomass dry weight and clavulanic acid concentration followed a 
proportional increase. In these conditions, phosphate should be consumed over a maximum 
of 100 h, when ammonium and glycerol are still largely in excess. This calculation is based 
on the assumption that the consumption rates of ammonium and glycerol do not change 
when the phosphate concentration changes.
The growth curve obtained with the same medium but with 0.25 g.L^ KH2PO4 instead if 
O.lg.L"^ is shown in Figure 2.9.
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Cell dry weight, clavulanic acid and substrates concentrations
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Figure 2.9. Biomass, clavulanic acid and substrates concentration in the improved phosphate-limited medium. The 
error bars represent + /-  standard deviation of three replicates.
It can be seen on this curve that the medium was stiii phosphate-limited as phosphate was 
consumed after 90-100 h whereas glycerol and ammonium still remained in excess by the 
end of the culture. Biomass maximum concentration was increased from 1.4 g.L^ to 4 g.L'  ^
(2 .8 -fold increase) while clavulanic acid maximum concentration was increased from 35  
mg.L'  ^ to 110 mg.L'  ^ (3.1-foid increase). The increase in clavulanic acid concentration was 
even higher than the increase in biomass, suggesting that this improved medium 
composition might be even more appropriate for clavulanic acid production. Glycerol and 
ammonium were still in excess compared to phosphate, because over a third of their initial 
amount was left at the end of the culture. It was important that neither glycerol nor 
ammonium became limiting, as it would not have supported an extensive clavulanic acid 
production. The biomass dry weight and the clavulanic acid concentration being satisfactory 
at this point, the medium was not further modified.
2.3.2. Batch cultivations
Using the modified medium described above, three replicate batch cultivations were run to 
analyse the changes in metabolic fluxes, using flux analysis, and in gene expression, using
C h a p te r 2 . C u lt iv a t io n  o f  S t r e p t o m y c e s c l a v u l ig e r u s ih  B atch  and
C h em o sta t
48
DNA microarrays (cf. Chapters 4 and 5). Biomass dry weight, biomass macromolecular 
composition, and extraceiiuiar metabolites measurements were aiso performed (cf. Chapter 2 
and 3). These three batch cuitivations wiii be referred to as TSl, TS2 and TS3 (where TS 
stands for time-series).
From the anaiysis of the time courses, it can be observed that there are different phases in 
the growth of S. davuHgerus. These different phases correspond to different physiologicai 
states (different growth rates and different ciavulanic acid production rates), and must 
therefore correspond to different metaboiic fluxes and gene expression proflies. Sampies 
were hence taken during these different phases. On the foliowing graphs, the verticai red 
lines represent the time-points chosen to study transcriptomics and fluxomics.
2.3.2.1. Resuits from batch experiment TSl
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Figure 2.10. Biomass, clavulanic acid and substrates concentration in T S l. The error bars represent + /-  standard
deviation of three replicates.
Sampies for microarray anaiysis were taken at 14.5 h, 38.5 h, 66.5 h, 86.25 h, 138 h and 
214 h after inocuiation, as iilustrated on Figure 2.10.
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The 6 chosen time-points corresponded to the main stages of S. davuHgerus growth and 
clavulanic acid production:
- T1 (14.5 h): lag phase (no growth, no clavulanic acid production);
- T2 (38.5 h): exponential phase (fast growth, no clavulanic acid production);
- T3 (66.5 h): end of exponential phase (fast growth, slow clavulanic acid production);
- T4 (86.25 h): deceleration phase (slowing growth, fast clavulanic acid production);
- T5 (138 h): stationary phase (no growth, fast clavulanic acid production);
- T6 (214 h): end of stationary phase (no growth, no clavulanic acid production).
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As it can be observed on the above graph, p, glycerol, O2 and CO2 production/consumption 
rates all peak together at about 50 h, which corresponds to the middle of the exponential 
phase. Clavulanic acid production rate only peaks after around 90 h, during the deceleration 
phase, after the phosphate has been depleted and growth has stopped due to phosphate 
depletion.
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Sample # 1 2 3 4 5 6
Time (h) 14.5 38.5 66.5 86.25 138 214
Clavulanic acid concentration 
(mg.L^) 0.86 1.37 6.81 20.36 78.39 115.27
CA specific production rate 
(mmol.h'\g biomass'^ ) 0 5.4x10'* 7.7x10'* 1.4x10^ 9.9x10"* 0
Biomass (g.L' )^ 0.13 0.55 2.70 3.52 4.50 3.64
M (h ') 0.020 0.089 0.023 0.008 0.002 0
Glycerol (g.L' )^ 57.78 55.24 48.67 42.43 28.64 19.19
Glycerol specific utilisation rate 
(mmol.h"\g biomass’ )^ 4.41 3.27 1.19 1.01 0.42 0.35
O2 specific consumption rate 
(mmol.h'\g biomass'^ ) 0.94 3.42 2.39 1.93 1.41 1.28
CO2 specific production rate 
(mmol.h'^g biomass'^ ) 2.29 3.48 1.96 1.70 1.14 0.68
Carbon balance 22 .86% 68.25% 78.37% 66.41% 95.74% 65.36%
Table 2.8.: Main results of T S l
The carbon balance, which measures the difference between the carbon input and carbon 
output, was calculated, to check whether most of the carbon had been taken into account. 
For instance, if 0.25 Cmol (moles of carbon) of glycerol is used, and the culture produces 
0.20 Cmol CO2, 0.001 Cmol clavulanic acid and 0.007 Cmol biomass, the carbon balance will 
be:
0.20 + 0.001 + 0.007
0.25 = 0.832 = 83.2%
The biomass was considered having a weight of 27.59 g.Cmol'\ by using the formula 
CH1.82O0.62N0.21P0.02S0.02 proposed by Roubos (2002) and changing the percentage of ash from 
6% to 1% (cf. Chapter 3).
At most time-points, the carbon balance did not close completely, which is often the case in 
batch cultures, where the measurements are made in a constantly changing environment. 
The carbon balance closed best in late exponential and stationary phases. In the early 
phases, the measurements are more prone to error as the biomass and the clavulanic acid 
concentrations, as well as the changes in glycerol utilisation rate and CO2 production rates 
are very low. In the late stationary phase, the carbon balance does not close well either, 
possibly because of cell lysis.
The effects of carbon balance will be discussed further in this Chapter.
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2.3.2.2. Results from batch experiment TS2
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Figure 2.12. Biomass, clavulanic acid and substrates concentration in TS2. The error bars represent + /-  standard
deviation of three replicates.
N.B.: The first two points of the phosphate assay were discarded as they gave abnormal 
results.
Similarly to TSl, samples were taken at 7 chosen time-points corresponding to the 6 main 
stages of S. davuHgerusqrovAh and clavulanic acid production:
- T1 and T2 (14 h and 38 h): lag phase - no growth, no clavulanic acid production;
- T3 (51 h): exponential phase - fast growth, no clavulanic acid production;
- T4 (67.5 h): end of exponential phase - fast growth, slow clavulanic acid production;
- T5 (86.25 h): deceleration phase - slowing growth, fast clavulanic acid production;
- T6  (121.5 h): stationary phase - no growth, fast clavulanic acid production;
- T7 (181.5 h): end of stationary phase - no growth, no clavulanic acid production.
That particular batch culture exhibited a longer lag phase than usual, which is why two 
samples were taken during that first phase. A longer lag phase is usually due to an inoculum
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in a different growth phase from the usual (either too early in its exponential phase or too 
late in its stationary phase).
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Figure 2.13. Calculated rates of TS2.
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Again, p, glycerol and CO2 consumption/production rates all peaked during exponential 
phase. Surprisingly, 0% consumption only peaked slightly later, during the deceleration 
phase, together with clavulanic acid production. This could be due to a problem with the gas 
analyser, because O2 uptake rate is expected to peak at the same time and at about the 
same level as CO2. Indeed, RQ, the respiratory quotient (CO2 production rate/0 2  uptake 
rate), of 5. davuHgerus growing on glycerol equals about 0.8 (Baptista-Neto et a!., 2000). 
Here, CO2 peaks after 40h at 2.17 mmol.h'\g biomass'  ^whereas O2 only peaks after 90h at 
1.12 mmol.h'\g biomass'\ The RQ remains higher than 1 during the whole culture, 
indicating an atypical culture, or, a gas analyser malfunction. Since RQ should be the same 
when the same medium is used, the difference probably comes from a malfunction or a 
incorrect calibration of the gas analyser. Again, at most time-points, the carbon balance did 
not close properly. It closed best around late exponential phase and stationary phase 
(although it is still very low) and worst in early and late samples.
C h a p te r 2 . C u lt iv a t io n  o f  S t r e p t o m y c e s c l a v u l ig e r u s ih  B atch  and
C h em o sta t
53
Sample # 1 2 3 4 5 6 7
T im e (h ) 14 38 51 67 .5 86 .25 121.5 181.5
Clavulanic acid concentration  
(m  g.L ' ) 0 .90 0 .9 0 0 .9 0 6 .1 8 28 .47 87 .10 143.13
CA specific production rate  
(m m o l.h '\g  biomass'^) 0 0 0 2x10^ 3x10^ 2x10^ 2x10"*
Biomass (g .L ‘ )^ 0 .20 0 .2 8 0 .7 7 1.92 3.00 3 .6 7 3 .66
M (h-^) 1x10^ 0 .0 60 0 .0 76 0 .0 37 0 .0 1 4 0 .001 0
Glycerol (g.L'^) 54 .92 5 6 .14 54 .90 51.41 46 .41 38 .53 29 .28
Glycerol specific utilisation  
rate (m m o l.h '\g  biomass'^) 0 1.18 2 .20 1.43 0 .9 6 0 .52 0 .7 5
O 2 specific consumption rate  
(m m o l.h '\g  biomass'^) 0 0 0 1.05 1.12 0 .7 6 0 .51
CO2 specific production rate  
(m m ol.h  \ g  biom ass^) 0 .7 7 2 .1 7 1.69 1.63 1.41 1.02 0 .81
Carbon balance N/A 12 3% 6 7 % 70 % 6 7 % 7 0 % 3 6 %
Table 2.9. Main results of TS2
2.3.2.3. Results from batch experiment TS3
As explained in 2.2., TS3 batch experiment was run in a five-litre bioreactor. This allowed 
more frequent sampling without changing the volume too drastically.
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Figure 2.14. Biomass, clavulanic acid and substrates concentration in TS3. The error bars represent + /-  standard
deviation of three replicates.
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In that third time-series experiment, I tried to capture more data during the transition 
between primary metabolism and secondary metabolism. Therefore the bioreactor was 
sampled every 6  hours between 25h and 55h (cf. Figure 2.14.).
The first sample T1 was taken during lag phase. The next 6  samples (T2 to T7) were taken 
during exponential phase and during deceleration phase, when clavulanic acid starts being 
produced. Therefore, they were taken at 6  hours interval, in order to get a good picture of 
the transition from primary to secondary metabolism. Nine more samples were then taken, 
covering the end of the deceleration phase (T8 , T9 and TIO), the stationary phase (T i l,  T12 
and T13) and the end of the stationary phase, when clavulanic acid stops being produced 
(T14, T15 and T16).
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Figure 2.15. Calculated rates of TS3
As in TSl, p, glycerol, O2 and CO2 consumption/production rates all peaked during 
exponential phase, while clavulanic acid production rate only peaked during deceleration 
phase.
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Sample # 1 2 3 4 5 6 7 8
Tim e (h) 13.5 25 31 37.25 43.5 49.25 55.5 64.25
Clavulanic add  
concentration 
(mg.L'^)
1.59 1.98 2.30 3.62 8.59 21.37 48 .99 94.45
CA specific 
production rate  
(m m o l.h '\g  
biomass^)
9 .1x10" 2 .9x10" 5 .4x10" 1.4x10-3 3.5x10-3 6.6x10-3 9.4x10-3 6.9x10-3
Biomass (g.L^) 0.25 0.55 0.88 1.37 1.97 2.47 2.87 3.16
jj (h'^) 0.056 0.078 0.077 0.066 0.048 0.032 0.017 0.006
Glycerol (g.L“^ ) 55.73 54.64 53.40 51.33 48.28 45.05 42.22 39.96
Glycerol specific 
utilisation rate 
(m m o l.h '\g  
biomass'^)
1.39 3.19 3.21 3.24 3.05 2.35 1.36 0.65
O2 specific 
consumption rate  
(m m o l.h '\g  
biomass'^)
4 .34 2.99 2.80 3.30 3.34 2.61 2.02 1.65
CO2 specific 
production rate 
(m m o l.h '\g  
biomass’ )^
2.07 2.53 2.58 2.69 2.69 2.29 1.79 1.47
Carbon balance 98 .90% 55 .81% 55 .56% 52 .37% 48 .79% 49 .35% 60 .71% 89 .36%
Table 2.10. Main results of TS3, part 1
Sample # 9 10 11 12 13 14 15 16
Tim e (h) 73.25 85.25 96.75 109.25 120.25 133.25 157 181
Clavulanic add  
concentration 
(m  g.L-^)
123.56 148.82 171.43 192.52 204.80 213.55 222.79 189.95
CA specific 
production 
rate (mmol.h- 
\ g  biomass'^)
3.7x10*3 3.0x10-3 2.8x10*3 2.0x10*3 1.2x10*3 7 .8x10" 0 0
Biomass (g.L"^) 3 .26 3.32 3.39 3.49 3.58 3.68 3.78 3.68
M (h ') 2.1x10-3 1.4x10-3 2.0x10*3 2.4x10*3 2.4x10*3 1.9x10*3 7.9x10*3 0
Glycerol (g.L'^) 38 .44 36.39 34 .20 31.67 29.42 26.82 22.37 18.41
Glycerol 
specific 
utilisation rate  
(m m ol.h -\g  
biomass-^)
0 .54 0.59 0.63 0.64 0.62 0.58 0.51 0.45
O2 specific 
consumption 
rate (mm ol.h' 
\ g  biomass^)
1.51 1.45 1.41 1.37 1.32 1.25 1.09 0.86
CO2 specific 
production 
rate (m m ol.h’ 
\ g  biomass'^)
1.40 1.39 1.34 1.26 1.18 1.13 1.11 0.83
Carbon
balance 93 .22% 82 .01% 75 .38% 71 .12% 69 .17% 69 .22% 72 .70% 61 .07%
Table 2.11. Main results of TS3, part 2
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Again, at most time-points, the carbon balance does not close properly, except for the late 
exponential and stationary phase samples. The meaning and consequences of a carbon 
balance not closing properly will be discussed further In this Chapter.
2.3.2.4. Comparison of the time courses
In all three time courses, the production of clavulanic add started when the phosphate 
became exhausted from the medium. This phenomenon was expected and had been 
reported before (Kirk, 2000; Roubos, 2002).
Biomass concentration in the three time courses
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Figure 2.16.: Biomass concentration in the three time courses. The error bars represent + /-  standard deviation of
three replicates.
Figure 2.16. shows that the biomass dry weight is reasonably reproducible between the three 
time courses. The main difference Is the length of the lag phase. This Is usually due to a 
difference In the state of the inoculum. If the inoculum is in exponential phase, and therefore 
actively growing. It will be able to adapt quickly to the new medium and start growing
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immediately. But if the inoculum is in stationary phase, it will first have to start synthesizing 
new enzymes before being able to start growing on the new medium.
The difference could also be due to the amount of time the inoculation took. Between the 
moment the inoculation flask is taken from the shaker at 30°C and the moment the inoculum 
gets into the bioreactor, the inoculum can undergo considerable stress due to lack of 
oxygenation and a lower temperature and can consequently require a longer recovery time.
Clavulanic acid concentration in the three time courses
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Figure 2.17.: Clavulanic acid concentration in the three time courses. The error bars represent + /-  standard
deviation of three replicates.
Unlike the biomass concentration, the clavulanic acid concentration was not very 
reproducible between the three time courses. The difference between TSl and TS2 was not 
very high, but the concentration in TS3 was almost twice the concentration in TSl.
The difference between TSl and TS2 could partly be explained by the improvement with 
time of the sampling technique. As stated in the first Chapter, clavulanic acid is a very 
unsTable molecule. It degrades even when refrigerated or frozen, and degrades even faster
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at room temperature. The presence of live microorganisms also causes a faster degradation. 
Therefore, the more time there is between the moments the sample is taken and the 
clavulanic acid assay is performed, the more degradation of the molecule there will be. 
Secondly, the cell bank was prepared from several sporulating plates. It is possible that the 
microorganisms on the different plates, and therefore in the different vials of the cell bank, 
possessed slightly different capabilities to produce clavulanic acid.
Finally, TS3 was run in a five-litre bioreactor instead of a two-litre one. This suggests that 
growing 5. davuHgerus in a larger tank enables much higher clavulanic acid concentration 
despite obtaining a similar biomass concentration. It is not uncommon to see this type of 
effect when scaling up the production of antibiotics.
2.3.3. Chemostats
Using the results from the batch cultures (cf. Table 2.12.) and from previous projects in the 
laboratory (Kirk, 2000), It was decided to compare two dilution rates, D = 0.02 and D = 0.05 
h'S that would support respectively a high and a low production rate of clavulanic acid.
As explained in Chapter 1, a low growth rate triggers the stringent response, which in turns 
can trigger antibiotic production. That was confirmed by the results obtained in the three 
time courses as illustrated Table 2.12.
Growth rate
Batch # 0.02 h i 0.05 h'l
TSl 8 x10^ 6x10^
TS2 2.25x10'^ 1.25x10-3
TS3 7.5x10^ 3x10-3
three time courses at the two dilution rates chosen for the chemostat culture
Chemostats at D = 0.02 h'  ^ were the runs named LI, L2 and L3, where L stands for low 
growth rate, and the chemostats at D = 0.05 h"^  were the runs HI, H2 and H3, where H 
stands for high growth rate.
The samples were taken after at least four volume changes.
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2.3.3.1. Chemostats' main results
Dilution
Rate
(h -')
Biomass
( g .L ')
Clavulanic 
Acid (m m ol. 
gD W  \  h ^ )
Glycerol
(m m ol.
g D W Lh -^)
C 0 2
(m m ol.
gDW -Lh-^)
O 2
(m m ol.
g D W -\h -^ )
L I 0 .0 2 3.3 4.3x10-3 0.73 1.08 1.23
L2 0.02 3 .3 4.1X10-3 0.67 0 .81 1.16
L3 0 .0 2 3 .5 3.4X10-3 0 .77 0 .9 4 1.3
H I 0 .0 5 2.3 3.2X10-3 0 .98 2 .4 4 3 .1 5
H2 0.05 2.3 2.7X10-3 1.66 2 .06 2 .5 7
H3 0 .05 2 .4 2.7X10-3 1.57 2 .03 2 .4 8
Average 0 .0 2  h'^ N/A 3 .3 7 3.9X10-3 0 .72 0 .9 4 1.23
Standard  
deviation 0 .0 2  h'^ N /A 0.12 4.7X10-"^ 0 .0 5 0 .1 4 0 .0 7
Average 0 .0 5  h'^ 
(w ith o ut H I ) N /A 2.35 2.7X10-3 1.61 2 .0 4 2 .53
Standard  
deviation 0 .0 5  h'^ 
(w ith o ut H I )
N /A 0 .0 7 0 0 .06 0 .02 0 ..6
Table 2.13.: Main measured and calculated parameters of the 6 chemostats. H I  
data for the 0.05 h'  ^ dilution rate as It gave abnormal
was not Included In the average 
data.
As it can be observed from the above Table, the values obtained from the triplicate 
chemostats are reasonably close, except for HI, which shows quite different values for 
glycerol, CO2 and 0 % production and consumption rates from the values obtained for the 
other two replicates H2 and H3. The problem could come from a sampling error, and/or a 
mutation, and/or an error in the gas analyser data, although each reason on its own does 
not seem sufficient to explain the large differences obtained with HI. It was therefore 
decided not to use it to calculate the average values for each dilution rate (cf. Table 2.13.).
2.3.3.2. Chemostats' carbon balances
Carbon output
Carbon
input Carbon balance
Biomass
(Cmol)
Clavulanic
Acid
(Cmoi)
C02
(Cmoi)
Giycerol
(Cmoi) in ®/o in Cmol
L I 0 .1 2 0 0.0056 0.178 0.360 84.14% -0.057
L2 0 .1 2 0 0.0055 0.134 0.331 78.32% -0.072
L3 0.127 0.0048 0.164 0.407 72.69% -0 .1 1 1
H2 0.083 0 .0 0 1 0 0.095 0.230 77.95% -0.051
H3 0.087 0 .0 0 1 0 0.097 0.226 82.09% -0.040
Table 2.14.: Carbon balances for the 6 chemostats. Cmol stands for moles of carbon
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For all the chemostats, the carbon balance fell between 72% and 84%, which is an 
accepTable value. It means that between 16% and 28% of the carbon used does not go 
towards any quantified product. In our case, the unknown products are probably some 
organic acids (the culture's pH tends to drop during growth), and/or possibly an extracellular 
polysaccharide, as suggested by Kirk (2000). Part of the error could also be explained by the 
lack of accuracy of the CO2 detector. The meaning and consequences of a carbon balance 
not closing completely will be discussed further In this Chapter.
2.4. Summary
We ran three batch cultivations and two triplicate chemostats at two dilution rates in order to 
perform transcriptomics and Flux Balance Analysis (FBA) on them.
We obtained a very good reproducibility between chemostats at the same dilution rate, 
except for HI which showed very different glycerol, CO2 and O2 values. It was therefore 
decided to discard HI. In the following Chapters, the average data for the two dilution rates 
will be used as the chemostats are so reproducible.
The batch cultures all showed the same trends but some parameters such as maximum 
clavulanic acid production or length of the lag phase varied quite a lot between batches. It 
was therefore decided to treat the three batch cultures separately, in order to take into 
account their differences, because they can not be averaged like chemostats. These three 
technical replicates will actually have the advantage of representing a wide range of growth 
rates and clavulanic acid production rates, potentially providing a better Insight into the gene 
expression and flux partition of 5. davuHgerus éwfmq the different growth stages.
Batch culture is a very interesting tool to study the temporal transcription as well as the co­
expression of genes. It is more difficult to apply FBA to them because the measurements 
taken only represent transient states.
Chemostat is also an interesting tool for transcriptomics, because it enables one to look at a 
particular set of conditions in an accurate and reproducible manner, and compare it to 
another set of conditions. Chemostats are also very easy to use for FBA because they reach
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a steady state at which it is easy to determine the carbon going in and the carbon going out 
of the system.
In both batch and chemostat culture, the clavulanic acid production rate was higher when 
the growth rate was lower, as it was expected. The clavulanic acid production rates obtained 
in chemostat cultures were actually of the same order as the ones obtained in the 
corresponding phases of the batch cultures. This shows that batch cultures can be 
successfully used to choose conditions for chemostat culture.
The carbon balances in batch did not close. Unfortunately, the CO2 measurement provided 
by the gas analyser was not very reliable. Our organism also probably produces other 
external metabolites that we have not taken into account such as some other antibiotics, 
organic acids or polysaccharides. In the early stages of a batch culture, the organism also 
uses a lot of carbon in order to produce new enzymes in order to adapt to its new conditions. 
However, this is not a problem in Flux Balance Analysis, as that particular method does not 
require having a closed carbon balance.
C h ap ter 3 
Biomass M ac ro m o le cu la r  
Com position o f  
S tr epto m yc es
CLAVULIGERUSM\D ITS
Effect on Flux Balance
A n a ly sis
Contribution of the different biomass components to the totai 
biomass in batch cuiture100%
□  Galactosef  70%
□  T re ha lose
Protein
& 10%
Time (h)
C h a p te r 3 . Biomass M a c ro m o le c u la r  C om position  o f  S tr epto m yc e s  62
CLAVULIGERUSkHO ITS EFFECT ON FLUX BALANCE ANALYSIS
3.1. Introduction
It is well known that Streptomyces spp. experience many physiological changes 
during growth, including changes in the biomass composition. For example, Packter 
and Olukoshi (1995) showed that Streptomyces spp. can accumulate lipids up to 
80% of their cell volume In stationary phase. Miguélez et al. (1997) also showed that 
S. antlbiotlcus can accumulate up to 15% glycogen following nitrogen starvation.
When performing flux balance analysis or metabolic flux analysis (cf. Chapter 4), it is 
necessary to determine the biomass macromolecular composition since most of the 
carbon going through the metabolic pathways will be incorporated into any of the 
several biomass components. Therefore, it is important to be able to provide the 
most accurate biomass composition as possible, as an error there will reflect in an 
incorrect net flux calculation.
Since it is often difficult to measure accurately all the biomass components, most 
studies use a standard and constant composition throughout the growth stages, 
based on microorganisms such as E coH (Avignone-Rossa et a!., 2002; Zhu et a!., 
1998). However, it has been shown that the biomass composition can have 
repercussions on the calculated metabolic fluxes (Jaques, 2004; Roubos, 2002). 
Jaques (2004) showed that, in Saccharopoiyspora erythraea, it is necessary to take 
into account the changing biomass composition when performing Metabolic Flux 
Analysis in stationary phase. Roubos (2002) also showed that, when using an 
average biomass composition instead of a specific one while performing Metabolic 
Flux Analysis on S. davuHgerus, he obtained an unsatisfactory fit using the Chi- 
square test. Therefore, this Chapter will describe the determination of biomass 
components in batch and chemostat cultivations of 5. davuHgerus and how the cell 
composition can affect the results of flux analysis.
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3.2. Materials and methods
3.2.1. Elemental and macromolecular composition analysis
Samples for elemental and macromolecular analysis were obtained from a dedicated 
and typical batch culture as well as from the chemostat cultures. During batch 
culture, lOOmL samples were taken every 24h on ice, then centrifuged at 13,000 g 
for 15 minutes at 4°C and washed twice with chilled RO water. The pellets were then 
frozen at -80°C before being freeze-dried in an Edwards Modulyo freeze-dryer and 
kept in a vacuum dessicator.
The composition of the biomass was determined from the freeze-dried pellets.
3.2.1.1. Elemental analysis
Carbon (C), hydrogen (H) and nitrogen (N) composition of freeze-dried biomass was 
determined using a CHN elemental analyser CE-440 (Exeter Analytical).
3.2.1.2. DNA assay
The DNA assay was based on the acetaldehyde and diphenylamine method (Burton, 
1956).
First of all, the DNA was extracted by incubating 50 mg biomass in 4mL HCIO4 (60%) 
at 70°C for 15 minutes. The sample was then centrifuged and the protocol was 
repeated on the supernatant until no pellet was found after centrifugation.
The reagent was prepared by adding lOOpL acetaldehyde (1.6%) to 20mL 
diphenylamine reagent (1.5g diphenylamine with 1.5mL concentrated H2SO4 in 
lOOmL glacial acetic acid). ImL of standard was mixed with 2mL reagent and 
incubated at 30°C for 17 hours. The absorbance was then measured at 600nm and 
the DNA content was calculated using calf thymus DNA standards (Sigma) dissolved 
in 60% HCIO4 to 100 to 500pg/mL.
3.2.1.3. RNA assay
The RNA assay was based on the orcinol method (Ashwell, 1957).
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First of all, the RNA was extracted by incubating 15 mg biomass in 4mL HCIO4 (60%) 
at 70°C for 15 minutes. The sample was then centrifuged and the protocol was 
repeated on the supernatant until no pellet was found after centrifugation.
The reagent was prepared by adding 1 volume 1% orcinol solution to 4 volumes of a 
solution of 0.02g FeCl3.6 H20  in lOOmL concentrated HCI. 2mL of the orcinol reagent 
were mixed to 2mL of sample and boiled at 100°C for 15 minutes. llm L  butan-l-ol 
were added to the sample and the absorbance was read at 640nm. The RNA content 
was calculated using RNA standards dissolved in 60% HCIO4 to 100 to 500pg/mL.
3.2.1.4. Protein assay
Proteins were analysed using the Lowry assay (Hartree, 1972; Lowry et a i, 1951). 
200 pL of freeze-dried biomass was resuspended in 1 mL water. Standards were 
prepared using bovine serum albumine at concentrations between 25 and 2 0 0  
pL/mL.
0.5 mL of the sample or standard was placed in a thick walled test tube and 0.5 mL 
of ImL NaOH was added. The mixture was boiled at 100°C for 5 minutes before 
cooling the tubes in water. 2.5mL of a solution containing 48 parts of 5% NaCOs, 1 
part 0.5% CUSO4.5H2O, 1 part 1% sodium-potassium tartrate were added to the 
tube. After 10 minutes, 0.5 mL of Folin-Ciocalteu (phosphomolybdate and 
phosphotungstate) was added and the tube was mixed. After another 30 minutes, 
the absorbance at 750nm was read and the protein content was calculated using the 
bovine serum albumine calibration curve.
3.2.1.5. Lipid assay
Lipids were measured using the vanillin method (Izard and Limberger, 2003). 0.5 g 
biomass was resuspended in 100 pL water. Each tube was added 2 mL of 
concentrated sulphuric acid and then incubated in boiling water for 10 minutes. After 
cooling the tubes at room temperature for 5 minutes, 5 mL of a reagent composed 
of 6 8 % phosphoric acid and 0 .12% vanillin were added and the tubes were 
incubated at 37°C for 15 minutes before reading the absorbance at 530nm. The lipid 
content was calculated using triolein standards.
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3.2.1.6. Trehalose and glycogen assay 
This assay was based on Parrou and Francois (1997).
Around lOmg biomass was digested in 0.25mL of 0.25M NazCOg at 95°C for 4h. The 
pH was then adjusted to 5.2 by adding 0.15mL of IM acetic acid and 0.6mL of 0.2M 
sodium acetate.
500pL of the digested biomass solution were incubated with 0.025U trehalase 
overnight at 37°C overnight, while the other 500pL were incubated with 0.6U 
amyloglucosidase from Aspergillus nIgeraX. 57°C overnight with constant agitation. 
Trehalase and amyloglucosidase hydrolyse trehalose and glycogen, respectively, into 
glucose.
The samples were then centrifuged for 3 minutes at 5000g and the glucose released 
from the enzymatic reactions was measured using the Sigma Aldrich Ltd glucose 
(Trinder) reagent. The glucose (Trinder) method is based on the following enzymatic 
reactions:
glucose + H^O + O 2  oxidase  ^ gi^j^onic acld +
H 2 O 2  + 4-aminoantipyrine + p-hydroxybenzene sulphonate — — -> quinoneimine dye 
+ H2O
The glucose concentration is proportional to the formation of quinoneimine dye, 
which is measured by reading the absorbance at 505nm. The assay was performed 
by following the instructions provided by Sigma Aldrich Ltd.
3.2.1.7. Carbohydrate assay
This assay was based on the phenol method (Dubois et a i, 1956). 600 pg biomass 
was resuspended in 2 mL RO water in glass tubes. 0.5 mL 5% phenol was added 
and the tubes were vortexed before adding 5 mL concentrated sulphuric acid and 
vortexed again. The tubes were then covered and incubated for 10 minutes at room 
temperature followed by a further hour at 25-30°C. The absorbance was then read 
at 488nm and the carbohydrate content was calculated using a glucose standard 
curve.
!
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3.2.2. Flux Balance Analysis
Flux Balance Analysis (FBA) is a modelling approach used to model carbon fluxes in a 
cell. It Involves the reconstruction of a stoichiometric model of the metabolism of the 
organism studied. Constraints such as known rates, or reaction directions or 
capacities, are applied in order to determine the solution space containing all feasible 
fluxes within the network. These optimal flux distributions are calculated via linear 
programming and represent the metabolic phenotype of the organism under a set of 
particular conditions. FBA offers a wide range of applications, such as medium 
formulation optimization, or metabolic engineering.
FBA was performed using the stoichiometric metabolic network of Streptomyces 
davuHgerus described in Chapter 4, the data obtained in the experiments described 
in Chapter 2, and the online Flux Balance Analysis software developed by Dr Andrzej 
Kierzek (University of Surrey, UK).
A more detailed description of the technique will be given In Chapter 4.
3.3. Results and discussion
3.3.1. Determination of elemental and macromolecular composition 
in batch and chemostat cultures
3.3.1.1. Determination of elemental and macromolecular composition 
in batch culture
A dedicated batch cultivation was run in order to take large (100 mL) samples every 
24 hours to perform macromolecular composition analysis. Withdrawing large sample 
volumes during one of the batches run for FBA and microarray analysis might have 
affected the behaviour of the system.
In the following Tables, T1 corresponds to 24h, T2 to 48h etc.
C h a pter  3 . B io m a s s  M ac r o m o lec u la r  Co m p o s it io n  of  S trep to m y ces  67
CLAVULIGERUSMiD ITS EFFECT ON FLUX BALANCE ANALYSIS
Clavulanic acid and biomass dry weight
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Figure 3.1.: Clavulanic acid and biomass dry weight in the batch cultivation performed to determine 
macromolecular composition. The error bars represent + /-  standard deviation of three replicates.
The aim was to determine the changes in macromolecular composition throughout 
the growth stages and apply this information to the three batch cultivations 
performed for FBA and transcriptomics.
As it can be observed in Figure 3.1., the batch cultivation used for macromolecular 
sampling is representative of the usual trends observed in other batches (cf. Chapter 
2).
3.3.1.2. Elemental composition
The elemental composition of the samples T2 to T9 in the batch culture and the 
chemostat cultures LI, L2, L3 and H3 was analysed in duplicate. Samples T1 and H2 
were used up by the macromolecular analysis and HI, as explained in Chapter 2, 
was not analysed any further. The maximum difference in content of a single 
element between two duplicates was 3%. The results are shown in the Table 3.1.
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C (*>/o) H (% ) N (o/o)
T2 39.43 6.03 9.72
T3 41.51 6.40 9.94
T4 42.76 6.71 8.89
T5 42.80 6.65 8.48
T6 43.58 6.81 8.17
T7 43.97 6.87 7.83
T8 44.51 7.05 7.46
T9 44.73 6.98 7.07
D = 0.02 h ^ 42.22 6.59 9.19
D = 0.05 h^ 42.01 6.36 10.44
Table 3.1.: Elemental composition in batch and chemostat culture
Evolution of the elemental composition in batch culture
46
45 -
44 -
i.2 43 -
42 -
O
40 -
4
0 50 100 150 200
Time (h)
I
o
Figure 3.2.: Evolution of the elemental composition in batch culture
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Elemental composition in chemostat cultures at 
different dilution rates
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Figure 3.3.: Elemental composition in chemostat cultures at different dilution rates
The elemental composition of biomass evolves with time and with growth rate (Table
3.1. and Figures 3.2. and 3.3). In batch culture, the carbon content increases 
steadily during growth, together with the hydrogen content, while the nitrogen 
content decreases from 48h onward. In chemostat culture, the carbon and hydrogen 
contents are higher at low growth rate while the nitrogen content is higher at high 
growth rate. These results will be discussed in conjunction with the macromolecular 
assay results.
3.3.1.3. Macromolecular assays results
As we discussed in Chapter 2, the chemostat HI gave abnormal results and was not 
used for transcriptomics and MPA. Therefore, macromolecular analysis was not 
performed on that chemostat.
Because of the very low biomass concentration at 24h (0.5 g/L), there was not 
enough biomass in the sample to measure all the macromolecular components. DNA, 
RNA, and trehalose assays were not performed on that sample (T l). The missing 
values will be estimated using the general trends shown in the other samples.
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The- data obtained will be compared to the results from different other works: 
Roubos (2002), who studied S. davuHgerus at the end of the exponential growth 
phase in batch culture in a nitrogen-limited defined medium with glycerol and 
ammonium. Jaques (2004) who worked on 5, erythtraea in the exponential and 
stationary phase in batch culture in a nitrogen-limited medium, and Shahab (1996) 
who grew S. coelicolor in continuous culture in a yeast extract-malt extract medium 
at p = 0.024 h '\
In the Tables reporting the results in the batch culture described in 3.3.1.1., T l 
corresponds to 24h, T2 to 48h etc.
33.1.3.1. DNA assay
DNA is found as both chromosomal and plasmid DNA in bacteria. The results of the 
DNA assay are reported in Tables 3.2. and 3.3.
Sample
number DNA in o/o
T l N/D
T2 4.29%
T3 3.83%
T4 3.37%
T5 3.29%
T6 3.06%
T7 2.28%
T8 2.20%
T9 3.42%
Table 3.2.: Percentage of DNA In the biomass In batch culture
Chemostat
number D (h )^ DNA (o/o)
LI 0.02 3.32%
L2 0.02 3.67%
L3 0.02 2.82%
H2 0.05 4.54%
H3 0.05 3.17%
Table 3.3.: Percentage of DNA in the biomass in chemostat culture
The amount of DNA seems slightly high compared to values obtained by Roubos 
(0.4-0.6%) or Jaques (1%) but concurs with Shahab's data (4.4%). The reason
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could be that DNA synthesis requires a large amount of nitrogen and both Roubos 
and Jaques used nitrogen-limited media, whereas Shahab used a complex medium. 
The medium used in the present study is not nitrogen-limited but phosphate-limited. 
However, phosphate is also required in considerable amounts in DNA, which could 
explain why the DNA content decreases with time, while the phosphate is becoming 
exhausted. It also seems slightly lower at low dilution rate, where the phosphate is 
scarcer.
The change in DNA content could also be partially due to the fact that other 
compounds such as lipids or carbohydrates are accumulated as storage compounds 
during growth, making the DNA relatively less important.
3.3.1.3.2. RNA assay
RNA is present in the cell as ribosomal, transfer and messenger RNA. The results of 
the RNA assay are reported in Tables 3.4. and 3.5.
Sample
number RNA in %
T l N/D
T2 6.87%
T3 5.77%
T4 4.57%
T5 4.21%
T6 4.01%
T7 3.81%
T8 4.13%
T9 4.24%
Table 3.4,: Percentage of RNA in the biomass in batch culture
Chemostat
number D (h i) RNA (o/o)
LI 0.02 6.57%
L2 0.02 5.55%
L3 0.02 5.06%
H2 0.05 7.58%
H3 0.05 8.50%
Table 3.5.: Percentage of RNA in the biomass In chemostat culture
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The amount of RNA found here is in agreement with Roubos' data (5.7-7.8%), and 
with Jaques' data (8.6% in exponential phase and 3.6% in stationary phase). Shahab 
reported a slightly higher value of 9.8% in chemostat cultures.
Again, Roubos and Jaques used nitrogen-limited media while Shahab used a complex 
medium. RNA, like DNA requires both nitrogen and phosphate for its synthesis, 
which could explain the decrease observed with time and the lower RNA content at 
low dilution rate, when phosphate is scarcer. Wanner and Egli (1990) also reported 
that RNA Is the major internal source of phosphorus, and that RNA disappears fairly 
quickly in E co//following phosphorus exhaustion.
The increased concentration of RNA at higher growth rates also reflects the fact that 
ribosomes always function at maximum efficiency; therefore an increase in growth 
rate can only be achieved by increasing the number of ribosomes, and therefore of 
RNA (Bremer and Dennis, 1987; Shahab etaL, 1996).
Cox (2003 and 2004) reported the following equation for E. coli:
/
^RN A(av)
V ^ d c (a v )  J
where mRNA(av) is the average mass of RNA per cell, and mdc(av> is the average dry cell 
mass per cell.
3.3.1.3.3. Protein assay
Cells contain enormous numbers of proteins which can be distinguished between 
enzymes, structural, signalling or transport proteins. Neidhardt (1990) estimated that 
his reference cell contained 2.4 million protein molecules. Their concentration and 
distribution change with time and with changes in the environment. The results of 
the protein assay are reported in Tables 3.6. and 3.7.
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Sample
number Protein (% )
T l 49.90%
T2 53.13%
T3 50.31%
T4 54.06%
T5 50.19%
T6 48.85%
T7 48.13%
T8 40.21%
T9 41.15%
Table 3.6.: Percentage of protein In the biomass in batch culture
Chemostat
number D (h-i) Protein (% )
LI 0.02 47.92%
L2 0.02 47.14%
L3 0.02 47.58%
H2 0.05 55.52%
H3 0.05 55.06%
Table 3.7.: Percentage of protein in the biomass in chemostat culture
The values obtained are within the expected range. Roubos found 46-53% protein in 
5. davuHgerus, and Shahab 45.6% in 5. coelicolor, but Jaques only 27-42% in 
Saccharopoiyspora erythraea.
The protein concentration seems to decrease with time in batch culture. This 
decrease could be partly explained by the fact that the concentration of some 
storage compounds increases with time. Jaques (2002) obtained the same type of 
protein profile in 5. eryhtraea.
In chemostat, the protein concentration is also higher at higher growth rates. 
Bremmer and Dennis (1987) and Shahab (1996) obtained the same profile in E coH 
and S. coelicolor, respectively.
Cox (2003 and 2004) demonstrated the existence of a linear relationship between 
specific protein synthesis rate and the third power of RNA concentration in E coH 
and 5. coelicolor through the equation:
®p(av)=0>^ ^ R N A (a v )
\  ^dc(av) y
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where Wp(av) is the specific protein synthesis rate in fg protein synthesized per cell h"\ 
0 is the slope, niRNAov) is the average mass of RNA per cell, and mdc(av) is the average 
dry cell mass per cell. Since the RNA content decreases with time and with 
decreasing growth rate, it is natural to see the protein content decreasing too.
Finally, the protein profile is backed up by the elemental analysis profile, in which the 
nitrogen content decreases with time in batch culture, and is higher at high dilution 
rates.
3.3.1.3.4. Lipid assay
Lipids are found in cells as part of their membranes, although they can also be 
accumulated as storage compounds. The results of the lipid assay are reported in 
Tables 3.8. and 3.9.
Sample
number Lipid (o/o)
T l 7.50%
T2 9.00%
T3 10.00%
T4 14.00%
T5 13.50%
T6 17.00%
T7 17.50%
T8 18.00%
T9 19.50%
Table 3.8.: Percentage of lipid in the biomass In batch culture
Chemostat
number D (h i) Lipid (% )
LI 0.02 15.00%
L2 0.02 15.00%
L3 0.02 12.00%
H2 0.05 8.00%
H3 0.05 9.00%
Table 3.9.: Percentage of lipid in the biomass in chemostat culture
These results are difficult to interpret because of the lack of appropriate standard. 
Triolein probably does not react to this assay like the average S. davuHgerus'\\\>\û.
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The general trend (a concentration of lipid increasing over time in batch) seems 
right. It is common for lipids to be accumulated during growth, especially when the 
culture is not carbon-limited (Jaques, 2004; Packter and Olukoshi, 1995).
Jaques obtained 3-9% lipid, and Roubos 12.5-12.8%, so our findings are coherent 
with previous findings in 5. davuHgerus.
3.3.1.3.5. Trehalose and glycogen assay
Trehalose and glycogen are the two major forms of storage carbohydrates in 
actinomycetes (Hodgson, 2000). Their metabolism is believed to be closely 
associated, and the genome of Streptomyces coelicolor A3(2) actually contains 
duplicated opérons containing genes for both trehalose and glycogen metabolism 
(Schneider et ai., 2000). However, glycogen was detected neither in batch culture, 
nor in chemostat culture using this assay. There are very few reports on the 
modulation of trehalose and glycogen in actinomycetes in liquid culture as most 
actinomycetes are unable to undergo morphological differentiation in liquid culture 
(Hoskisson et ai., 2004). Glycogen might only be synthesized during morphological 
differentiation, as it is suggested in many reports (Hodgson, 2000), and which could 
explain why we could not detect it in this study.
The results of the trehalose assay are reported in Tables 3.10. and 3.11.
Sample
number
Trehalose
(% )
T l N/D
T2 3.95%
T3 4.67%
T4 7.32%
T5 6.00%
T6 7.06%
T7 5.09%
T8 7.17%
T9 11.84%
Table 3.10.: Percentage of trehalose In the biomass In batch culture
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Chemostat
number D (h-i)
Trehalose
(®/o)
LI 0.02 4.78%
L2 0.02 3.26%
L3 0.02 4.74%
H2 0.05 1.71%
H3 0.05 1.97%
Table 3.11.: Percentage of trehalose In the biomass in chemostat culture
Trehalose was found in S. davuHgerus in surprisingly high amounts. The general 
trend in batch culture seems to be an increase with time, and the concentration is 
higher at low growth rate in continuous culture. This is typical of a storage 
compound.
Trehalose has already been detected in many actinomycetes such as 
Saccharopoiyspora eryhtraea by Jaques (2002), Streptomyces antibioticus by Brana 
et al. (1986) and Micromonospora echinospora (Hoskisson et a!., 2004) at 5-13%, 
0.3% and 3% of the cell dry weight, respectively.
Brana's hypothesis was that trehalose is used as a protection from dessication rather 
than energy storage, which can not be its role in the case of a liquid culture. 
However, the role of trehalose as a storage compound has also been reported 
(Elbein et al., 2003). Schneider et al. (2000) hypothesized that trehalose might be 
used to carry carbon from glycogen to parts of the colonies that require energy, but 
no glycogen was detected in our study, so this is obviously not the role played by 
trehalose here.
Similarly to our findings, trehalose was also shown to accumulate in Micromonospora 
echinospora as growth rate declines in batch cultures, and at low dilution rates in 
chemostat cultures (Hoskisson e t ai., 2004). Micromonospora echinospora is able to 
undergo morphological differentiation in liquid culture. It is not clear whether 
Streptomyces davuHgerus can do the same as the presence of spores was not 
assessed in this study, but it is unlikely as only a few actinomycetes sporulate in 
liquid culture. If 5. davuHgerus does not undergo morphological differentiation in 
liquid culture, this result would suggest that trehalose does not only play a role in 
morphological differentiation, but also as excess carbon storage.
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Miguélez et al. (1997) showed that Streptomyces antibioticus accumulates both 
trehalose and glycogen in liquid culture following nitrogen starvation, but that 
trehalose accumulated without any lag phase while glycogen first required the 
hyphae to undergo some structural changes typical of stationary-phase cultures (i.e. 
frequent branching and cross-wall formation and highly condensed nuclear bodies), 
suggesting two distinct regulatory mechanisms.
33.1.3.6. Carbohydrate assay
Carbohydrates can either be found as part of the cell wall, or as storage compounds. 
The results of the carbohydrate assay are reported in Tables 3.12. and 3.13.
Sample
number
Carbohydrate
(% )
T l 14.78%
T2 12.08%
T3 16.00%
T4 18.11%
T5 21.73%
T6 21.35%
T7 21.09%
T8 21.12%
T9 23.97%
Table 3.12.: Percentage of carbohydrate In the biomass In batch culture
Chemostat
number D (h-i)
Carbohydrate
(o/o)
LI 0.02 13.62%
L2 0.02 14.13%
L3 0.02 13.94%
H2 0.05 9.74%
H3 0.05 9.62%
Table 3.13.: Percentage of carbohydrate In the biomass In chemostat culture
The carbohydrate profile is in agreement with the elemental analysis profile, which 
showed an increase in carbon and hydrogen content with time in batch culture, and 
higher concentrations of carbon and hydrogen at low growth rate.
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However, these values appear fairly high compared to Roubos (2002) who found 
only 2.2-3.3% using the same method. Herbert et al. (1971) showed that the 
phenol-sulphuric acid assay tends to overestimate the amount of carbohydrate 
present compared to other methods such as the anthrone method because it also 
reacts with the ribose and desoxyribose components of RNA and DNA. Some other 
sugars such as mannose also give a much higher absorbance with the phenol- 
sulphuric acid method. It is not clear whether Roubos (2002) corrected the amount 
of carbohydrates found to take into account the absorbance of DNA and RNA.
Trehalose has already been shown to represent part of the carbohydrate pool (cf.
3.3.1.2.5.). The absorbance of trehalose in the phenol-sulphuric acid assay is not 
known and was therefore assumed to be 100% the absorbance of glucose. Herbert 
et ai. (1971) provided values for the absorbance of yeast RNA and calf thymus DNA 
relative to glucose, therefore these values were used to calculate the contribution of 
RNA and DNA to the total absorbance.
The remaining portion of carbohydrate was assumed to be a galactose polymer 
because no specific information was found on specific carbohydrates found in 5. 
davuHgerus and galactose was found in the cell wall of different streptomycetes 
(Skoblilova et a!., 1983; Zaretskaia and Polin, 1987). It could however be another 
carbohydrate such as N-acteylglucosamine. Taking into account the lower 
absorbance of galactose, the content of that sugar was calculated and is shown in 
Tables 3.14. and 3.15.
Sample
number
Galactose
(% )
T l N/D
T2 5.53%
T3 10.87%
T4 11.03%
T5 18.22%
T6 16.41%
T7 19.22%
T8 16.17%
T9 13.10%
Table 3.14.: Percentage of galactose in the biomass in batch culture
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Chemostat
number D (h 1)
Galactose
(% )
LI 0.02 7.07%
L2 0.02 10.42%
L3 0.02 8.70%
H2 0.05 4.85%
H3 0.05 4.25%
Table 3.15.: Percentage of galactose In the biomass in chemostat culture 
3.3.1.3.7. Summary
DNA, RNA, protein, lipid, trehalose and total carbohydrates have been measured in 
both batch and continuous cultures. Each macromolecular compound showed a 
specific trend, which can be more easily represented in a graph (cf. Figure 3.4. and
3.5.). The values for DNA, RNA, trehalose and galactose in the first sample (T l) 
were assumed to follow the general trend that these components showed in later 
samples and an arbitrary value was used for them (cf. Table 3.16.).
Contribution of the different biomass components to the totai 
biomass in batch cuiture100%
24 48 72 96 120 144
Time (h)
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□  Upid
■ RNA
■  DNA
□  Protein
216
Figure 3.4.: Contribution of the different biomass components to the total biomass in batch culture
Chapter 3. Biomass Macromolecular Composition of S t r e p t o m y c e s  80
CLAVUUGERUSMAD ITS EFFECT ON FLUX BALANCE ANALYSIS
Contribution of the different biomass components to the total 
biomass in chemostat culture
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Figure 3.5.: Contribution of the different biomass components to the total biomass in continuous culture
We were able to measure about 80-90% of the biomass components, which is 
comparable to Roubos (2002) and Jaques (2004).
Since both our batches and chemostats were run with a medium containing an 
excess of carbon, it is not surprising to find that the microorganism accumulated 
carbohydrates and lipids during growth, or, in the case of chemostat cultures, 
contained more carbon storage compounds such as trehalose or lipids at low dilution 
rate. It is common for microorganisms to store more carbon when they are growing 
slowly (Beste eta!., 2005; Brana etaL, 1982; Jaques, 2004).
There was also a diminution of the RNA and protein levels during growth and lower 
levels of both components at low dilution rate. As explained earlier, the number of 
ribosomes and therefore RNA levels normally follow growth rate. It was also 
explained that protein levels follow RNA levels.
Finally, it was surprising to find trehalose in such large amounts. The presence of 
trehalose in actinomycetes had already been reported by others (Jaques, 2004) but.
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to the author's knowledge, never in Streptomyces davuHgerus, and only seldom in 
liquid culture. The role of trehalose Is still not well understood.
A number of components (teichoic acid, murein, small molecules and inorganic ions) 
could not be measured and their proportions have therefore been taken from other 
sources.
Teichoic acid and murein are components of the cell wall. Roubos (2002) estimated 
the amount of teichoic acid and murein in S. davuHgerus grown in glycerol and 
ammonium by measuring the other biomass components, calculating the elemental 
and degree-of-reduction balances, and adjusting the murein and teichoic acid 
accordingly. He estimated the biomass to be composed of 6.5% teichoic acid and 
9.5% murein. Since that calculation was performed for a culture in late exponential 
phase, these proportions were assumed to be true for the corresponding sample in 
this study, which was sample T3. Zaretskaia (1987) studied the cell wall composition 
of Streptomyces antibioticus and showed that, during development, the quantity of 
murein remained constant, the quantity of teichoic acid decreased, and the quantity 
of polysaccharide increased. It was shown that. In Streptomyces davuHgerus, the 
quantity of polysaccharide increases during development. It was therefore assumed 
that the murein and teichoic acid would also follow the same trend as in S. 
antibioticus. The murein content was fixed at 9.5% in all samples, while the teichoic 
acid content was decreased by 0.25% every 24h, starting at 7% at T l. In the 
chemostats, the biomass composition profile of the cultures at low dilution rate was 
similar to the biomass composition profile at T3, therefore the teichoic acid content 
was assumed to be the same as well. At high dilution rate, the biomass composition 
profile was similar to the profile at T l, therefore the teichoic acid content was 
assumed to be the same as well.
Other unmeasured compounds are the small molecules, which are the metabolic 
intermediates contained in the cell at the time of sampling. Both Ingraham (1983) 
and Neidhardt et ai. (1990) estimated their concentration to 3% of the cell dry 
weight. Finally, the biomass also contains some inorganic salts (sulphate and 
phosphate). Neidhardt et ai. (1990) estimated their content to 1% of the cell dry 
weight.
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When the measured macromolecules as well as the unmeasured ones described 
above were added together, most samples showed a weight balance of 101-106%, 
which is accepTable. However, some samples showed a weight balance above 
110%. The protein level in these samples appeared inordinately high, and did not 
seem to follow the general decreasing trend supported by decreasing RNA and 
nitrogen levels. It was therefore decided to adjust the protein levels of these samples 
accordingly.
Table 3.16. shows the macromolecular composition of S. davuHgerus based on the 
measurements performed in this study and the assumptions explained above.
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3.3.2. Macromolecules' monomeric composition
The next step was to detail the monomeric composition of each macromolecule of 
the biomass in order to create stoichiometric equations for their synthesis in the 
metabolic model.
As explained in this Chapter's introduction, when performing flux analysis, it is very 
important to make sure that the biomass composition used in the model is as precise 
as possible and therefore data from the organism studied, or from organisms that 
are as close as possible, must be used.
In most cases, we tried to use data from Streptomyces avermitilis, since it is, with S. 
coelicolor, one of the two sequenced Streptomycetes, and we have shown that it is 
genetically closer to S. davuHgerus \hd^ r\ S. coelicolor {d . Figure 3.4.).
S.albidoflavus 
S.fungicidicusg •SrfYCTitilig- s  h ik in iA H R iÂ•S.clavuligerusS.virgimae S.scabiei
-S.lividans 
S.ambofaciens 
pS.maritimus 
— S.afghaniensis 
^S.œ erulescens 
j —S.virginiae 'S.violaceus 
^S.violarus 
S.limosus
S.bi color 
 S.cattleya---------------------------------------------------------------------------------------------------S.erythraea
S.rimosus
S.thermovulgaris
S.coelicolor
Scale: k
Figure 3.6. Maximum-likelihood, neighbour-joining phylogenetic tree based on the 16S rRNA sequences 
of different actinomycetes (tree built using the Phylip interface of the Ribosomal Database Project 
Release 8.1. http://rdp8.cme.msu.edu/html/anaiyses.html).
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3.3.2.I. DNA
The monomeric composition of 5. davuHgerus DNA was calculated based on S. 
avermitilis DNA GC content of 70.7%.
Nucleotide mol/mol DNA
MW,
g/mol
mmol/g
DNA
dAMP 0.147 313.2 0.474
dCMP 0.354 289.2 1.144
dTMP 0.147 304.2 0.474
dGMP 0.354 329.2 1.144
Total 3.236
Energy requirement for polymerisation (ATP):_________ 4.417
Table 3.17.: Monomeric composition of DNA
The molecular weight of the nucleotides corresponds to the weight of the nucleotide 
monophosphate substracted one H2O, which is lost during estérification.
The energy expenditure was calculated based on Neidhardt e t ai. (1990), and was 
estimated at 1.365 ATP per nucleotide, allocated as follows:
- Energy for unwinding the helix 1 ATP
- Energy for discontinuous synthesis 0.006 ATP
- Energy for proofreading 0.35 ATP
- Energy for negative supercoiling 0.005 ATP '
- Energy for méthylation 0.0001 ATP
The equation for DNA biosynthesis was therefore (in mmol/g DNA):
4.417 ATP + 0.474 DATP + 1.144 DCTP + 1.144 DGTP + 0.474 DTTP = 4.417 ADP 
+ 4.417 PI + 3.236 PPI + DNA
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S.3.2.2. RNA
The RNA was assumed to be composed of (Neidhardt etaL, 1990):
RNA type Percentage of total RNA weight (% )
mRNA 4
55 rRNA 2
165 rRNA 27
235 rRNA 52
tRNA 15
Table 3.18.: Distribution of the different types of RNA
Since the monomeric composition of mRNA depends on the composition of DNA it is 
transcribed from, the mRNA was assumed to have the same GC bias as the DNA. The 
5S rRNA and the 23S rRNA of 5. davuHgerus have not been sequenced, so they were 
assumed to have the same composition as those of S. avermitilis. The sequence of 5. 
davuHgerus 165 rRNA was available. Finally, the composition of tRNA was caicuiated 
based on the average composition of 6 tRNA from 5. avermitilis.
Nucleotide
mol/mol RNA
MW,
g/mol
mol/mol 
RNA
mmol/g
RNA
mRNA
4%
5S
rRNA
2%
16S
rRNA
27%
23S
rRNA
52%
tRNA
15%
AMP 0.147 0.190 0.182 0.201 0.198 329.2 0.193 0.602
GMP 0.354 0.246 0.251 0.229 0.296 345.2 0.250 0.782
CMP 0.354 0.325 0.341 0.340 0.346 305.2 0.342 1.068
UMP 0.147 0.238 0.226 0.230 0.161 306.2 0.215 0.671
Total 3.124
Energy requirement for polymerisation (ATP): 1.268
Table 3.19.: Monomeric composition of RNA
The energy expenditure to synthesise RNA was taken from Neidhardt et ai. (1990),
and was estimated at 0.406 ATP per nucleotide, allocated as follows:
- Energy for discarded segments of primary transcripts 0.384 ATP
- Energy for modification 0.022 ATP
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The equation for RNA biosynthesis was therefore (in mmol/g RNA):
1.87 ATP + 1.068 CTP + 0.782 GTP + 0.671 UTP = 1.268 ADP + 1.268 PI + RNA 4- 
3.124 PPI
3.3.2.3. Proteins
According to Roubos (2002), the composition of proteins does not vary very much 
between species. Therefore, we used the protein composition estimated for 
Streptomyces avermitilis using the average amino acid composition of all the ORFs 
(www.ebi.ac.uk/integr8). Unfortunately, this does not take into account the 
abundance of the different proteins.
Amino acid %  in genome MW (g/mol) mmol/gprotein
Ala 13.44 71.08 1.255
Arg 8 156.2 0.747
Asn 1.81 114.11 0.169
Asp 5.94 115.09 0.555
Cys 0.81 103.14 0.076
Gin 2.85 128.14 0.266
Glu 5.61 129.12 0.524
Gly 9.49 57.06 0.886
His 2.35 137.15 0.220
He 3.14 113.17 0.293
Leu 10.21 113.17 0.954
Lys 2.3 128.18 0.215
Met 1.72 131.21 0.161
Phe 2.73 147.18 0.255
Pro 6.1 97.12 0.570
Ser 5.26 87.08 0.491
Thr 6.24 101.11 0.583
Trp 1.54 186.21 0.144
Tyr 2.12 163.18 0.198
Val 8.34 99.14 0.779
Total 9.341
Energy requirement for polymerisation (ATP): 40.353
Table 3.20: Amino acids composition of S. avermitilis 
(based on the genome composition)
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The energy expenditure to synthesise proteins was taken from Neidhardt et a i 
(1990), and was estimated at 4.32 ATP per amino acid, allocated as follows:
- Energy for activation and incorporation 4 ATP
- Energy for mRNA synthesis 0.2 ATP
- Energy for proofreading 0.1 ATP
- Energy for assembly and modification 0.02 ATP
The equation for protein biosynthesis was therefore (in mmol/g protein):
1.255 ALA + 0.747 ARG + 0.169 ASN + 0.555 ASP + 40.3879 ATP + 0.076 CYS + 
0.266 GLN + 0.524 GLU + 0.886 GLY + 0.22 HIS 4- 0.293 ILE 4- 0.954 LEU 4- 0.215 
LYS 4- 0.161 MET 4- 0.255 PHE 4- 0.57 PRO 4- 0.491 SER + 0.583 THR 4- 0.144 TRP 
+ 0.198 TYR 4- 0.779 VAL = 40.3879 ADP + 40.353 PI 4- PROTEIN
3.3.2.4. Lipids
Due to a lack of information on lipids in 5. davuHgerus and 5. avermitilis, the same 
composition as Borodina et ai. (2005) was used.
The lipids were assumed to be composed of 60% phospholipids and 40% 
triacylglycerols in exponential phase (Olukoshi and Packter, 1994). However, lipids 
accumulated in stationary phase are generally neutral lipids (Jaques, 2004). 
Therefore, all the lipids accumulated after T4 (96h) were considered to be 
triacylglycerols.
In chemostat, a composition of 60% phospholipids and 40% triacylglycerols was 
chosen for the high dilution rate, while a composition of 40% phospholipids and 60% 
triacylglycerols was arbitrarily decided for the low dilution rate.
3.3.2.4.1. Phospholipids
The composition of phospholipids was assumed to be the same as in E coH and 
Salmonella typhlmurium, because they are the species in which the most accurate 
measurements have been made (Stanier, 1986).
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Component g/g phospholipids mmol/gphospholipids
Phosphatidylethanolamine 0.75 1.089
Phosphatidylglycerol 0.18 0.250
Cardiolipin 0.07 0.052
Table 3.21.: Distribution of the different types of phospholipids
Still using Borodina's data, the composition of fatty acids tails in phospholipids was 
assumed to be the same as in S. antibioticus (Zuneda et ai., 1984). The fatty acids 
for the biosynthesis are supplied in an activated form (conjugated to acyl-carrier 
protein (ACP)).
Fatty acid
g/g total 
fatty acids MW, g/mol
mmol/g 
total fatty 
acids
mol/mol 
total fatty 
acids
C14 0.084 227 0.37 0.094
C15 0.279 241 1.16 0.294
C16 0.263 255 1.03 0.262
C17 0.311 269 1.16 0.293
C18:l 0.063 281 0.22 0.057
Average molecular weight: 254
Table 3.22.: Fatty acid composition of phospholipids
Therefore, the molecular weight of the individual monomers could be calculated.
Constituent backbone
MW, g/mol
#  of fatty acids 
residues
totai
Phosphatidylethanolamine 181.128 2 688.82
Phosphatidylglycerol 212.139 2 719.83
Cardiolipin 332.183 4 1347.56
Table 3.23.: Molecular weight of the monomers composing phospholipids
The equation for phospholipids biosynthesis wais therefore (in mmol/g 
phospholipids):
1.089 PE + 0.250 PG + 0.052 CL > PHOSPHOLIPID
The stoichiometric model contains the equations for the synthesis of the monomers 
based on the assumed fatty acid composition.
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3.3.2.4.2. Triacylglycerols
Triacylglycerols (TAGs) are composed of a glycerol core and of three fatty acids 
residues.
Still based on Borodina et ai. (2005), the composition of fatty acids tails in TAGs was 
assumed to be the same as in S. a n t i b i o t i c u s e t a L ,  1984).
Fatty
acid
g/g total 
fatty acids
MW%
g/mol
mmol/g
total
fatty
acids
mol/mol 
total 
fatty 
acids
C14 0.012 227 0.05 0.013
CIS 0.426 241 1.77 0.450
C16 0.113 255 0.44 0.113
C17 0.445 269 1.65 0.421
€18:1 0.004 281 0.01 0.004
Average molecular 
weight: 254 SUM: 1.00
Table 3.24.: Fatty acid composition of triacylglycerols
Hence, the monomeric composition of the triacylglycerols could be calculated as 
shown in Table 3.24.
TAG components mol/molTAG
mmol/g
TAG
Glycerol-3-phosphate 1 1.244
C14 0.040 0.050
CIS 1.349 1.677
€16 0.338 0.421
€17 1.262 1.570
€18:1 0.011 0.014
Average molecular weight: 803.9
Table 3.25.: Fatty acid composition of triacylglycerols
The equation for phospholipids biosynthesis was therefore (in mmol/g 
phospholipids):
1.244 GL3P + 0.050 C140ACP + 1.677 C150ACP + 0.421 C160ACP + 1.570 C170ACP 
+ 0.014 C181ACP -> TAG + 3.732 ACP + 1.244 PI
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3.3.2.5. Carbohydrates
The equation for trehalose-6-phosphate synthesis was added to the metabolic 
network:
UDPG + G6P = UDP + TRE6P.
The reaction leading to trehalose was already present in the metabolic network: 
TRE6P = TRE + PI.
Galactose was assumed to be present as a polymer, made from activated building 
blocks. The molecular weight of galactose being 162 g.mor\ the equation for 
carbohydrate synthesis is:
6.173 UDPGAL ^  6.173 UDP + CARB
3.3.2.6. Peptidoglycan and teichoic acid
3.3.2.6.1. Peptidoglycan composition
Peptidoglycan, or murein, is the main component of the bacterial cell wall. It is a 
polymer consisting of sugars and amino acids. Its composition was taken from 
Borodina et ai. (2005) as an average composition in several Streptomyces species. 
The blocks of the glycan chain are supplied in the activated form (UDP-NAG and 
UDP-NAM), therefore energy is needed only for the pentapeptide formation (1 ATP 
per mol of amino acid joined). Half of the alanine in the peptidoglycan was assumed 
to be D-alanine. D-alanine joins the growing amino acids chain as D-alanyl-D-alanine. 
The fifth D-alanine residue is cleaved extracellularly to allow bond formation between 
diaminopimelinic acid and the fourth residue (Ingraham, 1983).
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Component
Average
molar
ratio
MW,
g/mol
mmol/g
peptidoglycan
N-acetylmuramic acid 0.9 275 1.007
N-acetylglucosamine 1.1 203 1.197
Alanine 1.7 71 1.900
Diaminopimelinic acid 1.0 154 1.140
D-glutamate 0.9 129 1.014
Glycine 0.9 39 0.973
Energy requirement for polymerisation (ATP):____________ 5.026
Table 3.26.: Monomeric composition of peptidoglycan
Water was subtracted from the molecular weight to account for the bond formation. 
In glycine and DAP, two H2O were subtracted each to account for cross-linking.
The equation for peptidoglycan biosynthesis was therefore (in mmol/g 
peptidoglycan):
1.007 UDPNAM + 1.197 UDPNAG + 1.900 ALAALA + 0.950 ALA + 1.140 MDAPIM + 
1.014 DGLUTAMATE + 0.973 GLY + 5.026 ATP -> PEPTIDOGLYCAN + 0.950 DALAxt 
+ 1.197 UDP -h 1.007 UMP + 5.026 ADP + 5.026 PI
3.3.2.6.2. Teichoic acid composition
Teichoic acids are polymers of glycerol or ribitoi linked via phosphodiester bonds 
found only in Gram-positive bacteria. Their composition varies greatly between 
species, and even between variants of a species.
The values used In this study were borrowed from Borodina e t ai. (2005) who 
assumed that the teichoic add had the same composition as 5. roseoflavus var. 
roseofungini (Skoblilova et ai., 1983). In 5. roseofiavus var. roseofungini, the main 
polycarbohydrate polymer of the cell wall is glycerol teichoic acid. This is also in 
agreement with the findings of Roubos (2000), who reported that 5. davuHgerus 
grown in glycerol and ammonium contains glycerol teichoic acid, and no ribitoi 
teichoic acid, which is the other type of teichoic acid. Roubos also assumed the 
teichoic acid to have the same composition as S. roseofiavus var. roseofungini 
(Skoblilova et ai., 1983). The teichoic acid was therefore assumed to be composed of 
a 1,3-poly (glycerol phosphate) chain of 11-13 units, among which 20-30% have L- 
lysine residues and 25-30% alpha-N-acetylglucosamine residues.
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Components molar
ratio
MW“,
g/mol
mmol/g
teichoic
acid
PolyCglycerophosphate)
chain 1 1849 0.518
Lysine 0.25 128 0.129
N-ace^lg lucosa mine 0.25 203 0.129
Energy requirement for polymerisation (ATP): 0.129
Table 3.27.: Monomeric composition of teichoic acid
The molecular weight of the poly(glycerolphosphate) chain was calculated as 
(C3H705p)i2, the molecular weight of lysine and N-acetylglucosamine was subtracted 
water to account for the bond formation.
The equation for teichoic acid biosynthesis was therefore (in mmol/g teichoic acid): 
0.518 POLYGP + 0.129 LYS + 0.129 UDPNAG + 0.129 ATP -> TEICH + 0.129 UDP + 
0.129 ADP -I- 0.129 PI
3.3.2.7. Small molecules
It was assumed that all the small molecules were present in the same amount (w/w). 
The following values were borrowed from Borodina etaL (2005).
Molecule MW, g/mol
g/g pool of small 
molecules
mmol/g pool of 
small molecules
NAD 664.438 0.125 0.188
NADP 744.418 0.125 0.168
COA 767.534 0.125 0.163
ACP 10689 0.125 0.012
MK 853.365 0.125 0.146 '
THF 445.434 0.125 0.281
FMN 456.348 0.125 0.274
FAD 785.557 0.125 0.159
Table 3.28.: Composition of the smail molecule pool
In Table 3.27., NAD stands for nicotinamide adenine dinucleotide, NADP for 
nicotinamide adenine dinucleotide phosphate, COA for coenzyme A, ACP for acyl 
carrier protein, MK for menaquinone, THF for tetrahydrofolate, FMN for flavine 
mononucleotide and FAD for flavin adenine dinucleotide.
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The equation for small molecules biosynthesis was therefore (in mmol/g small 
molecules):
0.188 NAD + 0.168 NADP + 0.163 COA + 0.012 ACP + 0.146 MK + 0.281 THF + 
0.274 FMN + 0.159 FAD -> SMALL MOLECULES
3.3.3. Effect of biomass macromolecular composition on FBA
Daae and Ison (1999) concluded from their study that biomass composition does not 
have a large impact on the fluxes in the metabolic network of 5. Hvidans. They 
therefore assumed that that the biomass composition of E co//could be used instead 
of measuring the biomass composition for 5. Hvidans. That conclusion was then used 
in a number of studies as a justification for the utilisation of E coifs biomass 
composition. Roubos (2002) challenged that conclusion by objecting that Daae and 
Ison only changed the composition of one monomer at a time, without taking into 
account the fact that there usually is more than one changing at a time.
Jaques (2004) recently showed that it was fundamental to use a dynamic model 
instead of a static one for biomass composition in stationary phase to perform flux 
analysis. The biomass composition changes significantly in that phase, and using a 
static biomass composition leads to erroneous calculation of some rates in the 
metabolic network, such as those closely related to biomass synthesis, but also those 
in the pentose phosphate pathway.
Using the model and software described briefly In "3.2.2. Flux Balance Analysis" and 
in more details in Chapter 4, Flux Balance Analysis (FBA) was used to determine the 
effect of a difference in biomass composition on the distribution of carbon fluxes in 
5. davuHgerus.
A flux analysis was run using as inputs the dilution rate, average clavulanic acid 
production, and average glycerol utilisation of the chemostats run at a dilution rate 
of 0.02 h '\ as well as the average biomass composition of these cultures. A second 
flux analysis was run using the same inputs but the average biomass composition of 
the chemostats run at a dilution rate of 0.05 h '\ In both cases, phosphate uptake 
was chosen as the function to be optimised.
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229 reactions out of 695 (33%) gave a different flux vaiue between the two runs. 
Most fluxes presenting variations were fluxes of reactions involved in nucleotide 
synthesis, amino acid synthesis, and lipid synthesis, but some reactions of the 
pentose phosphate pathway (ribulose-phosphate 3-epimerase, ribose-5-phosphate 
isomerase,...), pyruvate metabolism (acetyi-CoA carboxylase), and 
giycoiysis/giuconeogenesis (phosphoglucomutase, glucose-6-phosphate isomerase...) 
also presented significant changes (over 10% difference). Some of the results are 
shown on a map (Figure 3.7.).
This rapid test showed that it is essential to use the correct biomass composition 
when performing Flux Balance Analysis because almost a third of the reactions 
showed a different flux when the wrong biomass composition was used. This 
conclusion led us to use a biomass equation based on specific experimental values 
for each FBA run.
3.3. Summary
In this Chapter, the macromolecular composition of Streptomyces davuHgerus grown 
in both batch and continuous cuiture was determined and compared to previous 
studies in actinomycetes. The composition obtained proved to be in good agreement 
with that composition reported by Roubos (2000) for Streptomyces davuHgerus 
grown in a defined medium containing glycerol and ammonium, like the medium 
used in the present study.
In addition to the components measured by Roubos, trehalose was also measured 
and found in considerable amounts, especially during stationary phase. There was 
also accumulation of another carbohydrate, which was assumed to be a polymer of 
galactose, probably located in the ceil wail.
The monomeric composition of the different biomass components was also 
established, using data from both S. davuHgerus av\û closely related species.
Finally, flux balance analysis was performed in order to determine the effect of using 
the correct biomass composition, and showed that it is primordial to ensure that an 
accurate biomass composition is used in order to obtain reliable flux distribution 
data.
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4.1. Introduction
4.1.1. Flux Balance Analysis
As briefly explained In Chapter 3, Flux Balance Analysis (FBA) is a modelling 
approach used to predict carbon fluxes In a cell. It Involves the reconstruction of a 
stoichiometric model of the metabolism of the organism studied.
The first step Is to define all the reactions to be Included in the model. Not all the 
reactions will be active In all environmental conditions. The annotated genome Is 
usually a good starting point to reconstruct an organism's metabolic model. There 
are however always some gaps within the pathways that need to be manually filled 
with the missing reactions that are not present In the annotated genome. Transport 
reactions must also be added to the model.
The reactions can then be written In matrices where S is the stoichiometric matrix, 
with metabolites as rows and reactions as columns, and v the flux vector.
Mass balance can be defined by the equation:
^ = S . vdt
where XI Is the concentration of a given metabolite. At steady state, the change of a 
given metabolite concentration Is 0, and the above equation becomes
S.v = 0
The next step Is to add some constraints to the system in order to restrain the 
solution space. An easy way to add constraints Is to measure some fluxes such as 
production or utilisation rates of external metabolites. It Is also possible to constrain 
fluxes by allowing them to only go in one given direction, or give them a range of 
possible values. These constraints will create a flux cone that represents the 
metabolic capacity of the organism and can be described mathematically as:
oi < vl < (31
where vl Is the flux of interest, oi the lower bound of the flux, and (31 the upper 
bound of the flux.
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Large scale metabolic networks usually contain more reactions than metabolites and 
are therefore underdetermined. Using linear programming, optimization of an 
objective function such as growth rate or sugar uptake rate can be used as an 
alternative to measuring additional fluxes (Patll e t a!., 2004). The study of the 
distribution of metabolic fluxes within an organism has been referred to as fluxomics 
(Sanford etaL, 2002).
Stoichiometric models have typically been applied to flux analysis of systems In 
continuous cultures, but It can also be applied to batch cultures, under the 
assumption that the biomass composition does not change within a fixed time frame. 
This approach has been used for Instance by Roubos (2002).
4.1.2. Aims and objectives
In this Chapter, I will demonstrate the use of Flux Balance Analysis In understanding 
and manipulating metabolism, as well as outline the limitations of this technique. FBA 
will first be used to compare the obtained data to published results. It will then be 
applied to the batch and chemostat cultures run In this study, and used to propose 
some strategies to enhance clavulanic acid biosynthesis.
4.2. Materials and Methods
4.2.1. Metabolic network reconstruction and reannotation
Since Streptomyces davuHgerus has not yet been sequenced, the genome-scale 
metabolic network used In this study was based on the one developed for 
Streptomyces coelicolorby Borodina etaL (2005).
Borodina et aL first used the 5. coelicolor A3(2) pathways database In KEGG 
(ftp://ftp.genome.ad.jp/pub/kegg/pathways/sco) to extract a draft model. Only 926 
ORFs had an enzyme commission (E.G.) number assigned and, out of these, 711 
were included In the model. Considering the pathways known to be operative In 
streptomycetes and/or for which most of the pathway-specific enzymes were 
present, 971 metabolic reactions were Included In the model (819 metabolic 
conversion reactions and 152 transport reactions). 89% of the metabolic conversion
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reactions had an ORF assigned, while the others were Included on the basis on 
physiological evidence. Only 24% of the transport reactions had an assigned ORF. 
205 reactions without assigned ORF were added to the model In order to produce a 
viable cell: 79 enzymatic reactions, 117 transport reactions, five spontaneous 
reactions, and four artificial reactions such as maintenance energy and biomass 
assembly. The total number of metabolites Included In that model was 500.
Borodina's model was modified In our laboratories by Dr Zhao Hongjuan to take into 
account the following main differences:
- S. davuHgerus can not use glucose because it lacks a transport mechanism 
for that sugar (Aharonowltz and Demain, 1978a).
- S. davuHgerus does not produce the same antibiotics as 5. coelicolor. The 
pathways for clavulanic acid and cephamycin C were added and the ones for 
actinorhodin, calcium-dependant antibiotic and undecylprodlgiosin were 
removed.
- S. davuHgerus has been shown to possess an enzyme with arglnase activity 
(Romero et a i, 1986), which S. coelicolor does not possess, giving It a full 
urea cycle.
- A few other reactions were also modified because they were found to be 
Incorrect or had the wrong reversibility or cofactor (NAD  ^or NADP )^.
I further modified the metabolic network by replacing the equations for 
macromolecules and biomass synthesis by the ones determined In Chapter 3. Seven 
reactions were also removed because they were found to be redundant with other 
reactions, causing the system to create loops with extreme flux values. The reactions 
removed were the following:
- rl74 (AKG + 2 FERI + COA = C02 + 2 FERO + SUCCOA - 2-oxoglutarate synthase) 
was deleted because It was redundant with rl68 + rl72 + rl73 (AKG + NAD + COA 
= NADH + C02 + SUCCOA combined together - dihydrollpoyl dehydrogenase + 
oxoglutarate dehydrogenase + dihydrollpoyllyslne-residue succlnyltransferase). 
Transcriptomlcs data showed that the genes encoding the enzymes for the reactions 
rl68 + rl72 + rl73 were much more expressed than the ones for rl74 (data not 
shown). Moreover, rl68, rl72 and rl73 correspond to the reactions found In the 
textbooks. These 3 reactions were rewritten as one (rl73) because rl68 Is also used
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with the pyruvate dehydrogenase. Therefore, combining the reactions together 
enables to get the real flux through the complex.
- r9 (ARABITOL + NAD = LRIBULOSE + NADH) was equal to r6 (ARABITOL + NAD = 
LARABINOSE + NADH) + r8 (LARABINOSE = LRIBULOSE). Therefore, r9 was 
removed.
- rl35 (PHE + AKG = PHPYR + GLU) was equal to r332 (PHPYR + GLU = AKG + 
PHE). Therefore, rl35 was removed.
- rl51 (G6P = bDG6P) + rl53 (bDG6P = F6P) were equivalent to rl52 (G6P = F6P) 
as bDGGP was not used anywhere else in the metabolic network. Therefore, rl52 
was kept and r 151 and rl53 were deleted.
- r247 (AKG + NH3 + NADH = GLU + NAD) was equal to r59 (GLN = GLU + NH3) + 
r246 (AKG + GLN + NADH = NAD + 2 GLU). Therefore r247 was removed.
- r379 (GMP + DATP = GDP + DADP) was removed as It was equivalent to r409 
(DADP + ATP = DATP + ADP) + r412 (GMP + ATP = GDP + ADP).
The reactions for cephamycin synthesis were removed as It was assumed that no 
cephamycin was produced under the conditions used In this study. The final 
metabolic network contained 684 reactions and 587 metabolites. Not all reactions 
were active at all times. For Instance, uptake reactions of carbon sources not present 
in the medium, or reactions Involved In their utilisation, were not relevant for this 
work. These reactions were therefore deactivated by putting their bounds at 0. The 
excretion of organic adds and amino adds was allowed In this model. The final 
metabolic network as well as the abbreviations used for the metabolites are 
presented In the files "S. davuHgerus Metabolic Network.xls" and "5. davuHgerus 
Metabolites Abbrevlatlons.xls" In the attached CD.
4.2.2. Flux Balance Analysis calculation
The program used In this study was developed by Dr Andrzej Klerzec, of the 
University of Surrey, using the Gnu Linear Programming Kit (© Andrew Makhorin). It 
was accessible via an online interface on the University of Surrey's Systems Biology 
server (http://sysblo.sbs.surrey.ac.uk/). The program required an Input file 
containing the list of reactions as well as their default bounds, and a bound file, 
which was specific for each experiment and/or time-point and contained the
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measured fluxes (normally growth rate In h"\ clavulanic add production rate and 
glycerol uptake rate, both In mmol.g DW'\h'^).
An optimization target also had to be chosen to perform the linear programming. The 
choice of an optimization target will be discussed later In this Chapter.
Flux Balance Analysis
Optimisation target:
BIOMASS
Paste bounds file here (if needed)
r S 3 9  0 .0 5  0 .0 5
r 5 7 5  1 .6 1 4 5  1 .6 1 4 5
r 7 0 8  0 .0 0 2 7  0 .0 0 2 7
rS S  0 0
r 2 0 4  0 0
Paste input file here:
r2 S FRÜ + ATP =  F6P + ADP \ 0 1 0 0 0 0 0
r 2  6 FRU = GLC j # - 1 0 0 0 0 0 1 0 0 0 0 0
r 2 7 I-ÎAN6P = F6P 1 # - 1 0 0 0 0 0 1 0 0 0 0 0
r 2 8 I-ÎAN6P = MMÎ1P 1 # -1 0 0 0 0 0 1 0 0 0 0 0
r 2 9 GTP + MANIP =  PPI + GDPMAN 1 # 0 1 0 0 0 0 0
r 3 0 GLAC + .ATP =  GALIP + ADP 1 # 0 1 0 0 0 0 0
r 3 1 UDPG = UDPGAL | # -1 0 0 0 0 0 1 0 0 0 0 0
r 3 2 UTP + GALIP = P PI + UDPGAL 1 f - 1 0 0 0 0 0 1 0 0 0 0 0
r 3 3 GIP + UTP =  UDPG + P PI 1 # - 1 0 0 0 0 0 1 0 0 0 0 0
r 3 4 RAF -  GLAC + s u e  | # 0 1 0 0 0 0 0
=tTarHvr>qF — c a p  * a r .a r  i £ n 1 nnnnn
Figure 4.1.: Screenshot of the Input screen of the FBA software. The optimisation target (biomass, 
clavulanic acid, etc.) is entered in the first window. The bounds file, containing the different constraints 
(measured fluxes, reactions not relevant to the medium used, etc.) is entered in the second window, 
and the third window contains the input file, which is a list of the model's reactions with their default 
bounds. The bounds from the bounds file overwrite the default bounds of the input file.
In the Input file, the biomass composition equation was specific for each sample. As 
detailed In Chapter 3, the biomass composition was measured for each of the 
chemostats. In batch culture, because of the large number of time-polnts and the 
large samples already taken for analysis, It was not possible to take large samples for 
macromolecular analysis without changing the volume significantly; therefore a 
separate batch cultivation was run to obtain a macromolecular profile In batch 
cultivation. The samples from the three other batch cultivations were then matched 
to the time-polnts of the batch cultivation run for macromolecular analysis as 
detailed In Table 4.1.
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TSl Equivalent to TS3 Equivalent to
1 T l 1 T l
2 T 2 2 T2
3 T 3 3 T2
4 T 4 4 T 2
5 T 5 5 T3
6 T 9 6 T3
7 T 4
8 T 4
TS2 Equivalent to 9 T 5
1 T l 10 T 5
2 T l 11 T 6
3 T 2 12 T6
4 T 3 13 T 7
5 T 4 14 T 7
6 T 6 15 T 8
7 T 8 16 T 9
Table 4.1.: Matching of the samples of the three time series to the 
samples of the batch culture run to measure macromolecular composition. Each sample of the three 
time series was matched with a sample of the batch culture run to measure macromolecular analysis by 
identifying the sample with the closest clavulanic acid and growth rates.
The output file gave the list of flux values needed to optimise the given function as 
well as the value of the optimised function:
5 87M e t a b o l i t e s  ;
R e a c t io n s :  684
S t a t u s :  O PTIM ftL
O b je c t i v e ;  BIOMASS =  0 .0 6 6 8 7 0 3 6 0 7 5  (MAXimum)
R e a c t io n  
r l  
r2 
rS 
r4 
r5 
r6  
r 7  
rSn o  n i  
r l2  
r l3  
x l4  rl5 rl6 
r l7  
r l8  
r l9  
r20  
r21  r22 
r23  r24 
r25  x26 
r27
6 1 4 5
F lu x  0 
0 
0
.0 0 0 3 1 0 0 4 4
0
- 1 0 0 0 0 0
- 1 0 0 0 0 0
-1 0 0 0 0 0
0
0
0
-1 0 0 0 0 0
- 1 0 0 0 0 0
-1 0 0 0 0 0
-1 0 0 0 0 0
0
-1 0 0 0 0 0
0
-1 0 0 0 0 0
0
-1 0 0 0 0 0
0
0
0
-1 0 0 0 0 0
- 1 0 0 0 0 0
L o w e r  b o u n d  
1 0 0 0 0 0  r l  
1 0 0 0 0 0  r 2  
1 0 0 0 0 0  r 3
1 0 0 0 0 0
1 0 0 0 0 0  r 5  
1 0 0 0 0 0  r 6  
1 0 0 0 0 0  
1 0 0 0 0 0  
1 0 0 0 0 0  r lO  
1 0 0 0 0 0  r l l  
1 0 0 0 0 0  
1 0 0 0 0 0  
1 0 0 0 0 0  
1 0 0 0 0 0  
1 0 0 0 0 0  
1 0 0 0 0 0  
1 0 0 0 0 0  
1 0 0 0 0 0  
1 0 0 0 0 0  
1 0 0 0 0 0  
1 0 0 0 0 0  
1 0 0 0 0 0  
1 0 0 0 0 0  r 2 4
1 0 0 0 0 0  r 2 5
1 0 0 0 0 0  
1 0 0 0 0 0
r 7
r 8
r l 2
r l 3
r l 4
r l 5
r l 6
r l 7
r i a
r l 9
r 2 0
r 2 1
r 2 2
r 2 3
r 2 6
r 2 7
U p p e r  b o u n d  Th e  l i n e  f r o m  m o d e l f j  
GL + ATP =  GL3P +  ADP | #
GL3P + MK =  DHAP + MKH2 J #
T3  i- NAD =  NADH + DGLYCERATE | 
r 4  DGLYCERATE +  ATP =  3PG +  ADP
R IB  + ATP =  RSP 4  ADP | #
ARA B ITO L f  NAD = LARABINOSE +  NADH 
ARA B ITO L -r NAD =  LXYLÜLOSS 4 NADH 
LARABINOSE =  LRIBULOSE | #
LRIBULOSE +  ATP =  LR IB Ü LO SE5P +  ADP
LXYLULOSE + ATP =  LXYLUL0SE5P + ADP
LXYLÜLOSE +  ATP =  LXYLULO SEIP  + ADP
LXYLUL0SE5P =  LR IB U L0S S 5P  
LR IB U LO SE5P =  X5P  |
X Y L ÏT O L  + NAD =  LXYLULOSE +  
XYL + NADH =  X Y L IT O L  + NAD 
X Y L IT O L  + NAD =  DXYLULOSE +  
XYL =  DXYLULOSE | #
DARABITOL + NAD =  DXYLULOSE 
DLYXOSE =  DXYLULOSE |
DXYLULOSE + ATP =  X5P  
LLYXOSE =  LXYLULOSE 
F IP  + ATP =  FDP + ADP
F IP  =  DHAP + T 3  I
FRU +  ATP =  F6P  + ADP
FRU =  GLC 1
MAN6P =  F6P I
ADP
I
IT
NADH
I
NADH
-lOOOC  
+  NADH #
I
#
0#
-lOOOC
-1Û 00C
Figure 4.2. : Screenshot of the output screen of the FBA software. The upper part of the output gives 
details of the network (number of metabolites and reactions) as well as the result of the optimisation 
(optimal or undefined, value of the objective function). The rest of the file gives the calculated flux for
each reaction in the second column.
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The data could then be copied into an electronic spreadsheet (Microsoft Excel) for 
further analysis.
4.3. Results and Discussion
4.3.1. Estimation of bioenergetics parameters
While designing a metabolic model, it is very important to estimate the bioenergetics 
parameters such as P/0 ratio, growth-associated maintenance energy and non­
growth-associated maintenance energy.
Stouthamer and Bettenhaussen (1973) showed that the rate of ATP production rATP is 
equal to the ATP consumed for growth Yxatp-P and maintenance mAjp/ where p is the 
specific growth rate and Yxatp is the ATP yield coefficient. Borodina et al. (2005) 
estimated Yxatp and mAjp by varying them until they obtained a good fit with the 
experimental data, and the P/0 ratio was fixed to 1.5.
The bioenergetics parameters of the model used on this study were also varied in 
order to find the best fit with the measured data. Interestingly, the parameter values 
chosen by Borodina a t at. also gave us the best fit (data not shown) and were 
therefore used for further simulations.
4.3.2. Choice of optimisation function
When using Flux Balance Analysis, it is necessary to choose an objective function 
that is going to be either minimised or maximised. In order for the flux distribution to 
be realistic, the optimisation function must be relevant to the system studied. A 
classic optimisation is maximisation of the biomass, which is often considered as the 
main goal of microorganisms. However, it is sometimes more relevant to optimise 
the production of a particular product, if one is interested in finding out what flux 
distribution will enable this maximum productivity. It is also possible to minimise the 
utilisation of the carbon, nitrogen or phosphate source, assuming that the 
microorganisms have evolved to maximise the biomass yield.
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In order to determine which optirnisation function to use in this study, FBA 
simulations were run optimising different objective functions: biomass production 
maximisation, glycerol uptake minimisation, clavulanic acid production maximisation, 
ammonium uptake minimisation, and phosphate uptake minimisation.
These comparisons were performed using the average data from the chemostats at 
low and high dilution rates (0.02 and 0.05 h '\ respectively), as described in Chapter 
2, as well as the biomass composition data described in Chapter 3.
D (dilution rate, h^) 0.02 0.05
Glycerol uptake rate (mmol.gDW'^.h'^) 0 .7 3 0 1 .615
Clavulanic acid production rate (mmol.gDW 0 .0 0 4 0 .0 03
CO2 production rate (mmol.gDW \h ^ ) 0.9 43 2 .0 43
O2 production rate (mmol.gDW'^.h.i) 1.232 2.527
Table 4.2.: Average data for the chemostat cultures at D = 0.02h‘  ^ and D = O.OSh'
The biomass composition equation at D =0.02 h'  ^was assumed to be:
0.474 PROTEIN + 0.0573 RNA + 0.0327 DNA + 0.056 PHOSPHOLIPID + 0.084 TAG 
+ 0.03 SMALL MOLECULES + 0.095 PEPTIDOGLYCAN + 0.065 TEICH + 0.0426 TRE 
+ 0.0873 CARB + 47 ATP = BIOMASS + 47 ADP + 47 PI
whereas the biomass composition equation at D = 0.05 h'^  was assumed to be: 
0.5552 PROTEIN + 0.0804 RNA + 0.0385 DNA + 0.051 PHOSPHOLIPID + 0.034 TAG 
+ 0.03 SMALL MOLECULES + 0.095 PEPTIDOGLYCAN + 0.07 TEICH + 0.0184 TRE + 
0.0455 CARB + 47 ATP = BIOMASS + 47 ADP + 47 PI
For the biomass optimisation, glycerol uptake rate and clavulanic acid production 
rate were used as constraints. For glycerol uptake minimisation, specific growth rate 
and clavulanic acid production rate were used as constraints. For clavulanic acid 
production maximisation, specific growth rate and glycerol uptake rate were used as 
constraints. Finally, for ammonium and phosphate uptake minimisation, specific 
growth rate, glycerol uptake rate and clavulanic acid production rate were used as 
constraints. The constraints were chosen so that a maximum of constraints were 
applied to the model. The results of the simulations are shown in Table 4.3.
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Except for clavulanic acid production optimisation, which predicted clavulanic acid 
production rate to be much higher than the observed rate at D = 0.05h"\ the 
different optimisations gave about the same average error. The optimisation of either 
nitrogen or phosphate uptake enabled to use three constraints instead of two. It was 
therefore decided to use phosphate uptake minimisation as the optimisation function. 
Since the medium is phosphate-limited, it also seemed sensible to assume that the 
organism would try to minimise the uptake of that nutrient. The simulated CO2 and 
O2 rates were slightly more accurate with the other optimisations than with 
phosphate uptake minimisation. However, the measured CO2 and O2 rates were the 
rates with the highest potential error, as the instrument used to measure them was 
not very precise. Biomass, glycerol, and clavulanic acid concentrations, on the other 
hand, were measured using accurate methods, generally giving a very low standard 
deviation.
Table 4.3. also showed that, when optimising biomass, the simulated value at D = 
O.OZh"^  was very close to the measured value (0.76% error). The same was true 
when glycerol uptake rate was optimised: the error was only of 0.41%. However, at 
D = 0.05h'\ the error when the biomass production was optimised became 32.65% 
and the error when glycerol uptake rate was optimised became 19.63%. These 
results imply that, at D = 0.02h"\ S. davuligeruÉ metabolism functions very 
efficiently, and the system can be accurately modelled. However, at D = 0.05h'\ the 
simulation suggests that the organism could in theory produce more biomass with 
the amount of glycerol used. Therefore, some carbon must be used to produce other 
metabolites that we have not measured, such as excreted organic or amino acids.
The results of the maximisation of clavulanic acid production also gave some 
interesting information. The maximum clavulanic add production rate at D = O.OZh^  
was close to the actual production rate (20% error). However, at D = 0.05h‘\  the 
actual production rate was 3000% lower than the calculated maximum production 
rate. This suggests that, at D = 0.02h \  clavulanic acid production rate is not 
restricted by a phenomenon such as transcription repression or end-product 
inhibition, while it is very restricted at D = 0.05h'\ We have discussed before the 
complexity of clavulanic acid production regulation. This example confirms that 
clavulanic acid production gets somehow inhibited at higher growth rates.
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Finally, these calculations showed that the calculated CO2 and O2 rates were almost 
always higher than the measured rates. Although it has been mentioned before that 
the measured CO2 and O2 rates might not be completely accurate, it seems likely 
that there are other factors affecting these results. One explanation could be that the 
model was not completely correct, since it was based on the genome of a different 
organism, which had not been completely annotated. As explained earlier, a large 
number of reactions were manually added in order to create a viable metabolic 
model. Another explanation could be that we did not measure enough metabolites. 
The accuracy of the simulation is limited by the accuracy of the model but also by 
the accuracy and the number of constraints applied to that model. If 5. ctavuUgerus 
produced considerable amounts of organic acids, amino acids, or other metabolites, 
the model would not necessarily have been able to predict it based solely on the few 
constraints used.
4.3.3. Comparison with previous studies
Several authors have showed that feeding 5. davuHgerus with various compounds 
enabled a higher clavulanic acid yield. Ives and Bushell (1997) and Bushell et a!. 
(2006) studied the effect of feeding the culture with various amino acids. Both based 
their feeding strategy on the assumption that clavulanic acid production is limited by 
the availability of the C3 precursor, glyceraldehyde-3-phosphate. Ives and Bushell 
(1997) performed a clustering analysis of the intracellular amino acids and clavulanic 
acid production rates in phosphate-limited chemostat culture between 0.03 and 0.09 
They then supplemented the medium of a chemostat culture (0.03h'^) with 
amino acids found to be clustered with clavulanic acid, as well as arginine which, 
despite not being clustered with clavulanic acid, is the C5 precursor of the antibiotic. 
Bushell etaL (2006) supplemented the medium of a chemostat culture (0.03h'^) with 
amino acids derived from oxaloacetate, which would normally compete with 
clavulanic acid for glyceraldehyde-3-phosphate utilisation. In both the above studies, 
the medium used was the same as the one used in the batch and chemostat cultures 
of this study, except that the phosphate concentration they used was lower: glycerol, 
60g.L^; NH4CI, 7g.L'^; KH2PO4, O.lg.L’ ;^ MOPS, 21g.L’ ;^ trace elements (cf. Chapter 
2), lOmL.L ^ Chen et al. (2003) studied the addition of ornithine and arginine to a
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shake flask complex culture medium (glycerol, 15g.L^; soy meal extract, 500 mL.L^; 
peptone, lOg.L ^ ; KH2PO4, Ig.L'^). The additions carried out In these experiments will 
be simulated in our model.
In order to simulate the addition of amino acids, FBA was run using the constraints 
and biomass composition of the chemostat cultures at D = 0.02h'\ except the 
clavulanic acid production rate, which was chosen as the optimisation function. The 
addition of each amino acid was simulated by constraining this amino acid's transport 
reaction to 0.01 mmol.g biomass'\h'\ The amino acid concentrations added in slllco 
does not necessarily correspond to the concentrations added in the experiments 
described above, but the aim of this simulation is simply to compare the effect of 
different amino acids both in vivo and in siiico. Furthermore, the conditions used in 
our study differ from the conditions used in previous studies (culture type, medium, 
dilution rate), so a direct comparison would not be possible. The results of both our 
simulation and the previous experiments are shown in Table 4.4. Table 4.4. shows 
that feeding amino acids derived from oxaloacetate and/or closely clustered with 
clavulanic acid enabled the achievement of a much higher clavulanic acid yield. It 
also shows that FBA simulation generally agreed with the experimental data. For 
instance, FBA suggested that isoleucine was a better supplement than asparagine or 
aspartate. This result was validated by Bushell e t ai/s results. The main difference 
between the predicted results and the actual results was the effect of arginine. FBA 
predicted that arginine was one of the best additions, whereas Ives and Bushell 
(1997) and Chen et ai. (2003) both showed that it had no effect on clavulanic acid 
yield. Strangely, Chen et ai. (2003) showed that ornithine, unlike arginine, had a 
strong positive effect on clavulanic acid production. As illustrated on the map below 
(Figure 4.3.), ornithine is a precursor of arginine. Therefore, if supplementing 
arginine did not help improve the yield, ornithine was not expected to improve it 
either. Chen et ai. (2003) suggested that this lack of positive effect could be due to 
the pH fluctuation observed after addition of arginine. However, the pH was kept 
constant in Ives and Bushell's experiment. Another hypothesis is that the presence of 
high concentration of arginine represses clavulanic acid synthesis, possibly through 
arginine boxes (de la Fuente et ai., 2004). This was discussed in more details in 
Chapter 1. Finally, Chen et ai. (2003) used a complex medium, in which the 
interactions between nutrients could have been different.
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D6PGL D6PGC
RL5P R5P PRPP
glucose-6-P
XYL5P AlCAR
E4P
glycerol F6P
GL-3-P FDP :D7P
DHAI G3P clavulanic acid
1,3 PDG
cysteine serine <—3PG arginosuccinate
2PG
isoleucine ^ 
valine -*■ 
leucine
citrulline arginine
pyruvate
Ac-CoA
isoleucine
ornithine
glycine *4—threonine :;itrate
oxaloacetateaspartate <■ isocitrate glutamate
asparagine
aketogluterate
malate
fumarate
succinyl-CoA
Figure 4.3.: Map illustrating the synthesis of the different amino acids 
as well as the links between them
This comparison showed that, to some extent, FBA can be used to predict the effect 
of supplementation. However, FBA can not predict events such as end-product 
inhibition or transcription repression. The accuracy of the simulation is also restricted 
by the accuracy of the metabolic network itself. This network was based on the 
genome annotations of a different organism, which is itself not completely 
annotated. The reversibility of some enzymes is also still unknown and this 
uncertainty can lead to some biologically unfeasible flux patterns.
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4.3.4. Metabolic Fluxes in batch culture
FBA simulations were run for each time point of each batch culture (cf. Chapter 2 for 
details on the cultures), using phosphate uptake minimisation as the optimisation 
function. A correction was applied to each set of flux to take into account the 
different carbon inputs: each flux was normalised to the flux of r575, the glycerol 
uptake reaction. For each reaction, the Spearman correlation coefficient between the 
fluxes at every time point and the clavulanic acid production fluxes at every time 
points (r708) was then calculated. The Spearman correlation is a non-parametric 
measure of correlation. It is equivalent to Pearson correlation on ranks.
For instance, in the following example, the correlation coefficient will be calculated 
between the r64 line and the r708 line, and then between the r l l3  line and the r708 
line.
Reaction Time 1 Time 2 Time 3 Time 4 Time 5 Spearman correlation coefficient with r708
r64 0 .0 084 71 0 .0 3 5 7 8 4 0 .0 0 9 3 3 9 0 .0 0 4 1 3 5 0 .0 0 1 5 0 9 -0 .6
r l l3 0 .0 1 3 9 7 4 0 .0 5 7 3 7 4 0 .0 1 3 3 9 9 0 .0 0 4 2 6 4 0 .0 0 0 8 1 9 -0 .8
r708 0 0 .0 0 0 5 4 1 0 .0 0 0 7 7 0 .0 0 1 3 9 8 0 .0 0 0 9 8 6
Table 4.5.: Example of calculation of the Spearman correlation coefficient
At some early time points, no or very little glycerol was used, making the system 
impossible to solve. At some late time points, no biomass was produced, giving 
invalid sets of fluxes.
-T S l:
The last time point of this time series was not used to calculate the correlation 
coefficients as no biomass was produced according to our measurements, yielding 
incoherent flux sets.
-TS2:
In TS2, the fluxes of the first two time points could not be resolved. At the first time 
point, no glycerol was being used, according to our measurements, although some 
biomass was being produced. Therefore, the fluxes could not be resolved, as no 
carbon entered the metabolic network. At the second time point, the fluxes could not 
be resolved either, probably because the measured amount of glycerol utilisation
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could not sustain the measured biomass production. This could be explained by an 
error in measurement because the biomass in the lag phase is very low (about 0.2- 
0.3 g.L-1), and the glycerol is used too slowly for the changes to be measured very 
accurately.The last time point could not be used either for the calculation of 
correlation coefficients, as no biomass was produced, yielding incoherent fluxes. As a 
result, only 4 time points could be used to calculate the correlation coefficients, 
leading to extreme correlation coefficients (most of them >0.9 or <-0.9). Therefore, 
TS2 could not be used to study the correlation between clavulanic acid production 
fluxes and other fluxes.
-TS3:
TS3 is the time series that could yield the most significant data because it had much 
more time points that could be used to calculate correlation coefficients than TSl 
and TS2, making the results more reliable. The fluxes at the first time point could not 
be resolved, for the same reasons as mentioned above, and no biomass was 
produced at the last time point, yielding incoherent fluxes. As a result, 14 sets of 
fluxes were obtained for TS3 (time points 2 to 15).
The average correlation coefficients were the calculated for TSl and TS3. By 
averaging the correlation coefficients in TSl and TS3, the fluxes positively correlated 
to the production of clavulanic acid are shown in Table 4.6.
Pathway Reaction Enzyme
Pyruvate metabolism MAL + NAD = C02 + NADH + PVR malate dehydrogenase
Valine utilisation VAL + NAD = NADH + NH3 + OMVAL valine dehydrogenase
Valine utilisation OMVAL + LIPO = IBUTLIPO + C02 3-methyl-2-oxobutanoatedehydrogenase
Valine utilisation COA + IBUTLIPO = DLIPO + IBUTCOA
dihydrolipoyllysine-residue
acetyltransferase
Valine utilisation IBUTCOA + MK = MACRCOA + MKH2 acyl-CoA dehydrogenase
Valine utilisation MACRCOA = HIBUTCOA enoyl-CoA hydratase
Valine utilisation HIBUTCOA = HIBUT + COA 3-hydroxyisobutyryl-CoA hydrolase
Valine utilisation HIBUT + NAD = METHYLMALONATES + NADH 3-hydroxyacyl-CoA dehydrogenase
Valine utilisation
METHYLMALONATES + NAD + 
COA = PROPIONYLCOA + NADH + 
C02
methylmalonate-semialdehyde 
dehydrogenase (acylating)
Transport reactions UREA = UREAxt urea transport via facilitate diffusion
Table 4.6.: Fluxes positively correlated to the production of clavulanic acid in TSl and TS3
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The negatively correlated coefficients are shown in Table 4.7.
Pathway Reaction Enzyme
Coenzyme-A biosynthesis ASP = C02 + bALA aspartate 1-decarboxylase
Aspartate biosynthesis OA + GLU = ASP + AKG aspartate transaminase
Propanoate metabolism SMMALONYLCOA = PROPIONYLCOA + C02 methylmalonyl-CoA decarboxylase
Isoleucine utilisation RMMALONYLCOA = SMMALONYLCOA methylmalonyl-CoA epimerase
Isoleucine utilisation SUCCOA = RMMALONYLCOA methylmalonyl-CoA mutase
Table 4.7.: Fluxes negatively correlated to the production of clavulanic add In T S l and TS3
In order to obtain a better understanding of the flux patterns, a map (Figure 4.4.) 
was drawn representing the positive correlations in red and the negative correlations 
in green. Urea is produced during clavulanic acid synthesis. Therefore, it was logical 
to find the reaction for urea excretion positively correlated to clavulanic acid 
production. The molecule propionyl-CoA seemed to be playing an important role, as 
a few reactions leading to it were either up- or down-regulated. Propionyl-CoA is 
involved in fatty acid synthesis. As growth rate declines, and clavulanic acid 
production increases, the biomass lipid content increases as well. The more 
clavulanic acid was produced, the more propionyl-CoA was produced from valine and 
not succinyl-CoA. One of the reasons could be that the network required the TCA 
cycle to operate faster, or at least at the same rate, when clavulanic acid increased, 
and this was only possible if propionyl-CoA was not produced from succinyl-CoA. The 
flux through the malic enzyme, catalysing the conversion of malate to pyruvate, was 
positively correlated to clavulanic acid production, and the flux from acetate to 
aspartate was negatively correlated, suggesting that the flux through the last step of 
the TCA cycle decreased as clavulanic acid increased. In fact, the flux through the 
malate dehydrogenase was very low, and negative in most samples, yielding malate 
from oxaloacetate. It was somehow surprising to see that aspartate synthesis was 
negatively correlated to clavulanic acid synthesis because aspartate is involved in 
arginine synthesis but, as demonstrated by Kirk et a!. (2000), glyceraldehyde-3- 
phosphate, and not arginine, is the limiting precursor of clavulanic acid. As growth 
rate decreases and clavulanic acid synthesis increases, the biomass protein content 
decreases. Therefore, the requirement for amino acids decreases as well, which 
might also explain why the flux from oxaloacetate to aspartate decreased while the 
flux from valine to propnionyl-CoA increased.
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The above analysis suggested that, as clavulanic acid production rates Increased, flux 
through the TCA cycle was limited because some of the carbon was redirected 
towards clavulanic acid. This might be detrimental to the production of clavulanic 
acid. In order to check this assumption, FBA was run by simulating the addition of 
citrate and succinate at sample 7 of the third time series (highest clavulanic acid 
production rate) and optimising clavulanic acid production. When the addition of 0.01 
mmol.g'Mv^ citrate was simulated, the maximum clavulanic acid flux increased by 
0.003 mmol.g'\h"\ and when the addition of 0.01 mmol.g'\h'^ succinate was 
simulated, the maximum clavulanic acid flux increased by 0.002 mmol.g'\h'^ proving 
that replenishing the TCA cycle enables some alleviation of the limitation on 
clavulanic acid production. Therefore, supplementing the medium with intermediates 
of the TCA cycle should enable to obtain a higher clavulanic acid yield.
The flux from valine towards propionyl-CoA was also up-regulated when clavulanic 
acid increased. When an addition of 0.01 mmol.g'\h"^ valine was simulated, the 
maximum clavulanic acid flux increased by 0.0036 mmol.g'\h'\ Therefore, another 
strategy to increase clavulanic acid biosynthesis could be to supplement the medium 
with valine. This has already been proved to be a successful strategy by Ives and 
Bushell (1997).
4.3.5. Metabolic Fluxes in chemostat culture
FBA simulations were run for each of the two dilution rates (cf. Chapter 2 for details 
on the cultures), using phosphate uptake minimisation as the optimisation function. 
The average data for the two dilution rates (cf. 4.3.2.) were used as constraints. A 
correction was applied to each set of flux to take into account the different carbon 
inputs: each flux was normalised to the glycerol uptake rate, r575. The list of all 
changed fluxes is presented is appendix 2. The fluxes are also represented on the 
map below (Figure 4.5.).
Many up- or down-regulated fluxes belonged to macromolecular compound 
pathways. The biomass at D = 0.05 h'  ^ contained more protein, DNA and RNA, 
therefore it was normal to find a lot of fluxes involved in amino acids and nucleotides 
synthesis in the fluxes higher at D = 0.05 h '\ More sulphate was also required to
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produce the sulphur-containing amino acids, which explains why the reactions of the 
sulphate metabolism pathway were also upregulated. Similarly, the biomass 
contained more lipids, trehalose and other carbohydrates at D = 0.02 h '\ therefore it 
followed that the reactions leading to lipids, trehalose and carbohydrates had higher 
fluxes at D = 0.02 h '\ Of course, the reactions of the clavulanic acid pathway as well 
as the urea excretion reaction were also found on the list of reactions up-regulated 
at D = 0.02 h '\
One reaction of the valine biosynthesis pathway (r263, OIVAL + GLU = AKG + VAL) 
as well as 8 reactions of the valine utilisation pathways (r87, r88, r89, r90, r91, r92, 
r93, r94, r95, giving the lumped reaction ; VAL + MK + 3 NAD + LIPO + COA = 3 
NADH + NH3 + 2 C02 + DLIPO + MKH2 + PROPIONYLCOA), and one of the 
isoleucine utilisation pathway (r77, RMMALONYLCOA = SUCCOA) were also present 
on the list of reactions with a higher flux at D = 0.02 h '\ These reactions were also 
found in batch to correlate well with clavulanic acid biosynthesis reactions. They 
seemed to enable the TCA cycle to operate faster under clavulanic acid producing 
conditions by relieving it from propionyl-CoA synthesis. When an addition of 0.01 
mmol.g"\h'^ pyruvate was simulated, the maximum clavulanic acid flux increased by 
0.0017 mmol.g Sh’  ^ (36%), while an addition of 0.01 mmol.g'\h'^ citrate increased 
the maximum clavulanic acid flux by 0.003 mmol.g'\h'^ (64%). Therefore, feeding 
these two organic acids might help increase the clavulanic acid biosynthesis.
Ys g S ï i f l ?
& M  «i
î '
Chapter 4. Flux Analysis of S t r e p t o m y c e s c l a v u l ig e r u s ih  118
Batch and'in Chemostat
As shown on the map above (Figure 4.5.), the enzyme malate dehydrogenase of the 
TCA cycle changed direction between D = 0.02h’  ^ and D = 0.05h'\ At the highest 
dilution rate, it went In the following direction: MAL + NAD = NADH + OA, while at 
D = 0.02h"\ malate was being produced. On the other hand, malate was being 
consumed at D = 0.02h‘  ^ by the pyruvate-forming enzyme malate oxydoreductase 
(MAL + NAD = C02 + NADH + PYR), which was inactive at D = 0.05h'\
The last reaction of the glycolysis pathway, leading from pyruvate to acetyl-CoA 
(catalysed by pyruvate dehydrogenase) was also only active at D = 0.02h'\ 
Furthermore, the reaction ACCOA + ATP + C02 = MALCOA + ADP + PI catalysed by 
the enzyme acetyl-CoA carboxylase was also more active at D = 0.02h'\ Malonyi- 
CoA was then utilised in the lipid biosynthesis pathway. Therefore, the flux values 
suggested that these reactions, eventually yielding malonyl-CoA, could have higher 
fluxes at D = 0.02h‘  ^ in order to sustain a higher production of lipids. When an 
addition of 0.01 mmol.g'\h'^ malate was simulated, the maximum clavulanic acid flux 
increased by 0.002 mmol.g'\h'^ (42%). Supplementing the medium with malate 
could therefore be another strategy for increasing clavulanic acid biosynthesis.
The non-oxidative part of the pentose phosphate pathway was down-regulated at D 
= 0.02h'^ This meant that less ribose-5-phosphate was synthesised, and therefore 
less PRPP (5-Phospho-alpha-D-ribose 1-diphosphate). PRPP is the precursor for 
nucleotide synthesis, as well as histidine, tryptophan, and NAD synthesis. It is also 
Involved, through GTP, in folate and riboflavin synthesis. NAD kinase, catalysing the 
conversion of NAD into NADP, is also down-regulated at D = 0.02h"\ The fact that 
the biomass content of RNA, DNA and protein was lower at D = 0.02h'^ than at D = 
O.OSh'^  might explain why this pathway was down-regulated at D = 0.02h'\
4.3.6. Comparison of metabolic fluxes in batch and in chemostat 
cultures
The results of FBA in batch and chemostat cultures seemed to be in good agreement 
when one considers the correlation of fluxes with clavulanic acid production. For 
instance, both in chemostat and batch cultures, the reactions yielding propionyl-CoA 
seemed to play an important role. When clavulanic acid production was low, 
propionyl-CoA was synthesised from succinyl-CoA, whereas it was derived from
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valine when clavulanic acid production was high. Moreover, the pyruvate-forming 
enzyme malate oxydoreductase (MAL + NAD = C02 + NADH + PYR) was inactive at 
D = 0.05h'\ It was also positively correlated to clavulanic acid production in batch 
culture.
Based on the FBA results, it can be suggested that a chemostat culture at a low 
growth rate is a good model of the clavulanic acid production phase in batch, while a 
chemostat at a high growth rate is a good model of the exponential or linear phase 
in batch.
4.3.7. Effect of varying the amount of clavulanic acid produced
In order to separate the effect of varying the amount of clavulanic acid produced 
from the effect of varying the growth rate or the glycerol uptake, two FBA 
simulations were run using phosphate uptake minimisation as the optimisation 
function and the constraints and biomass composition from the chemostat cultures at 
D = 0.05h'\ In the first simulation, clavulanic acid flux was set at the flux observed 
at D = O.OSh'^  (0.027 mmol.g' .^h'^). In the second simulation, clavulanic acid was set 
to 0.08 mmol.g'\h'\ which is close to the flux obtained when clavulanic acid 
production was maximised. The full list of the reactions changing when constraining 
clavulanic acid flux to a high or low value is presented in appendix 3. The results are 
also shown on the map below (Figure 4.6.).
When clavulanic acid flux was high, the flux through glycolysis was lower by 0.08 
mmol.g"\h'^ because carbon was redirected towards clavulanic acid production. As a 
result, the flux through the TCA cycle was also lower. Not only did the TCA cycle 
receive less carbon from glycolysis, but it also supplied precursors for clavulanic acid. 
The pentose phosphate pathway, however, remained unchanged. As the fluxes 
through glycolycis and the TCA were lower, the oxidative phosphorylation was less 
active: the flux through succinate dehydrogenase and the oxygen uptake were both 
lower. More NH3 was transported Into the cell, as it was needed to produce 
glutamate and glutamine, which are precursors of arginine. Some fluxes from the 
cysteine, methionine, threonine and isoleucine pathways were also changed, so that 
the overall reaction was followed at low clavulanic acid flux: HSER + SUCCOA = NH3
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+ OBUT + SUCC + COA, while at high clavulanic acid flux, the reaction was: HSER +  
ATP = ADP + OBUT + NH3 + PI. This could be explained by the fact that less carbon 
went through the TCA cycle, making it difficult for the organism to use succinate-CoA 
to produce 2-oxobutanoate. Similarly, glyoxylate followed different pathways 
depending on the clavulanic acid flux. At low clavulanic acid flux, glyoxylate followed 
the reaction ACCOA + GLX = COA + MAL while at high clavulanic acid flux, it 
followed the lumped reaction 2 GLX + NADH + ATP = 3PG + ADP + NAD + 2 C02. 
Once again, at high clavulanic acid flux, the reaction did not require the utilisation of 
TCA cycle or glycolysis intermediates whereas at low clavulanic acid flux. It did use 
acetyl-CoA. Obviously, the reactions directly leading to clavulanic acid and its 
precursors also presented higher fluxes at high clavulanic acid flux. Finally, the flux 
through NADPH dehydrogenase was reduced at high clavulanic acid flux, possibly 
because NADPH is required in the clavulanic acid pathway.
These simulations illustrated the diversity of reactions which varied when clavulanic 
acid production alone was varied. It was interesting to observe that the flux through 
several reactions from amino acid pathways was changed when clavulanic acid flux 
changed, in a way that would have been impossible to predict by simply observing 
the metabolic network. This suggests once again that feeding the organism with 
certain amino acids could help clavulanic acid production. Threonine, which has 
already been proved to have a positive effect on clavulanic acid production (Bushell 
e t a i, 2006), appears once again as a potential supplement. Glutamate would also 
be expected to enhance the clavulanic acid production, and simulating its addition 
does yield a higher yield. However, Bushell e t aL (2006) showed that glutamate did 
not have any effect of clavulanic acid production. This could be due to a regulation of 
clavulanic acid production by a phenomenon such as transcription repression or end- 
product inhibition.
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4.3.8. Conclusions and future work
The genome scale metabolic network used in this study seemed to be able to predict 
with relative accuracy the distribution of metabolic fluxes of Streptomyces 
davuHgerus. The best simulations were obtained when phosphate uptake was 
minimised. However, when studying the effect of supplements on clavulanic acid, for 
instance, it was more useful to optimise clavulanic acid production. One of the 
downside of using a static metabolic network is that regulation by end-product 
inhibition or transcription repression can not be taken into account. This can lead to 
inaccurate simulations. It is also important to remember that this network was 
constructed based on the annotations of the genome of a different species 
{Streptomyces coelicoloi). These drawbacks might hamper the accuracy of the 
predictions.
The simulations operated using the batch and chemostat data available suggested 
the use of different supplements in order to produce more clavulanic acid. Some had 
already been tested and either showed to be useful (threonine) or showed to have 
no effect (arginine, glutamate). The addition of the organic acids maiate, pyruvate 
and citrate was also suggested as a way to Increase clavulanic acid production, and 
their simulation showed an increase in the flux towards the antibiotic. The FBA of 
chemostat and batch data also revealed that the results from batch and chemostat 
were comparable when considering flux associated to clavulanic acid production.
It was also found useful to run simulations by changing only one parameter at a time 
(here, clavulanic acid flux) in order to dissociate the effect of this parameter from the 
effect of other parameters, such as growth rate or glycerol uptake.
In the future, it would be useful to measure more external fluxes in order to apply 
more constraints to the model and make it more accurate.
In order to curate the network itself, it might be possible to use microarray data in 
order to predict which reactions are present or not in 5. davuHgerus, as well as 
which genes are active or not. However, it is important to remember that the 
microarrays that are presently available have also been designed for S. coelicolor, 
and the information obtained from them has to be used carefully. If  a gene appears
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to be absent on these microarrays, it could be because the probe on the microarray 
is specific for a portion of the gene sequence that is different between 5. davuHgerus 
and 5. coelicolor.
Performing FBA on chemostats at several different dilution rates would also be very 
interesting as chemostats are better tools than batch cultures to perform FBA. 
Chemostats are very reproducible and, being at steady-state, the measurement of 
external metabolites is much more reliable.
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5.1. Introduction
5.1.1. DNA microarrays
The term 'DNA microarrays' describes an experimental format in which probes representing 
genes that one wants to study are affixed to a substrate (e.g., a glass slide) and then 
exposed to target molecules. The level of hybridization between a specific probe and a target 
(typically indicated through fluorescence and measured through image analysis) indicates the 
level of the gene corresponding to that probe in the test solution.
The terminology of this new technology is still evolving and DNA microarrays have many 
synonyms such as DNA chip, biochip, gene array, genome chip etc.
The principle behind microarrays is that the quantification of mRNA levels under different 
conditions indicates what genes are being transcribed. The study of the ievel of transcription 
of an organism's genes can be referred to as transcriptomics.
5.1.2. Application of DNA microarrays in functional genomics
As Chater e t ai. (2002), as well as Huang e t ai. (2001), highlighted, one of the main 
applications of microarrays is to analyse the dynamic changes in the transcriptome of an 
organism during its different growth phases. The transcriptome is the set of all messenger 
RNA (mRNA) molecules, or "transcripts", produced in one or a population of cells. This 
approach can help reveal some relationships between genome (set of genes) and 
metabolome (set of metabolites produced). Indeed, microarrays enable us to study the 
whole genome at once.
Examples of information that can be extracted from DNA microarrays are (Hughes and 
Shoemaker, 2001):
- genes which are up- and down-regulated in specific conditions;
- identification of clusters of co-regulated genes, which can be used to assign a potential 
function to uncharacterised open-reading frames.
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5.1.5. Aims and objectives
In this Chapter, we will describe how custom microarrays were designed in order to measure 
gene expression in S. davuHgerus on S. a?e//co/o/'microarrays. These microarrays were then 
used to measure gene expression both in batch and in chemostat cultures. The possible role 
of the genes found to be either significantly correlated to clavulanic acid production rate in 
batch or significantly up- or down-regulated in chemostat will be discussed, and 
transcriptome in batch and chemostat cultures will be compared.
5.2. Experimental strategy
5.2.1. Streptomyces DHK microarrays
Streptomyces coelicolor microarrays were developed at UMIST (UK) by Colin Smith's group 
(Chater e t aL, 2002). Their design presented a challenge because of the size of the genome, 
its high G+C content and the presence of large numbers of gene families, which could create 
cross-hybridisation problems. They were produced by Dr Graham Hotchkiss and Dr Vassilis 
Mersinias at the University of Surrey. A two-stage PCR-based strategy was used to produce 
the 5, coeto/ormicroarrays (cf. Figure 5.1.).
PCR I
P Genomic 
^ DNA
.................................... i . i j . i . i ........... round'Mlill III1III1II111IM1 llilllll lllllll II Mil' product
PCR I
_ ...................................      2^ round
i l l l l l l  product
Figure 5.1. The two-stage PCR-based strategy to produce 
probes for 5. coe/zco/or microarrays 
(University of Surrey Microarray Facility WebSite )
During the first PCR round, the primers were constituted of a portion specific for the target 
gene (dark blue) and of 'universal tag' sequence (light blue). The second round of PCR was 
run using the universal primer, enabling the incorporation of 5'-end modifications such as the
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amine group that allows covalent attachment to aldehyde-coated surfaces. This method also 
facilitates the provision to other laboratories simply with a small aliquot of the first-round 
PCR product and a sample of the universal primers.
The primers were designed from Streptomyces coelicolor M145 genomic DNA provided by 
the John Innes Centre and were selected using automated scripts, assuring there could not 
be cross-hybridisation between sequences.
The final probes were 100-500 bp long. This relatively small size allows to minimise the risk 
of cross-hybridisation with other sequences from the genome (Chater etaL, 2002).
5.2.2. S. coelicolo^s microarrays design
Each slide is composed of four columns and twelve rows of sub-grids, as it is illustrated 
Figure 5.2.
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Figure 5.2. Design of the microarrays produced at the University of Surrey 
(University of Surrey Microarray Facility Website - 
http://www.surrey.ac.uk/SBMS/Fgenomics/Microarrays/html_code/PCR_grid.html)
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Each slide also possesses duplicate spots of each probe, both in the same sub-grid. Each 
sub-grid is composed of 19 x 18 spots, approximately spaced by 230 pm. There are 
therefore a total of 16,416 spots on each slide, of which 7,177 x 2 are unique probes, 281 x 
2 are non-unique or alternative probes (multi-genes probes) and the rest of them (1,500) are 
controls or empty spots.
5.2.3. 5. davuHgeruscustom microarrays design and production
87 genes were chosen to be added to the custom microarrays (see appendix 4). Most of 
them were genes of the arginine biosynthesis pathway, the clavulanic acid cluster, the 
cephamycin C cluster, the paralogue cluster, and the cla va m cluster. They were chosen 
because they had been identified and/or part of an important gene cluster, and at least 
partially sequenced.
5.2.3.1. Primer design
5.2.3.1.1. Gene databases used
The first step was to design primers for the probes to be added on the microarrays. Three 
FASTA format databases were constructed:
- The "input file": a database containing the 5. davuHgerus'qenes of interest
- The "paralogues file": a database containing all the currently available ORFs from S. 
avermitiUs and S. davuHgerus genome
- The "mis-priming file": a database containing S. avermitiUs'\Nho\e genome sequence and S. 
davuligerus'kno\NV[ sequences
A program called TransPrime written in the peri language by Dr Graham Hotchkiss 
(University of Surrey) was used. This program can select primer pairs to design probes for 
microarrays and other applications where selectivity of the probe is desired.
Since 5. davuHgerus'qer\orc\e sequence is not yet available, it was decided to design the 
primer pairs against S. avermitiUs'gewome sequences instead of S. coelicolot's because the 
former is phylogenetically closer to 5. davuHgerus {d . Figure 5.3.).
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S.albidoflavus
S.fungicidicus
■S.avermitllis■S.bikiniensis
 S.clavuligerus
'------S.VirginiasS.scabiei
r— S.lividans 
"^S.ambofaciens 
nS.maritimus 1_j— S.afghaniensis 
-S.coerulescens 
r-S.virginiae 'S.violaceus 
^S.violarus S.limosus S.coelicolor
■S.bicolor 
 S.cattleya--------------------------------------------------------------------------------------------------S.erythraea
S.rimosus
S.thermovulgaris
Scale: t- 0.1
Figure 5.3.: Maximum-llkellhood, neighbour-joining phylogenetic tree based on the 16S rRNA sequences of 
different actinomycetes. I t  shows that S. davuHgerus \s closer to S. avermitiUs thaw to 5. coeiicoioriXree built 
using the Phylip interface of the Ribosomal Database Project Release 8.1. 
http://rdp8.cme.msu.edu/html/analyses.html).
To begin with, the BLAST program (Basic Local Alignment Search Tool, a program that 
detects regions of similarity in proteins and nucleotides) was run to detect orthologues 
between S. davuHgerus and S. avermitiHs genomes. Following this procedure, 17 5. 
avermitiUs genes were removed from the "paralogues file" in order to avoid finding some 
false paralogues. Most of these genes were actual orthologues of 5. d a v u H g e r u s '(cf. 
Table 5.1.).
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5. davuHgerus S. avermitiHs
Seq Name Gene Name SAV number Gene Name
aceA aceA SAV2043 aceA
aceB aceB SAV2000 aceBl
apt apt SAV6839 apt
argl argC SAV6763 argC
arg2 argJ SAV6764 argJ
arg3 argS SAV6765 argB
arg4 argD SAV6766 argD
argS argR SAV6767 argR
arg6 argG SAV6778 argG2
arg7 argH SAV6779 argH
blip4 atpA SAV5763
putative ABC 
transporter 
ATP-binding 
protein
cephyd SAV3223
putative Mg or 
Mn-dependent 
protein 
phosphatase
nrdlll dinG SAV2464 dinG
nrdII2 lexA SAV2463 iexA
nrdII3 nrdR SAV2462
putative
regulatory
protein
trxA trxA SAV4306 trxA l
trxB trxB SAV4305 trxB l
Table 5.1. S. avermitiUs qenes removed from the paralogues 
database because of their high similarity with S. ciavuiigeruë genes
The TransPrime script first ran the BLAST program between the input file and the paralogues 
file to check for paralogues that were unavoidably going to cross-hybridise.
It then ran primerS, a primer design program, and ran the BLAST program between the 
product predicted by primer3 and the paralogues file until a primer pair yielding a product 
that was not going to miss-hybridise was found.
The primer3 settings were the following (also see appendix 5 for the whole parameter file):
- Primer size between 16 and 20 bp
- Primer Tm (melting temperature) between 60 and 70°C, with a maximum difference of 3°C 
between the primer pair, and an optimum Tm of 65°C
- Maximum primer GC content of 85%
- Product size between 150 and 500 bp
- Maximum product Tm of 91°C and optimum product Tm of 89°C
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The script finally ran the BLAST program between the primers sequences and the "mis- 
priming" file to check for mis-priming.
5.2.3.1.2. Troubleshooting
All the primer pairs were rejected for the following 3 genes:
• blips - there was unavoidable cross-hybridisation with blip4
• clav4 - the partial sequence available was too short to enable the synthesis of a
unique probe long enough to satisfy the script's settings (product size range: 150-500, when
clav4 is only 282 bp)
• SC70 -  SC7.0 is a cold-shock protein. There are many cold-shock proteins with similar 
sequences, and they cross-hybridise with each other.
blip5 and SC70 were abandoned but the script was run again for clav4 by changing the 
settings to allow for probes to be shorter than 150 bp. The settings were therefore changed 
to a product range of 70-150 bp and the program managed to design a primer pair yielding a 
product 113 bp long.
The remaining 85 primer pairs were then synthesised by Illumina, Inc. (San Diego, CA, USA). 
Their sequence can be found in the file "S. clavuligerus Custom Microarrays Primers.xls" on 
the supplementary CD.
5.2.3.2. Probes synthesis
As explained in 5.2.1., the probes were synthesised following a two-stage PCR-based 
method.
5.2.3.2 .I. Protocol
First of all, a primer mix was prepared by mixing 152 pL of autoclaved MilliQ water with 4 pL 
of each primer of the primer pairs, for a final concentration of 2.5 pM for each primer. The 
PCR reaction mix was then prepared as detailed in Table 5.2.
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Per reaction
Autoclaved MilliQ water 31.9 pL
Qiagen HotStar 10 x Buffer 5pL
DMSO 2.5pL
dNTP mix (25 mM each) 0.1 pL
Genomic DNA (10 ng/pL) 5pL
Qiagen HotStar Tag DNA polymerase (5 U/pL) 0.5pL
Primer mix 5pL
Table 5.2. First-round PCR mixture
The first round PCR was then performed using the following conditions:
Lid heating 95°C 12 cycles of:
95°C, 15 min 95°C, 40 sec
10 cycles of: 65°C, 40 sec
95°C, 40 sec 72°C, 40 sec
55°C, 40 sec 72°C, 10 min
72°C, 40 sec 8°C, forever
The PCR products were then purified using a Millipore PCRge Cleanup plate and resuspended 
Into 40 pL MilliQ water. A 1.5% agarose gel was then run to check that the PCR products 
were present and of the right size.
The second round PCR mix was prepared by mixing together:
Per reaction
Autoclaved MilliQ water 68.8 pL
Qiagen HotStar 10 x Buffer 10 pL
DMSO 5 pL
dNTP mix (25 mM each) 0.2 pL
Qiagen HotStar Tag DNA polymerase (5 U/pL) Ip L
Primer mix (untagged) 10 pL
First round PCR products 5pL
Table 5.3. Second-round PCR mixture
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The second round PCR was then performed using the following conditions:
Lid heating 95°C 
95°C, 15 min 
10 cycles of:
95°C, 40 sec 
55°C, 40 sec 
72°C, 40 sec
25 cycles of:
95°C, 40 sec 
60°C, 40 sec 
72°C, 40 sec 
72°C, 10 min 
8°C, forever
The PCR products were then purified using a Millipore PCR% Cleanup plate and resuspended 
into 40 pL MilliQ water. A 1.5% agarose gel was then run to check that the appropriate PCR 
products were present and of the right size, and revealed that 44 out of 85 were.
Figure 5.4. A typical gel showing the results of the second round PCR
5.2.3.2.2. Troubleshooting
Different methods were used when the first set of PCRs yielded no product, a product of the 
wrong size, or multiple products, as it was the case in 41 instances.
The Tm of the 5. davuHgerus primers was actually higher than the Tm of the 5. coeiicoior 
primers because the peri script used was written in order to design primers to which 
universal tags would be attached, which would ultimately change their Tm. During a PCR, 
the choice of the annealing temperature depends on the Tm of the primers (the annealing
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temperature is usually chosen 5°C under Tm). The use of a lower temperature results in less 
specificity in the PCR reaction and can explain the multiple products and the wrong-sized 
products.
First, for the case where there did not seem to be a probe after the first round (25 
instances), the first PCR was performed on the primers again.
The first repeat was performed with a lower annealing temperature for cycles 11-22 (60°C 
instead of 65°C) because some primer pairs had not given any product at all, suggesting that 
the annealing temperature was too stringent:
95°C 15 min 12 cycles of:
95°C 40 sec
10 cycles of: 60°C 40 sec
95°C 40 sec 72°C 40 sec
55°C 40 sec
72°C 40 sec 72°C 40 sec
8°C forever
This allowed obtaining 12 out of 25 first round products of the right size.
For the next repeat, a touchdown PCR was performed, where the annealing temperature 
starts by being very stringent (73°C) and then goes down by 1°C every cycle until it reaches 
a temperature of 57°C, which it keeps for another 15 cycles. The reaction was then left at 
72°C for 10 minutes at the end of the cycles. This allowed obtaining another 3 of the 13 
remaining products.
In the following repeat, a touchdown PCR was performed by bringing the temperature down 
from 73°C to 60°C and performing 20 cycles at 60°C. This allowed to obtain another 8 of the 
10 refractory products.
The two primer pairs that did not give any product after four attempts were abandoned. 
They were:
- asp2 {askB), unknown product, BLIP region
- asp3 {asd), acetylornithine aminotransferase, BLIP region
Chapter 5. Transcriptomics Analysis of S t r e p t o m y c e s  cla  v u l ig e r u s  134
IN Batch and in Chemostat
Next, a second round PCR was performed on:
- the products obtained from the repeat first rounds and,
- the products that had been obtained from the initial first round but had not yielded the 
right second-round product.
Following the success of the touch down PCR with 20 cycles at 60°C, the same protocol was 
followed for the first repeat of the second round PCR. All but 9 reactions yielded a product of 
the right size.
A touchdown PCR going from 73°C to 64°C with 25 cycles at 64°C was performed on the 9 
remaining primer pairs. No single product of the right size was obtained this way. It is 
interesting to note that 8 out of the 9 refractory products had already been difficult to obtain 
after the first round.
Next, a basic PCR was performed with 30 cycles at 68°C, because most of the reactions from 
the previous attempt had yielded multiple products, so it seemed necessary to make the 
annealing more stringent. This repeat enabled to obtain the right product from 4 out of 9 
reactions.
Two additional PCR repeats were performed on the remaining 5 primer pairs, with 
increasingly stringent annealing temperatures (70°C, and then 72°C), but three reactions 
kept yielding multiple bands:
- cephl4, unknown protein, cephamycin cluster
- clavl {cvm3), unknown product, partial cds, clavam cluster
- kin, protein kinase-like, partial sequence
5.2.3.3. Results
At the end, 5 primer pairs did not yield a PCR product of the right size. These were the 
primer pairs for:
- asp2 {askB), unknown product, BLIP region
- asp3 {asd), acetylornithine aminotransferase, BLIP region
- cephl4, unknown protein, cephamycin cluster
- clavl {cvm3), unknown product, partial cds, clavam cluster
- kin, protein kinase-like, partial sequence
These genes were therefore abandoned at this stage.
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5.2.3.4. Custom microarrays printing
The synthesized probes were added in duplicate on the S. coeiicoior microarrays in some 
empty spots (cf. Figure 5.2.). Therefore, the custom microarrays were composed of all the 5. 
coeiicoior probes found on the normal microarrays as well as the custom S. davuHgerus 
probes.
5.2.4. Microarray experiments
5.2.4.1. DNA extraction and quality control
DNA was extracted from 25 m l of S. davuHgerus zuWure grown in tryptone soya broth for 24 
hours, following a modified Kirby DNA extraction method. The mycelium was spun down and 
rinsed with 10.3% sucrose until the supernatant was clear. The pellet was then resuspended 
in 2 mL of lysozyme solution (2 mg lysozyme/mL in 0.3 M sucrose, 25 mM Tris, 25 mM 
EDTA) and incubated for 10 minutes at 37®C. 2.3 m l of 2x Kirby mix (2% sarkosyl, 12% 
phenol and 12% sodium 4-amino-salicylate) were added and the solution was vortexed for 1 
minute. 5.3 mL of phenol/chloroform/isoamyl alcohol (24/24/1) were added and the solution 
was vortexed for 15 seconds before being centrifuged for 10 minutes at 4000 rpm at 4°C. 
The aqueous (upper) phase was transferred into a new tube and the previous step 
(phenol/chloroform extraction) was performed twice more, using every time a fresh tube to 
transfer the aqueous phase. 1/10 volume 3 M Sodium Acetate and 1 volume isopropanol 
were added to the aqueous phase, which was vortexed and then left at room temperature 
for 10 minutes to allow DNA to precipitate before being centrifuged for 10 minutes at 9000 
rpm at 4°C. The DNA pellet was washed with 1 mL 70% ethanol and centrifuged again for 5 
minutes at 9000 rpm at 4°C. The remaining ethanol was allowed to evaporate at room 
temperature before redissolving the pellet in 3 ml TE buffer (10 mM Tris, 1 mM EDTA). 40 
pg/mL RNase was added to the solution and incubated at 37°C for 30 minutes. Another 
phenol/chloroform extraction was performed using 0.9 mL of the phenol/chloroform/isoamyl 
alcohol mix, followed by DNA precipitation and ethanol wash. After the ethanol had 
evaporated, DNA was dissolved in 500 pL TE buffer, quantified and then stored at -20°C.
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The DNA quality and concentration was checked on the Nanodrop® ND-1000 UV-Vis 
Spectrophotometer, which only requires 1 pL of liquid. The Nanodrop® is able to provide 
nucleic acids concentration, as well as absorbance ratios reflecting nucleic acids quality. A 
low 260/280 ratio (< 1.8) is an indication of protein or phenol contamination, and a low 
260/230 ratio (<2) can be a sign of polysaccharide, peptides or reagent contamination. Both 
ratios should ideally be close to 2.
DNA quality was also verified on a 0.8% agarose gel in TBE buffer (54 g/L Tris, 27.5 g/L 
Boric Acid and 10 mM EDTA) at 80 V. 1 pL of 1/10 and 1/20 dilutions of the extracted DNA 
were mixed with 9 pL water and 2 pL 5x Orange G Dye (50% Sucrose, 1% Orange G Dye, 5 
mM EDTA) and loaded on the gel beside the ladder AHindlll. The gel was stained in 100 mL 
TBE + 5 pL ethidium bromide for 30 minutes and then photographed under UV light.
5.2.4.2. RNA extraction and quality control
A volume of culture equivalent to about 10 mg biomass was sampled directly into two 
volumes of RNAprotect™ (Qiagen). This chemical provides immediate stabilisation of RNA in 
the cell, preventing any further changes. The sample was immediately vortexed for 5 
seconds and then left at room temperature for 10 minutes before being centrifuged at 3500 
rpm for 10 minutes. The supernatant was then carefully removed and the pellet was placed 
at -80°C and was processed for RNA extraction within one month.
RNA extraction was performed following a modified protocol using an RNeasy mini kit 
(Qiagen). This kit can purify a maximum of 100 pg RNA. Using a higher amount of RNA 
would lead to a decrease in yield and quality. It was calculated from a test extraction that 
about 15 pg of RNA could be extracted from 1 mg S. clavuligerus biomass. Therefore, a 
maximum of about 6 mg biomass was used with each kit.
The pellet was resuspended in 100 pL TE buffer (10 mM Tris, 1 mM EDTA) pH 8.0 containing 
5 mg/mL lysozyme and incubated at room temperature for 10 minutes. 350 pL of RLT buffer 
(provided with the kit) were added and the mix was vortexed. The lysate was sonicated 6 
times 30 seconds on /  20 seconds off at full power. The lysate was then transferred to a 15 
mL RNase-free tube and 1 volume phenol/chloroform/isoamyl alcohol (24/24/1) was added. 
The solution was vortexed for 30 seconds and centrifuged for 10 minutes at 4°C. The
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aqueous phase was transferred to a fresh 15 mL tube and the extraction was repeated with 
one volume phenol/chloroform/isoamyl alcohol. The aqueous phase was transferred to a 
fresh tube and one volume chloroform was added. The solution was vortexed for 30 seconds 
and centrifuged for 5 minutes at 4°C. The aqueous phase was transferred to a fresh tube 
and 250 pL ethanol was added to the lysate. The lysate was then applied to the RNeasy mini 
column and centrifuged for 5 minutes at 10 000 rpm. The flow-through was discarded and 
the column was rinsed with 350 pL RWl buffer before being centrifuged for 15 seconds. The 
flow-through was discarded again and the DNA was digested on the column using 20 pL 
RNase-free DNase I  (Qiagen) in 140 pL RDD buffer. The DNase was left on the column for 
15 minutes at room temperature. 350 pL RWl buffer (provided with the kit) were then 
added to the column and then centrifuged for 15 seconds. The flow-through was discarded 
and the column was transferred to a new 2 mL tube. The column was rinsed twice with 500 
pL RPE buffer (provided with the kit), and was then centrifuged for another 2 minutes to get 
rid of the residual ethanol. The RNA was finally eluted in a new 1.5 mL tube with 40pL 
RNase-free water. The eluent was passed a second time through the column in order to 
optimise the RNA elution.
The quantity and quality of the RNA were then assessed using the Nanodrop® ND-1000 UV- 
Vis Spectrophotometer. The RNA was also analysed on the Agilent 2100 Bioanalyzer. The 
Bioanalyzer can analyse RNA, DNA and proteins using small chips consisting of 
interconnected fluid reservoirs and pathways. It only requires 200 pg of RNA. While running 
a sample, it measures fluorescence vs. time and uses this information to produce the picture 
of a virtual gel, the total RNA concentration, and the rRNA ratio (23s/16s), which should be 
close to 2 in non-degraded RNA (cf. Figure 5.5.).
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a) b)
c)
Sample 1 Settings | RNA Results 1 Errors |
RNA Area 1.901.74
RNA Concentration 2355 ng/ul
rRNA Ratio (23S/16S] 1.07
Figure 5.5.: Example of data obtained from the BioAnalyzer. a) The BioAnalyzer produces the picture one would 
have obtained by agarose gel electrophoresis, b) It  actually measures fluorescence vs. time of the dyed RNA. c) 
The BioAnalyzer also gives RNA concentration and rRNA ratio (23S/16S).
When the RNA concentration was lower than 1 pg/pL, it was lyophilised and resuspended in 
a smaller volume of RNase-free water. It was then stored at -20°C until labelling.
5.2.4.3. DNA labelling
DNA was first sonicated twice 10 seconds off /  6 seconds on. 25 pg DNA was then run 
through a GFX PCR DNA Purification kit (Amersham Biosciences) to purify it and eluted in 70 
pL Tris-HCI 10 mM pH 8.0.
4 to 5 pg of purified DNA were mixed with 1 pL random primers (Invitrogen) and the volume 
was made up to 41.5 pL using autoclaved MilliQ water. After denaturing the DNA for 5 
minutes at 95°C, it was snap-cooled on ice and added:
- 5 pL Klenow Buffer (lOx) (New England Biolabs),
- 1 pL dNTPs (5mM each dA/G/TTP, 2mM dCTP) (Invitrogen),
-1 .5  pL Cy3-dCTP or Cy5-dCTP (Amersham Biosciences),
- 1 pL Klenow Fragment (5U/pL) (DNA Polymerase from New England Biolabs).
This labelling mix was incubated at 37°C in the dark overnight.
C h a p te r 5. T ra n s c rip to m ic s  A n a ly s is  o f  S trep to m yces  c la  v u lig e ru s  139
IN Batch  a n d  in  Ch em o sta t
The labelled DNA was then purified using Qiagen MinElute columns. Five volumes PB buffer 
(provided with the kit) were added to the labelling reaction and spun through the column for 
1 minute at 13 000 rpm. 500 pL of PE buffer (provided with the kit) were then spun down 
the column for 1 minute, followed by another 250 pL of PE buffer for 2 minutes. The column 
was then transferred to a clean tube. The DNA was eluted by adding 10 pL Tris-HCI ImM pH
7.5, leaving it on the column for one minute at room temperature before centrifuging for one 
minute. This was followed by another 8 pL of the same solution left for one minute followed 
by centrifugation. The final volume was about 17-18 pL.
The quality and quantity of labelled DNA was assessed using the Nanodrop® ND-1000 UV-Vis 
Spectrophotometer, which gives the concentration of DNA present in ng/pL as well as the 
concentration of Cy dye in pmol/pL (Cy3 absorbs at 650 nm and Cy5 absorbs at 550 nm). 
This can be used to calculate how much volume of labelled DNA is required for hybridisation 
on a microarray.
5.2.4.4. cDNA synthesis and labelling
15 pg RNA (in a maximum volume of 15.2 pL) were mixed with 1.7 pL random primers 
(Invitrogen) and the volume was made up to 16.9 pL (Cy3) or 15.9 pL (Cy5) using RNase- 
free water.
RNA was denatured at 70°C for 10 minutes, snap-cooled on ice and added:
- 6 pL 5x First Strand Buffer (Invitrogen),
- 3 pL lOOmM DTT (Invitrogen),
- 0.6 pL dNTPs (25mM each dA/G/TTP, lOmM dCTP) (Invitrogen),
- 2 pL Superscript I I I  (Reverse Transcriptase from Invitrogen),
-1 .5  pL Cy3-dCTP (Amersham Biosciences).
The labelling mix was incubated at 25°C for 10 minutes in the dark, and then overnight at 
42°C in the dark. RNA was denatured using lOpL NaOH IN at 70°C for 10 minutes, followed 
by neutralisation with lOpL HCI IN. The labelled cDNA was then purified using MinElute 
columns and assessed by the Nanodrop spectrophotometer.
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5.2.4.5. Pre-Hybridisation
Slides were pre-soaked and pre-hybridised using the Corning® Pronto!™ Universal 
Hybridization Kit following the manufacturer's instructions. They were eventually dipped in 
nuclease-free water at room temperature and then centrifuged for 5 minutes at 800 rpm in a 
slide staining rack placed between two microplate lids padded with absorbent cloth.
5.2.4.6. Hybridisation
The volumes required to obtain the required quantity of each dye were placed together in a 
1.5 mL tube and dried in a speed-vacuum concentrator. The dried nucleotides were then 
resuspended in 45 pL of Pronto!™ Hybridization Solution. The solution was then heated at 
95°C for 5 minutes before briefly centrifuging to collect any condensation. The pre-hybridised 
slides were gently blown to remove any dust particle and pre-warmed on a heating block. 
They were then placed Into Corning® Hybridization Chambers. 30 pL 3x SSC (0.45M sodium 
chloride, 45mM sodium citrate, pH 7) were placed in each well of the hybridisation chamber 
to avoid drying out during hybridisation. The 45 pL labelled reaction mix was then pipetted 
onto the arrayed surface of the pre-warmed slide and a 24 x 60 mm plastic cover slip was 
quickly placed over It. The slides were sealed in the hybridisation chambers and incubated at 
42°C for 12-16 hours.
For all the time series experiments (TSl, 2 and 3), 5. davuHgerus'cDHfK was labelled with 
Cy3 and hybridised against S. d a v u H g e r u s 'labelled with Cy5 as a control. In TSl and 
TS2, a quantity of DNA containing 40 pmol of each dye was used. In TS3, 80 pmol of Cy3 
and 40 pmol of Cy5 were used, because cDNA usually gives a lower signal than gDNA.
In the chemostats experiments, S. davuHgerus'cDHIK was labelled with Cy3 and hybridised 
against 5. coeiicoior M145's gDNA labelled with Cy5 as a control, because 5. davuHgerus 
gave a low yield of gDNA after extraction. 80 pmol of Cy3 and 30 pmol of Cy5 were used on 
these microarrays, since 5. coeiicoioHs gDNA is expected to give higher signals than S. 
davuHgerus'q DNA.
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5.2.4.7. Post-Hybridisation
The washes were performed using Corning® Pronto!™ Universal Hybridization Kit following 
the manufacturer's instructions. They were eventually dipped in nuclease-free water at room 
temperature and then centrifuged for 5 minutes at 800 rpm in a slide-staining rack placed 
between two microplate lids padded with absorbent cloth.
5.2.4.8. Scanning and image analysis
The arrays were scanned on an Affymetrix 428 scanner with a 10 pm resolution. Signal was 
measured for each dye by excitation at 532 nm and 635 nm for Cy3 and Cy5 respectively, 
and measurement of the emission at 570 nm and 665 nm, respectively. For each channel 
(Cy3 and Cy5), the gain was chosen in order to avoid saturated spots and/or high 
background.
The scanning software created two TIF (Tagged Image File format) images that were then 
loaded into the image analysis software BlueFuse (BlueGnome). This software adjusted the 
two images according to a grid specific to the type of array used, automatically located the 
spots, flagged the ones considered as absent or of low quality, and finally calculated the 
intensity of each channel for each spot, as well as the background intensity around each spot 
for each channel. A manual check was also performed, allowing additional flagging and/or 
repositioning of spots incorrectly allocated by the software. The BlueFuse data files of all the 
microarrays used in this study can be found in the folder "4- Microarray BlueFuse Files" on 
the supplementary CD.
5.2.4.9. Data analysis
The obtained data was loaded into the data analysis software GeneSpring GX 7.3. (Silicon 
Genetics). The data was normalised by first performing a per spot normalisation, in which 
each measurement was divided by the signal in the control channel (gDNA), followed by a 
per chip normalisation, in which each measurement was divided by the 50^  ^ percentile of all 
measurements in that sample. The unfiltered data was then copied into an electronic 
spreadsheet (Microsoft Excel) for further analysis. The data analysis is detailed in the results 
and discussion.
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5.3. Results and discussion
5.3.1. Custom microarrays efficiency
In order to determine the efficiency of the custom probes, it is possible to compare the 
signal intensity of the custom probes to the signal intensity of, a) the empty spots, and b) 
the S. coe//co/or probes.
The custom microarrays were used for two experiments: a batch culture time-series of 5. 
davuHgerus grown on phosphate-limited medium (TS3) and 6 chemostat cultures of 5. 
davuHgerus grown on phosphate-limited medium (2 dilution rates in triplicate, D = 0.02h'^ 
and D = O.OSh' )^. More information about these cultures can be found in Chapter 2.
The average raw signal (Cy3, cDNA) and the average control signal (Cy5, gDNA) are given 
for each experiment for: the empty spots, the custom probes, the 5. coeiicoior probes, and 
the individual custom probes (the probes names are explained in appendix 4).
From the results of Table 5.4., it is clear that the custom probes are, on average, a success. 
The average signals from the custom probes in both the cDNA (Cy3) and the gDNA (Cy5) 
channels are much higher than the signals obtained from the S. coeiicoior probes (2231 vs. 
1598 for Cy3, 3013 vs. 1769 for Cy5). This shows that 5. davuHgerus'DHk hybridises better 
to the custom probes than to the 5. coeiicoioi's probes. In addition to this, most probes also 
give a signal in the Cy5 channel higher than the average Cy5 signal for the empty spots, 
except for the ones in bold and italics. The probes giving Cy5 signals under around 300 
should generally be considered as dubious and the results obtained from them should be 
considered carefully.
The results in Table 5.5. show that 30 pmol of 5. coeiicoiofs gDNA, used in the chemostats 
microarray experiments, give almost exactly the same average Cy5 signal intensity as 40 
pmol of 5. ciavuiigeruë gDNA, used in the time series experiment TS3 (1756 vs. 1769 
respectively). Since the control in the chemostats experiment was S. coeiicoioHs gDNA and 
not 5. davuiigerud gDNA, the average control signal of the custom probes is very low (332) 
compared to what it was in TS3 microarrays (3013). Therefore, we can not use the results of 
this experiment to decide whether or not the probes hybridise well with the 5. davuHgerus 
genes. In bold and italics are the probes that were found to have a Cy5 signal lower than 
average Cy5 signal of the empty spots in TS3.
Chapter 5. Transcriptomics Analysis of S trep to m yces  c la v u lig e ru s
IN Batch and in Chemostat
143
TS3 cDNACCy3) gDNA(Cy5)
Average 'empty spots' 602.71 147.35
Average 'custom probes' 2230.66 3013.41
Average 'coeiicoior 
probes' 1597.59 1768.75
Individual custom cDNA gDNA
probes' CCy3) (Cy5)
aceB 658.20 99.43
cmcH 485.89 115.39
argR 576.79 117.40
b is l 562.25 126.12
epeA 432.79 127.49
kin 569.35 132.73
ceasl 306.25 134.27
oat2 470.47 134.39
cmcl 588.91 181.87
cal2 216.67 200.75
bltp6 287.53 201.17
asd 508.88 207.63
blip4 758.57 219.28
cal5 842.80 222.84
cefF 400.04 234.43
fd 364.65 308.14
bla 451.95 310.19
pcbC 393.50 316.76
gdh 706.53 334.50
cvm5 373.92 339.36
trxA 631.97 374.00
epeR 560.73 386.46
cefE 730.12 400.36
casl 1187.51 434.30
cephyd 418.89 437.79
scaR 331.36 470.35
nrdA 645.39 479.02
cvm2 309.06 485.66
cal7 429.12 516.83
argB 364.30 536.18
askA 311.29 558.50
pcbAB 530.44 563.47
relA 402.56 689.13
pcbR 1192.03 720.69
spoT 503.92 789.41
b llpl 294.70 800.66
calS 388.39 874.93
bip 740.04 896.04
cyp 1580.10 975.10
nrdJ 599.18 1011.74
Individual custom 
probes'
cDNA
(Cy3)
gDNA
(Cy5)
blip2 435.54 1085.07
nrdB 640.59 1154.39
pcd 1635.60 1218.66
apt 371.23 1259.43
argC 866.44 1328.04
oppAl 1308.01 1387.50
cal9 426.92 1545.85
cal6 1635.72 1791.46
c a ll 2751.45 1879.75
pbp74 705.78 2386.03
askB 694.60 2523.14
bls2 2172.26 2783.48
cmcT 778.72 2931.24
argJ 1279.64 2991.81
oatl 723.09 3038.59
argD 1304.36 3057.90
aceA 1217.01 3201.31
car 7766.35 3268.92
cal3 1720.57 3452.83
rhsA 622.94 3493.25
claR 3609.52 3553.33
blip 2706.92 3952.38
oppA2 3123.10 4274.97
epe3 908.22 4528.07
pahl 3388.93 5157.49
ceas2 5208.12 5252.92
IS116 708.13 5525.15
argH 2345.36 5677.03
cmc] 4009.64 5936.24
pah2 18656.33 6070.42
nrdR 1856.31 6385.13
cephl4 1284.58 6600.91
ccaR 11725.82 6838.42
cvm6 1048.69 7380.81
cvml 1285.62 8108.54
argG 25649.54 8345.36
cvm4 1914.61 8427.83
dinG 1896.47 8514.16
sclU 972.12 9099.48
cefD 5720.91 9721.94
cvm3 4853.12 10225.23
lexA 6037.56 10594.29
cas2 12028.24 12755.00
trxB 8445.18 13381.84
lat 9059.51 17589.85
Table 5.4. Average Cy3 and Cy5 signals for the custom probes, the S. coe//to/or spots, and the empty spots on 
the TS3 microarrays. In bold and italics are the probes that were found to have a Cy5 signal lower than average
Cy5 signal of the empty spots in TS3.
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Chemostats cDNA(Cy3) gDNA(Cy5)
Average 'empty spots' 461.83 70.53
Average 'custom probes' 2323.98 332.29
Average 'coeiicoior 
probes' 2137.78 1755.64
Individual Custom cDNA gDNA
genes' (Cy3) (CyS)
kin 281.76 17.01
epeA 280.01 20.65
pcbC 299.84 23.48
cmcl 391.06 24.96
aceB 314.75 25.22
cefE 595.74 26.71
cvm5 308.43 28.59
b is l 239.61 29.39
oat2 355.62 29.63
argR 258.65 30.12
ceasl 209.42 31.72
cvm2 249.75 33.61
cefF 561.70 36.30
trxA 348.50 38.45
bla 361.84 39.65
cal5 245.64 41.70
gdh 196.62 46.69
bllp4 298.88 48.36
epeR 207.36 53.41
cmcH 261.02 53.69
fd 1285.23 57.11
pcbAB 438.07 58.06
bllpl 359.84 60.25
cal2 416.48 64.51
blip6 446.58 65.24
pbp74 806.35 66.51
cephyd 289.77 67.76
nrdA 191.89 68.52
_cyp 1520.37 69.20
bip 518.66 72.36
scaR 413.03 72.51
oppAl 1694.65 73.04
bllp2 1370.44 80.90
spoT 264.49 83.12
relA 340.32 89.67
askA 389.73 89.79
cal7 493.36 92.66
casl 260.19 93.64
nrdJ 294.74 113.78
nrdB 350.96 123.24
Individual Custom 
genes'
cDNA
(Cy3)
gDNA
(Cy5)
asd 247.19 123.71
cal8 386.02 134.72
argB 401.77 145.97
pcbR 3283.75 146.59
cal6 1543.21 155.57
c a ll 4091.69 161.06
cmcT 475.91 175.31
pcd 1535.30 176.14
ca l9 852.45 216.30
askB 2391.58 219.13
car 9798.39 236.02
claR 2275.18 265.41
ccaR 6597.25 308.04
apt 979.37 311.29
bliP 1890.22 330.39
epe3 670.72 338.37
cvm6 633.77 350.22
rhsA 561.32 350.84
cephl4 1460.73 364.14
bls2 1565.54 383.95
cal3 2145.69 464.52
pahl 2317.83 468.56
IS116 667.74 468.88
argC 734.63 485.49
oppA2 3825.11 497.52
pah2 25426.80 501.61
oatl 696.44 585.96
nrdR 1074.88 607.54
cas2 14854.33 610.05
cvm4 1520.64 621.33
sclU 1038.67 643.70
dinG 1696.43 741.52
cvm3 5721.29 836.43
argJ 1815.13 841.16
cefD 5130.42 863.42
cvml 932.51 906.64
trxB 4816.26 920.08
cmc] 4859.15 978.12
argD 1928.04 985.51
argG 25456.86 1073.20
lexA 5381.61 1134.21
ceas2 10003.11 1244.58
aceA 1085.51 1285.36
argH 2461.11 1336.40
lat 11895.45 2008.62
Table 5.5. Average Cy3 and Cy5 signals for the custom probes, the 5. coeiicoior and the empty spots on 
the chemostats microarrays. In bold and italics are the probes that were found to have a Cy5 signal lower than
average Cy5 signal of the empty spots In TS3.
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It can be concluded that the following probes might not successfully hybridise to the genes 
they were designed for (cf. appendix 4 for details about these probes) aceB, cmcH, argR, 
bisl, epeA, kin, ceasl, oat2, cmcl, cal2, blip6, asd, blip4, cal5, and cefF.
5.3.2. Time series experiments
The first two time series were performed in a 2L bioreactor, while the third one was 
performed in a 5L vessel (cf. Chapter 2). A higher level of clavulanic acid was obtained in this 
third time series. In addition to this, basic S. coeiicoior PCR microarrays were used for TSl 
and TS2, while custom microarrays displaying probes for some S. davuHgerus genes as well 
as the 5. coeiicoior qenes were used for TS3. Therefore, we will first study the first two time 
series and the third one separately, before looking at the three of them together.
Six, seven and sixteen samples were taken during time series 1, 2 and 3, respectively. All 
cDNA samples were labelled with Cy3 dye and the control S. davuHgerus gDNA was labelled 
with Cy5 dye.
5.3.2.1. Time series 1 and 2
In time series 1 (TSl), the microarrays were prepared in triplicate for each time point. The 
three replicates were averaged in GeneSpring before being further analysed. In time series 2 
(TS2), only one microarray was prepared for each time point. The aim was to pair the 
samples together between TSl and TS2 but the profiles of the time series were too different 
from one another. It was therefore decided to analyse the time series separately by 
calculating the Spearman correlation between the expression level of each gene and the 
clavulanic acid specific production rate. The average Spearman correlation coefficient 
between the two time series was then calculated. The genes with an average correlation 
over 0.7 or under -0.7 were considered as significant. The correlation file can be found on 
the supplementary CD in the file "5- Time Series Correlation Coefficients.xls".
As a reminder of the time series' profiles, some graphs representing the rates are shown 
below.
Chapter 5. Transcriptomics Analysis of S t r e p t o m y c e s  cla v u l ig e r u s  146
IN Batch and in Chemostat
Rates in TSl
0.16
Clavulanic acid specific prod rate 
(mmol/h.g biomass) x 100 
♦  p (h - l) 4.50.14
Glycerol specific utilisation rate 
(mmol/h.g biomass)__________
■ 3.5
E 0.08 --
10 0.04
0.02
0 50 100 150 200 250
?Ifll
»  ?  5  jc
T im e  ( h )
Figure 5.6.: Clavulanic acid specific production rate, glycerol specific utilisation rate, and growth rate in T S l
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Figure 5.7.: Clavulanic acid specific production rate, glycerol specific utilisation rate, and grov\rth rate in TS2
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5.3.2.1.1. Genes positively correlated to clavulanic add specific 
production rate in TSl and TS2
The 49 genes positively correlated to clavulanic acid specific production rate are listed in 
appendix 6 . Most of these genes did not have a known function or did not seem linked to 
clavulanic acid production or growth rate in any way and were therefore not studied further. 
Six of them however showed a plausible link with either clavulanic acid production and/or 
growth rate.
SCO/gene
name
Common
name
Spearman correlation 
coefficient Product
SCO4620 traBl 0.70 putative sporulation-related protein
SC05141 foiP 0.71 dihydropteroate synthase
SCO5470 giyA2 0.72 serine hydroxymethyltransferase
SCO4890 deoA 0.75 thymidine phosphorylase
SC04653 rpiL 0.78 50S ribosomal protein L7/L12
SC06691 0.81 putative phospholipase C
Table 5.6.: Genes positively correlated to clavulanic acid specific production rate In T S l and TS2
- tra B l encodes a putative sporulation-related protein. It is not known whether S. 
davuHgerus is able to produce spores in liquid medium but, if it does, it appears to be 
somehow synchronised with clavulanic acid production.
- fd P  encodes dihydropteroate synthase, an enzyme involved in folate, dihydrofolate, 
and tetrahydrofolate synthesis from chorismate. foiP is also correlated to clavulanic acid 
specific production rate in TS3 (correlation coefficient = 0.64).
- g!yA2 encodes serine hydroxymethyltransferase, which catalyses the conversion of 
serine to glycine via the reaction tetrahydrofolate + L-serlne = 5,10-
methylenetetrahydrofolate -i- glycine -f H20. The presence of both foiP and giyA2 on 
this list suggests that the upregulation of foiP might be required to enable the serine 
hydroxymethyltransferase to function. Ives and Bushell (1997) showed that feeding 5. 
davuHgerus with lOmM serine enabled to obtain 177% of the control clavulanic acid 
concentration. Unfortunately, glycine was not tested in that experiment. Glycine can 
also be produced from threonine via threonine aldolase. Kirk (2000) also showed that 
feeding lOmM threonine to 5. davuHgerus resu\XBû in a 100% increase of the clavulanic 
acid concentration. Therefore, it would seem that glycine is involved in clavulanic acid
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production. Arulanantham et a i (2006) showed that 0RF17 of the clavulanic acid 
cluster is an /V-glycyl-clavaminic acid synthetase, which converts clavaminic acid to N- 
glycyl-clavaminic acid in the presence of ATP and glycine. This could explain why 
feeding one of the two glycine precursors enhances so much clavulanic acid synthesis 
and why g!yA2s expression is correlated to clavulanic acid specific production rate.
deoA encodes a thymidine phosphorylase, which catalyses the reaction thymidine + 
phosphate = thymine + 2-deoxy-alpha-D-ribose 1-phosphate. 2-deoxy-alpha-D-ribose 
1-phosphate can then be conversed to D-glyceraldehyde-3-phosphate, one of the 
precursors of clavulanic acid, via 2-deoxy-D-ribose-5-phosphate. Therefore, the 
synthesis of D-glyceraldehyde-3-phosphate from thymidine could be a way of 
overcoming the C3 precursor limitation.
rpIL  encodes the 50S ribosomal protein L7/L12. The expression of ribosomal proteins 
genes normally decreases with decreasing growth rate. It is surprising to see that this 
particular ribosomal protein gene is correlated to clavulanic acid specific production 
rate, which is itself negatively correlated to the growth rate. Several ribosomal protein 
genes can actually be found on the list of genes negatively correlated to clavulanic acid 
specific production rate. Blanco e t a!. (2001) showed that rpH's expression in S. 
coeiicoior is growth-phase dependent and declines with declining growth rate. Its 
regulation might be different in 5. davuHgerus. Gomez-Escribano et ai. (2006) showed 
that a mutation in rpiK, a ribosomal protein gene in the same region as rpiL, reduces 
clavulanic acid production to 15-26% of the production in the wild-type, following an 
impaired transcription of the regulatory genes ccaR and ciaR and the ceaS2 genes. rpiL 
might have a similar role to rpiK'm S. davuHgerus.
SC06691 encodes a putative phospholipase C. These lipases convert 
phosphatidylcholine (or other phospholipids) into 1,2 -diacylglycerol and choline 
phosphate. 1,2 -diacylglycerol can then either be integrated into a new triacylglycerol, or 
be converted back to glycerol via monoacylglycerol, yielding two free fatty acids. This 
pathway could alleviate the C3 precursor limitation for clavulanic acid production.
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5.3.2.I.2. Genes negatively correlated to clavulanic acid specific 
production rate in TSl and TS2
The 32 genes found to be negatively correlated to clavulanic acid specific production rate in 
TSl and TS2 are listed in appendix 7. Only 8  of them showed a plausible link with clavulanic 
acid production and/or growth rate.
SCO/gene
name
Common
name
Spearman correlation 
coefficient Product
SCO3906 rpsF -0.74 putative 30S ribosomal protein 56
SCO4660 rspG -0.73 305 ribosomal protein 57
SCO4701 rpsJ -0.88 305 ribosomal protein 510
SCO4705 rpIB -0.79 505 ribosomal protein L2
SCO4707 rpiV -0.71 505 ribosomal protein 122
SC04712 rpiN -0.75 505 ribosomal protein L14
SC04662 tu fl -0.85 elongation factor TU-1
SC04562 nuoA -0.71 NuoA, NADH dehydrogenase subunit
Table 5.7.: Genes negatively correlated to clavulanic acid specific production rate in T S l and TS2
- rpsE, rspG, rpsJ, rplB , rp IV  and rp IN  all encode ribosomal proteins. It has been 
mentioned earlier that the expression of ribosomal proteins decreases with growth rate, 
which explains why so many of them are negatively correlated to clavulanic acid specific 
production rate. The presence of these genes on the list of negatively correlated genes 
suggest that ribosomal protein genes transcription might be sensitive to the same 
signal(s) as the genes involved in clavulanic acid biosynthesis.
- tu f l encodes the elongation factor TU-1. This protein facilitates the events of 
translational elongation. Like the ribosomal proteins, its expression is growth-phase 
dependent, and decreases with growth rate (Tieleman et ai., 1997).
nuoA encodes a NADH dehydrogenase (NADH + + ubiquinone = NAD  ^ +
ubiquinol). The fact that this gene is negatively correlated to clavulanic acid specific 
production rate suggests that oxidative phosphorylation is downregulated when 
clavulanic acid production increases, possibly because less glyceraldehyde-3-phosphate 
is available to go through glycolysis and through the Krebs cycle.
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5.3.2.2. Time series 3
TS3 was sampled much more often than TSl and TS2 and was therefore run in a larger 
bioreactor. Higher clavulanic acid production rates were observed. During transition between 
exponential and linear phase, when clavulanic acid starts being produced, samples were 
taken every six hours, which enabled to obtain a complete profile of gene expression during 
that switch. Figure 5.8. represents the evolution of the clavulanic acid specific production 
rate, glycerol specific utilisation rate, and growth rate, in TS3. Genes with an average t-test p 
value higher than 0.1 over the whole time series were discarded. The correlation file can be 
found on the supplementary CD in the file "5- Time Series Correlation Coefficients.xls".
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Figure 5.8.: Clavulanic acid specific production rate, glycerol specific utilisation rate, and growth rate in TS3
5.3.2.2.1. Genes positively correlated to clavulanic acid specific 
production rate in TS3
61 genes were found positively correlated to clavulanic acid specific production rate in TS3. 
These genes are listed in appendix 8. Of these 61 genes, 19 had a plausible link to clavulanic 
acid production and/or growth rate.
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SCO/gene
name
Common
name
Spearman correlation 
coefficient Product
ca2 b!s2 0.78 beta lactam synthetase (BLS)
call 0RF12 0.79 putative beta-lactamase
ca8 car 0.81 clavaldehyde dehydrogenase (CAR)
ca4 cas2 0.75 clavaminate synthase (CAS2)
cal ceas2 0.78 carboxyethylarginine synthase (CEAS)
cephlO cmcJ 0.73 Methyltransferase
ca6 oppAl 0.74 oligopeptide permease
cal4 oppA2 0.71 peptide transport protein
ceph6 pcd 0.70 semialdehyde dehydrogenase
SC01090 0.80 putative phosphodiesterase
SC01174 thcA 0.78 aldehyde dehydrogenase
SC01271 fabH3 0.70 putative 3-oxoacyl-[acyl-carrier-protein] synthase III
SCO 1393 acsA 0.73 acetoacetyl-CoA synthetase
SC01579 argJ 0.73 putative glutamate N-acetyltransferase
SCO3096 eno 0.77 Enolase
SCO3202 hrdD 0.70 RNA polymerase principal sigma factor
SC04141 pstC 0.75 phosphate ABC transport system permease protein
SC04228 0.70 putative phosphate transport system regulator
SC06466 0.80 putative glycerate kinase
Table 5.8.: Genes positively correlated to clavulanic acid specific production rate in TS3
b!s2f c a ll,  car, cas2, ceas2, oppA l, and oppA2 are all genes of the clavulanic acid 
cluster. CEAS catalyses the first step of clavulanic acid synthesis, BLS, the second, 
CAS2, the third, fifth and sixth, and CAR the last one. The gene c a ll encodes a 
putative beta-lactamase, which can be a way for the organism to protect itself from its 
own antibiotics. oppAl and oppA2 are oligopeptide-permease-encoding genes and are 
required for clavulanic acid production (Lorenzana et al., 2004). 0RF12 seems to be 
involved in the last steps of clavulanic acid synthesis and is also required for its 
production (de la Fuente et aL, 2002). All these genes are necessary for clavulanic acid 
synthesis. It is encouraging to see these genes being positively correlated to clavulanic 
acid specific production rate as it means, firstly that the custom probes on the 
microarrays seem to be hybridising the right genes and, secondly, that the method we 
are using to find genes involved in clavulanic acid production is effective.
For the purpose of illustration. Figure 5.9. shows the expression of genes of the clavulanic 
acid cluster over time.
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Expression of clavuianic acid cluster genes in TS3
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Figure 5.9.: Natural logarithm of normalised expression of clavuianic acid cluster genes in TS3
The genes fd, cal2, cal5, and were not included, as too many time points did not have 
expression values (probably due to bad spot quality and/or bad probe design).
It is clear that most genes of the clavuianic acid cluster follow the same pattern, increasing 
abruptly around 37h (the time at which clavuianic acid production rate increased and p 
decreased) and then slowly decreasing until about 160h, at which point the expression of the 
clavuianic acid cluster genes decreased abruptly. The clavuianic acid transcriptional activator 
gene daR follows the same trend as most of the genes.
It is interesting to note that none of the genes of the paralogue cluster are positively 
correlated to clavuianic acid specific production rate, confirming that they are regulated in a 
different manner from the genes of the clavuianic acid cluster (Jensen et a!., 2000; Tahlan at 
a!., 2004a; Tahlan eta!., 2004c).
- pcd and cmcJ are genes of the cephamycin C cluster. They both encode enzymes 
involved in the synthesis of cephamycin C. Cephamycin C was not assayed during our 
experiments, but it is possible that it was produced. As both clavuianic acid and
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cephamycin C are under the control of at least one common regulator, CcaR, it is not 
surprising to see that their genes get expressed at about the same time.
In order to see whether the expression of other genes of the cluster varies in the same way, 
the expression of each gene over time is graphically represented in Figure 5.10.
Expression of cephamycin cluster genes in TS3
cephl4
cmcT
cephyd
Time
Figure 5.10.: Natural logarithm of normalised expression of cephamycin C cluster genes In TS3
Most genes of the cephamycin C cluster follow the same pattern as the clavuianic acid 
cluster genes. Importantly, ccaR, the clavuianic acid and cephamycin C positive regulator 
gene, is very strongly upregulated around 37h, when both gene clusters start getting 
upregulated as well. It therefore looks like cephamycin C is indeed being produced in our 
conditions, or that at least the genes of its cluster get expressed. The latter is probably true 
as Bra ha et al. (1985) showed that nitrogen represses cephalosporin production through 
inhibition of expandase and cyclase activity.
- SC01090 encodes a putative phosphodiesterase. It catalyses the reaction: a 
glycerophosphodiester + H20 = an alcohol + sn-glycerol 3-phosphate, sn-glycerol 3- 
phosphate can then be converted to glycerol. This enzyme could therefore help
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alleviate the clavuianic acid C3 precursor limitation by generating a compound that can 
be converted into this C3 precursor, glyceraldehyde-3-phosphate.
eno encodes an enolase which catalyses the reversible reaction: 2-phospho-D-glycerate 
= phosphoenolpyruvate + H2O in glycolysis.
SC06466 encodes a putative glycerate kinase. It catalyses the reaction: ATP + (R)- 
glycerate = ADR + 3-phospho-(R)-glycerate, the latter being one of the glycolysis 
intermediates.
AAcA encodes a aldehyde dehydrogenase. It can catalyse many different reactions, 
including the conversion of glyceraldehyde to glycerate. Li and Townsend (2006) 
suggested that, when the gene encoding glyceraldehyde-3-phosphate dehydrogenase is 
deleted, glycerol can also be metabolized through glycerol hydrogenase, aldehyde 
dehydrogenase and glycerate kinase to form 3-phosphoglycerate, and then pyruvate, 
which can then enter the Krebs cycle (cf. Figure 5.14.). Therefore, thcA and SC06466 
could be working together to feed the Krebs cycle via an alternative pathway.
fabH3 encodes a putative 3-oxoacyl-[acyl-carrier-protein] synthase III. This enzyme is 
part of the fatty acid biosynthesis pathway. It works by adding an acetyl-CoA to the 
forming fatty acid. The macromolecular composition analysis showed that lipids 
accumulate with time in batch culture, which could explain why the expression of fabH3 
is correlated with clavuianic acid specific production rate.
acsA encodes a acetoacetyl-CoA synthetase. It catalyses the conversion between 
acetoacetate and acetoacetyl-CoA. Looking carefully at the annotations for that gene, it 
seems that it might actually be encoding a closely-related enzyme: acetyl-CoA 
synthetase, converting acetate to acetyl-CoA. I f  the latter is true, this enzyme could 
work together with the gene product of thcA to convert acetaldehyde to acetyl-CoA, 
which can then enter the fatty acid pathway through fabH3qewe product.
argJ is a gene of the arginine biosynthesis cluster. This enzyme catalyses the first and 
fifth steps of arginine biosynthesis. The role of this protein in clavuianic acid production 
could be the synthesis of arginine as C5 precursor of clavuianic acid. It is therefore
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Interesting to look at the expression pattern of the other genes of the arginine pathway. 
As explained earlier, the custom microarrays used in TS3 have both 5. coelicolor S. 
clavuligerus genes. Since the sequence for the arginine cluster genes of 5. clavuligerus 
was available, probes were designed for them, although these genes are normally very 
well conserved between species. Therefore, there are two sets of arginine cluster genes 
on the microarrays, that will be analysed and illustrated separately in Figures 5.11. and 
5.12.
The gene argR, encoding an arginine repressor, could not be added to the graph 
showing S. clavuligerus qenes (Figure 5.12.), as data for its expression level was only 
available for one of the time points. This Is probably due to a bad probe design. It Is 
clear that most if not all genes of the arginine pathway show the same trend as the 
clavuianic acid genes: their expression abruptly increases when clavuianic acid starts 
being produced, and slowly declines with clavuianic acid specific production rate. This 
suggests that the two pathways are under the same regulation, possibly through ArgR, 
as Liras and Rodriguez-Garcia (2000) suggested. The expression of argR could be 
obtained from the S. coeiicoior probes and it seems that argR follows the same 
expression pattern as the other arginine genes, which is surprising as it supposedly 
represses expression of these other genes.
As a side note, it is interesting to see that the gene expression using the 5. ciavuiigerus 
probes (Figure 5.12.) seems to be much less noisy than when using the 5. coeiicoior 
probes (Figure 5.11.). This might be due to interferences with cross-hybridising genes 
on the non-specific 5. coe/zco/or probes.
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Figure 5.11.: Natural logarithm of normalised expression of arginine cluster genes in TS3 (S. coe/zlco/orprobes)
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Figure 5.12.: Natural logarithm of normalised expression of arginine cluster genes in TS3 (S. c/avu//gerus probes)
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AnfO encodes the RNA polymerase principal sigma factor. Marcos et a i (1995) showed 
that, In 5. griseus, hdrD is expressed under sporulation conditions, after a nutritional 
shiftdown. Fujii et aL (1996) also showed that, in 5. coeiicoior, the promoters of the 
antibiotic pathway activator genes redD and c?cflI-0RF4 were recognised by an RNA 
polymerase holoenzyme containing but that the disruption of hrdD had no effect 
on the synthesis of the two antibiotics, undecylprodigiosin and actinorhodin, suggesting 
that both promoters must be recognised by at least one other sigma factor. It is 
possible that hrdD plays the same role with daR, the clavuianic acid pathway activator 
gene, when phosphate becomes depleted.
pstC and SC04228 both encode proteins involved in phosphate transport. As it was 
shown in Chapter 2, clavuianic acid starts being produced when phosphate becomes 
depleted. Genes involved in phosphate transport are probably upregulated when the 
phosphate concentration in the cell falls, in an attempt to obtain more phosphate from 
the medium.
The microarrays used had a total of 6 genes Involved in phosphate transport (Table 
5.10.). Their expression over time can be represented on a graph (Figure 5.13.).
SCO
number
Common
name Product
SC01845 putative low-affinity phosphate transport protein
SC04138 pitH phosphate transport protein
SC04139 pstB phosphate ABC transport system ATP-bindIng protein
SCO4140 pstA phosphate ABC transport system permease protein
SC04141 pstC phosphate ABC transport system permease protein
SC04228 putative phosphate transport system regulator
Table 5.9.: Genes involved in phosphate transport
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Expression of phosphate transport genes in TS3
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Figure 5.13.: Natural logarithm of normalised expression of phosphate transport genes in TS3
As shown on the graph above, most phosphate transport genes follow a similar pattern to 
clavuianic acid genes, their expression increasing rapidly when phosphate gets depleted 
around 37h, and then slowly decreasing from lOOh onwards. The expression of SCO1845, 
which is described as a low affinity phosphate transport protein, does not seem to follow this 
pattern at all, probably because it only has low affinity for phosphate.
53.2.2.2. Genes negatively correlated to clavuianic add specific 
production rate In TS3
28 genes were found to be negatively correlated to clavuianic acid specific production rate. 
They are listed in appendix 9. Twelve of them had a plausible link to clavuianic acid 
production and/or growth rate.
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SCO/gene
name
Common
name
Spearman correlation 
coefficient Product
SC01464 rpe -0.71 ribulose-phosphate 3-epimerase
SC04572 nuoK -0.77 NuoK, NADH dehydrogenase subunit
SC01598 rpIT -0.73 SOS ribosomal protein L20
SCO3909 rpH -0.73 505 ribosomal protein L9
SC04649 dpA -0.73 505 ribosomal protein LI
SCO4705 rplB -0.72 505 ribosomal protein L2
SC04713 rplX -0.82 505 ribosomal protein L24
SC04719 rpsE -0.78 305 ribosomal protein 55
SCO4720 rpmD -0.80 505 ribosomal protein L30
SC04721 rpIO -0.78 505 ribosomal protein L15
SCO4730 rplQ -0.73 505 ribosomal protein L17
SCP1.119 dnaN -0.70 putative DNA-polymerase III, beta chain
Table 5.10.: Genes negatively correlated to clavuianic acid specific production rate in TS3
- rpe  encodes the pentose phosphate pathway enzyme ribulose-phosphate 3-eplmerase, 
which catalyses the conversion between D-ribulose 5-phosphate and D-xylulose 5- 
phosphate. This enzyme is also downregulated at D = 0.02h  ^compared to D = O.OSh’  ^
in chemostat. It is not clear why this enzyme is correlated to clavuianic acid specific 
production rate as it does not appear directly related to the clavuianic acid pathway. 
One hypothesis is that 5. clavuligerus uses the alternative Entner-Doudoroff pathway to 
synthesise pyruvate and glyceraldehyde-3-phosphate from 6-phospho-D-gluconate. The 
Entner-Doudoroff pathway has been found active in at least one Streptomyces species, 
Streptomyces tenebrarius (Borodina et aL, 2005b), whereas both S. coeiicoior and 5. 
avermltllls seem to be lacking the gene edd encoding the phosphogluconate 
dehydratase. The Entner-Doudoroff pathway is energetically less efficient than 
glycolysis but yields one NADPH and one NADH instead of two NADH. Two NADPH 
molecules are required for clavuianic acid synthesis, which might partly explain why 
carbon would be redirected towards this pathway when clavuianic acid is being 
produced.
- nuoK  encodes a NADH dehydrogenase, catalysing the reaction NADH + H  ^ + 
ubiquinone = NAD  ^ + ubiquinol. As explained about nuoA, that was found negatively 
correlated to clavuianic acid specific production rate in TSl and TS2, the fact that this 
gene is negatively correlated to clavuianic acid specific production rate suggests that 
oxidative phosphorylation is downregulated when clavuianic acid production increases, 
possibly because less glyceraldehyde-3-phosphate is available to be oxidised through
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glycolysis and through the Krebs cycle. If the hypothesis that 5. clavuligerus uses the 
Entner-Doudoroff pathway is true, less NADH is also produced, decreasing further the 
need for that enzyme.
rpIT, rp tl, rp lA , rp lB , rplX^ rpsE, rpm D, rptO  and rplQ  all encode risobomal 
proteins. It was explained earlier that the expression of ribosomal proteins decreases 
with growth rate, which explains why so many of them are negatively correlated to 
clavuianic acid specific production rate. The presence of these genes on the list of 
negatively correlated genes suggest that ribosomal protein genes transcription is 
sensitive to the same signal(s) as the genes involved in clavuianic acid biosynthesis.
dnaN  encodes the beta chain of a putative DNA-polymerase III. As the growth rate 
decreases, DNA synthesis decreases as well, and less DNA polymerase is therefore 
required.
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5.3.2.3. Time series 1, 2 and 3
The Spearman correlation coefficient for each gene was averaged between the three time 
series. Only genes that were present in the three time series were studied here.
5.3.2.3.I. Genes positively correlated to clavuianic add specific 
production rate in a ll time series
Only 4 genes were positively correlated to clavuianic acid specific production rate in all three 
time series.
SCO/gene
name Product
SC03553 putative small membrane protein
SCO7150 putative acetyltransferase
SC06138 putative transmembrane protein
SC04625 conserved hypothetical protein
Table 5.11.: Genes positively correlated to clavuianic acid specific production rate in ail three time series 
No specific information could be found on any of these four genes.
5.3.23.2. Genes negatively correlated to clavuianic acid specific 
production rate in a ll time series
SCO/gene
name
Common
name Product
SCO4705 rplB SOS ribosomal protein L2
SCO4701 rpsJ 30S ribosomal protein 510
SC04712 rpIN 505 ribosomal protein L14
Tabie 5.12.: Genes negatively correlated to clavuianic acid specific production rate in all three time series
As explained before, it is expected to find ribosomal proteins gene negatively correlated to 
clavuianic acid specific production rate.
5.3.3. Chemostats experiments
The protocol and results of these chemostat experiments is detailed in Chapter 2. Each 
dilution rate (0.02h'^ and O.OSh'^ ) was run in triplicate. One microarray was prepared from 
each experiment. The results of one of the high dilution rate chemostats had to be discarded
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as the culture seemed to have behaved quite differently from the other two replicates. 
Therefore, the experiment was composed of three biological replicates at D = 0.02h'^ and 
two biological replicates at D = 0.05h'\ The custom microarrays including the 80 5. 
clavuligerus-s\ie€\f\c probes were used in this experiment. 5. clavuligerus cDNA was labelled 
with Cy3 dye while 5. coeiicoior qDHk was used as a control and labelled with Cy5 dye.
There are different techniques to identify differentially expressed genes. Jeffery et aL (2006) 
compared the efficiency of 11 selection methods: significance analysis of microarrays (SAM), 
analysis of variance (ANOVA), empirical bayes t-statistic, template matching, maxT, between 
group analysis (BGA), area under the receiver operating characteristic (ROC) curve, the 
Welch t-statistic, fold change, rank products, and sets of randomly selected genes. Although 
fold change is still a very popular method, Jeffery e t aL (2006) showed that it is not optimal 
because it does not control variance, therefore being susceptible to outliers. It is also always 
difficult to decide where to place the cut-off. Many research papers seem to be using 2-fold 
change as a standard, but it has no real meaning. Jeffery et aL (2006) concluded that rank 
products is a good method for noisy data sets with few samples, as it is the case in our 
experiment.
Breitling et aL (2004) proposed the rank products method as a simple and powerful way of 
selecting differentially expressed genes. It is based on the principle that, when x genes in 
each of y replicates are ranked according to their expression level, the average rank of an 
unchanged gene should be (x + l)/2 . Systematic deviations from this average rank indicate 
that a gene is differentially expressed. Once the ranks in each replicate have been 
calculated, the ranks for each gene are multiplied, giving its rank product (RP). The smaller 
the rank product of a gene, the more chance this gene has to be up-regulated. A percentage 
of false positives (PFP) is then calculated if the gene, and all genes with an RP value smaller 
than this cut-off, would be considered as significantly differentially expressed. It is good 
practise to consider as significant, genes with a PFP under 10%.
Breitling and Herzyk (2005) implemented the RP method via a Perl script, available on 
http://www.brc.dcs.gla.ac.uk/glama/, which was used to analyse the data of this study. The 
data file can be found on the supplementary CD under the name "6- Chemostats Rank 
Products Analysls.xls".
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5.3.3.1. Genes up-regulated at D = 0.02h'^ 
Five genes were found to be up-regulated at D = 0.02h'\
SCO/gene
name
Common
name
Percentage 
of false 
positives
Product
cephl3 ccaR 0% positive regulator
ca9 cyp 0% cytochrome P450
SC06681 ramC 7.3% putative serine/threonine protein kinase
SC05234 7.4% putative sugar transporter integral membrane protein
SC03267 8.5% hypothetical protein
- ccaR\
First of all, it is not surprising to find ccaR highly upregulated at D = 0.02h'\ when clavuianic 
acid production is high. As explained in the first Chapter, ccaR is the positive regulator of 
both clavuianic acid and cephamycin C. Its amplification results in a two- and three-fold 
increase in the production of cephamycin C and clavuianic acid, respectively (Liras and 
Rodriguez-Garcia, 2000). CcaR is believed to act indirectly on clavuianic acid production 
through ClaR (cf. 1.3.2.3.5. Regulatory genes). Paradkar et aL (1998) showed that daR- 
disrupted mutants lack transcription of the genes oppAl, cyp and car of the clavuianic acid 
cluster, whilst the early genes ceas2, b!s2, pah2 , cas2 and oat2 are transcribed 
independently. Thalan et aL (2004a) also showed that CcaR somehow controls the 
expression of the ceas2 promoter, yielding a polycistronic transcript composed of the genes 
involved in the early stages of clavuianic acid production {ceas2- b !s2 - pah2- cas2). CcaR 
has also been shown to bind to its own promoter (Santamarta et aL, 2002). It is therefore 
autoregulatory, possibly through a y-butyrolactone-based quorum-sensing system 
(Santamarta etaL, 2005; Wang etaL, 2004). Bignell etaL (2005) recently reported that the 
5. clavuligerus'b\àG, an anti-anti-sigma factor, also regulated the expression of ccaR.
-  cypr.
The gene cyp encodes the cytochrome P450 of the clavuianic acid cluster. As mentioned 
above, c/pis regulated by ClaR, which is itself regulated by CcaR. Li etaL (2000) suggested 
that the cytochrome P450 as well as the ferredoxin, encoded by the gene fd\x\ the clavuianic 
acid cluster, mediate the oxidative deamination that takes place between clavaminic acid and 
clavaldehyde. However, daR is not upregulated at D = 0.02h"\ The 0.02h‘V0.05h'^ ratio is in 
fact 0.88, which is not significantly different from 1.
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- ramC.
The gene /s/MCencodes a putative serine/threonine protein kinase. It is part of the gene 
cluster and has been shown to be required in the production of aerial hyphae but not in 
antibiotic production in S. coe//co/or (O'Connor et aL, 2002). Looking at the foid change, the 
cluster's regulator gene ramR a\so appears somewhat up-regulated (fold change = 1.53). It 
is not known whether 5. clavuligerus undergoes some morphological differentiation in liquid 
culture or whether the gene cluster has another role in 5. clavuligerus and/or in liquid 
culture.
Nguyen et aL (2002) also showed that overexpression of ramR restored aerial hyphae 
formation and SapB (a hydrophobic peptidic morphogen that facilitates aerial hyphae 
formation) synthesis in bald {bIdB, bIdK, bIdG, bIdD, dpPl, bIdN, bIdM and citA) mutants.
- SC05234:
SC05234 is a putative sugar transporter integral membrane protein, but it is not clear which 
sugar it is specific for. It contains conserved domains for maltose transport, but also for 
spermidine/putrescine transport. Since it is unlikely that there is maltose formed In our 
culture, this transporter is probably specialised in spermidine/putrescine transport. Both 
compounds are derived from ornithine. An hypothesis is that arginine synthesis gets up­
regulated when growth rate decreases and/or when clavuianic acid is being produced. 
However, the other precursor, glyceraldehyde-3-phosphate, is thought to be the rate-limiting 
precursor (Ives and Bushell, 1997). Therefore, there might be an overflow of arginine, which 
could be recycled into ornithine, and then into spermidine/putrescine.
It is also interesting to note than putrescine and proclavaminic acid have the same core 
structure.
proclavaminic acid putrescine
Figure 5.15.: Comparison of the structures of proclavaminic add and putrescine
Therefore, another hypothesis is that 5. clavuligerus exports proclavamic acid outside the 
cell, where it gets converted into clavuianic acid. This could help the organism protect itself
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from its own antibiotic. However, this theory infers that the enzymes CAS2, GCAS and CAR 
get excreted as well, which is doubtful.
- SC03267;
No information was available on SC03267.
5.3.3.2. Genes down-regulated at D = 0.02h-1
56 genes were found to be down-regulated at D = 0.02h'^ (cf. appendix 10). Among these, 
11 genes showed a possible link with clavuianic acid production and/or growth rate.
SCO/gene
name
Common
name
Percentage 
of false 
positives
Product
ca8 car 0.0% clavaldehyde dehydrogenase or clavulanate-9-aldehyde reductase
ca3 pah2 0.6% proclavaminate amidinohydrolase
ca4 cas2 0.8% clavaminate synthase or clavaminic acid synthetase
SCO2014 pykl 0.3% pyruvate kinase
SCO 1666 7.2% putative phosphatase
SC06584 0.4% acetolactate synthase large subunit
SC04662 tu fl 3.7% elongation factor TU-1
SC04711 rpsQ 7.8% 30S ribosomal protein S17
SCO4706 rpsS 1.6% 308 ribosomal protein 519
SCP1.228C mmyF 2.0% putative oxidoreductase, MmyF
SCO7120 qrcB2 2.0% ubiquinol-cytochrome C reductase cytochrome B subunit
Table 5.14.: Genes down-regulated at D = 0.02h’^
Three genes of the clavuianic acid cluster are downregulated:
- pah2, which encodes the enzyme proclavaminate amidinohydrolase, responsibie for the 
fourth step of clavuianic acid synthesis,
- cas2, which encodes the enzyme clavaminate synthase, responsible for the third, fifth 
and sixth steps of clavuianic acid synthesis,
- car, which encodes the enzyme clavulanate-9-aldehyde reductase, responsible for the 
last step of clavuianic acid synthesis.
This result is very surprising as the proteins encoded by these genes are needed for 
clavuianic acid production, and clavuianic acid is produced at higher levels at D = 0.02h'\ It 
is also surprising because the gene for the positive regulator CcaR is upreguiated at D = 
0.02h'\ Thalan et aL (2004a) also showed that CcaR controls the expression of the ceas2 
promoter, yielding a polycistronic transcript composed of the genes involved in the early
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stages of clavuianic acid production {ceas2 -  b!s2 -  pah2 -  cas2). However, despite ccaR 
being upregulated, pah2 and cas2 are downregulated, which suggests that there is another 
type of control in place.
Liras (1999) also showed that the daR transcript can not be found in cca/?-disrupted 
mutants, suggesting that CcaR is also a positive activator for that gene. Furthermore, 
Paradkar e t aL (1998) showed that c/a/?-disrupted mutants lack transcription of the genes 
oppAl, cyp and car of the clavuianic acid cluster. However, the gene daR is neither up- nor 
downregulated in this study (fold change = 0.88), and, although cyp is indeed upregulated, 
car is downregulated.
These results suggest that the regulation of clavuianic acid biosynthesis is very complex and 
involves more regulatory genes than have been found so far. The genes of the clavuianic 
acid pathway might be sensitive to end-product repression in some conditions. Another 
explanation could be that the enzymes encoded by pah2, cas2 and car are more active at D 
= 0.02h'\ and therefore can be produced in lesser quantity than at D = 0.05h'\ Finally, the 
up-regulation of pah2, cas2dtx\6 carat D = O.OSh'^  could be explained by a higher production 
of degradative enzymes.
- p y k l :
Pyruvate kinase is an enzyme of the glycolysis pathway. It catalyses the step between 
phosphoenol-pyruvate and pyruvate.
- SC01666:
This gene contains conserved domains suggesting it is part of the phosphoglycerate mutase 
family. Phosphoglycerate mutase reversibly catalyses the conversion between 3-phospho-D- 
glycerate and 2-phospho-D-glycerate in glycolysis.
Another gene of the glycolysis pathway, gapl, was found to be down-regulated (1.56 fold 
change) at D = 0.02h'\ when using the fold change method. The gene rpe of the pentose 
phosphate pathway, previously described as negatively correlated to clavuianic acid specific 
production rate in TS3, is also down-regulated (1.79 fold change). This suggests that 
glycolysis as a whole is probably downregulated at low growth rates, enabling more 
glyceraldehyde-3-phosphate to be directed toward clavuianic acid and/or that S. clavuligerus 
redirects some of its carbon through the alternative Entner-Doudoroff pathway at low growth 
rate.
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Interestingly, as mentioned earlier, Li and Townsend (2006) showed that the inactivation of 
gapl in S. clavuligerus enabled to increase clavuianic acid synthesis significantly. D- 
glyceraldehyde 3-phosphate being the rate-limiting precursor of clavuianic acid (Ives and 
Bushell, 1997), it is logical to obtain a higher titre of clavuianic acid when the flux is 
redirected towards its production. Li and Townsend (2006) also showed that, after 
inactivation of gapl, the pool of D-glyceraldehyde 3-phosphate is increased so much that 
arginine, the other precursor of clavuianic acid, becomes the limiting factor. They also 
suggested that, as illustrated on the map below (Figure 5.16.), in the absence of 
glyceraldehyde-3-phosphate dehydrogenase, glycerol can also be metabolized through 
glycerol hydrogenase, aldehyde dehydrogenase and glycerate kinase to form 3- 
phosphoglycerate, and then pyruvate, which can then enter the Krebs cycie. However, this is 
unlikely to be the case here as at least two genes encoding enzymes between 3- 
phosphoglycerate and pyruvate are also down-regulated (cf. Figure 5.16.). The hypothesis 
that 5. clavuligerus uses the Entner-Doudoroff pathway at low growth rate is therefore more 
likely, based on gene expression.
- SC06584;
Acetolactate synthase catalyses three reactions of the valine, leucine, and isoleucine 
pathway, starting from pyruvate. As explained above, several reactions ieading to pyruvate 
are down-regulated. Therefore, it is not surprising that a reaction from pyruvate to amino 
acids is down-regulated as well. Protein content decreases with growth rate, as shown in 
Chapter 3, so less amino acids need to be synthesised.
- tu fir  rpsQr rpsS.
As explained before, the expression of ribosomal protein genes, as well as tu fl, decreases 
with growth rate.
- mmyF.
The gene mmyF\s part of the methylenomycin cluster, on the SCPl plasmid if S. coeiicoior. 
Methylenomycin is an antibiotic that is particularly effective against Proteus species (Hobbs 
etaL, 1992). It is not known whether this antibiotic is also produced by S. clavuligerus, and 
why that gene is down-regulated at D = 0.02h'\ but it is interesting to see that the raw 
expression level of these genes on the microarrays suggest that they all have orthologues in 
5. clavuligerus ax\û are likely to be expressed at both dilution rates (data not shown).
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- qrcBZ:
This gene encodes a ubiquinol-cytochrome C reductase cytochrome B subunit. This enzyme 
is involved in oxidative phosphorylation. As it was mentioned earlier, this suggests that 
oxidative phosphorylation is downregulated when clavuianic acid production increases or 
when the growth rate decreases, possibly because less glyceraldehyde-3-phosphate is 
available to go down glycolysis and through the Krebs cycle.
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5.3.4. Batch and chemostat comparison
The chemostat experiments were originally designed to reproduce a specific phase of 
S. clavuligerus growth in batch. The chemostat experiment at D = 0.02h‘  ^ was 
designed to mimic the stationary phase, during which high titres of clavuianic acid 
can be observed, while the chemostats at D = 0.05h‘  ^ aimed at reproducing the 
conditions observed in exponential or linear growth phase, during which only little 
clavuianic acid is produced. Therefore, we can now compare the genes positively 
correlated with clavuianic acid specific production rate to the genes up-reguiated at 
D = 0.02h"\ and do the same with the genes negatively correlated with clavuianic 
acid specific production rate to the genes down-regulated at D = 0.02h'\
The gene lists were compared and only one gene, tu fl, was found on both the list of 
genes down-reguiated at D = 0.02h'^ and negatively correlated to clavuianic acid 
specific production rate In either TS l and TS2 or TS3. As explained before, the 
expression of tu fl is correlated to growth rate. No gene was found in common 
between the lists of genes up-reguiated at D = 0.02h’  ^ and positively correlated to 
clavuianic acid specific production rate in either TSl and TS2 or TS3.
Despite this apparent lack of similarities between the two lists, some trends can be 
noticed. First of ail, many ribosomal protein genes were found on both the list of 
genes down-reguiated at D = 0.02h'^ and negatively correlated to clavuianic acid 
specific production rate, confirming the role of growth rate regulation of clavuianic 
acid. Both lists also have genes involved in oxidative phosphorylation, suggesting 
that this process is down-reguiated both at low growth rate and at high clavuianic 
acid.
Both lists contained genes involved in glycolysis and/or glycerol metabolism. 
However, the genes listed in TS3 seemed to indicate that, when clavuianic acid 
production increased, glycerol was being oxidised through the pathway described by 
Li and Townsend (2006) through glyceraldehyde, and then through glycolysis toward 
pyruvate. In chemostat, the glycolysis pathway was clearly down-reguiated at D = 
0.02h"\ and there was no indication that the glycerol was going through the pathway
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proposed by Li and Townsend, which iead us to suggest that 5. clavuligerus might be 
using the Entner-Doudoroff pathway.
Finally, there was an even more striking difference between chemostat and batch 
experiments regarding clavuianic acid genes. In batch, most genes involved in 
clavuianic acid synthesis were highly correlated to specific clavuianic acid production 
rate, as expected. However, the trend was totally different in chemostat, where only 
ccaR and cyp were up-reguiated at D = 0.02h'\ Not only were merely two genes of 
the clavuianic acid -  cephamycin C supercluster up-regulated, but three of them 
{car, cas2, pah2) were actually down-reguiated at low dilution rate. This is very 
surprising as ccaR, the activator gene, was up-reguiated, and the clavuianic acid 
specific production rate was higher at D = 0.02h'\ This suggests that the regulation 
of clavuianic acid synthesis is still far from being understood, and that control of 
secondary metabolism in a dynamic environment such as a batch culture is very 
different from control in a stationary, fixed and somehow un-naturai environment 
that is the chemostat.
5.4. Summary and future work
We have shown that it is relatively easy to customise microarrays in order to use 
them for different related species. Most of the probes created for 5. clavuligerus 
genes gave adequate results, as both the signal level and the signal pattern in batch 
culture were satisfactory. However, a few probes seem to need redesigning as the 
signal level they gave was very poor.
It is important to remember that these microarrays were originally designed for 5. 
coeiicoior. We can therefore expect to have cross-hybridisation between some 5. 
ciavuiigerus genes and some microarray probes that were initially designed for other 
genes, giving us some misleading results. However, most genes of central 
metabolism are very well conserved between species and should not generate too 
much cross-hybridisation. For instance, the profiles in batch culture for the arginine 
cluster genes from both S. coeiicoior and 5. ciavuiigerus probes were very similar, 
suggesting that the 5. ciavuiigerus genes could hybridise on both sets of probes.
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In batch culture, we had a reproducibility issue, especially when another bioreactor 
was used in TS3. To counter this problem, TS3 was analysed separately from TSl 
and TS2. It was also later realised that more samples than in TSl and TS2 need to 
be taken as some genes are expressed very transiently. In that respect, TS3 
probably gave more meaningful results, as samples were taken every 6 hours during 
the transition phase.
In chemostat culture, reproducibility is obviously much easier to obtain, which makes 
the chemostat an ideal tool for this kind of Studies. However, because the results 
were so different between chemostat and batch cultures, we suggest that both 
techniques need to be used, if only to confirm the present findings, but also to 
understand better what makes the regulation of clavuianic acid production so 
different between the two types of culture.
The analysis of gene expression in both batch and chemostat cultures enabled a 
better understanding of clavuianic acid production. The results suggest that 
glycolysis is down-regulated at D = 0.02h'^ in chemostat. This could be because 
some of the giyceraidehyde-3-P that normally goes through glycolysis to the Krebs 
cycie gets redirected toward clavuianic acid production. I suggest that S. clavuligerus 
can use the Entner-Doudoroff pathway, which would also explain why the gene rpe 
of the pentose phosphate pathway is downregulated at D = 0.02h'^ and negatively 
correlated to clavuianic acid specific production rate. However, in batch culture, the 
gene expression patterns suggest that 5. ciavuiigerus uses an alternative pathway 
from glycerol to 3-phosphogiycerate through glyceraldehyde. It would be interesting 
to investigate further whether both these pathways are indeed present and active in 
5. ciavuiigerus. Oxidative phosphorylation is also down-regulated at D = 0.02h'^ and 
negatively correlated to clavuianic acid specific production rate.
The careful observation of some genes positively correlated to specific clavuianic acid 
production rate enables to suggest a few experiments that might confirm or refute 
some theories exposed in this Chapter. First of all, glycine seems to be an important 
amino acid for clavuianic acid production, possibly because it is required by the 
enzyme GCAS of the clavuianic acid pathway. Feeding a culture with it would be
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interesting, as wouid be feeding with thymidine, which can be converted into 
giyceraidehyde-3-P.
It was interesting to observe the presence of some unexpected genes. A few of them 
were related to morphological changes, such as traBl, the sporuiation-reiated 
protein, or ramC, which is required for production of aerial hyphae in 5. coeiicoior. It 
is not known whether S. ciavuiigerus can undergo morphological differentiation in 
liquid culture but it wouid be interesting to look at this possibility.
Some genes involved in the production of other antibiotics were also retrieved. For 
instance, most genes of the cephamycin C pathway followed the same trend as 
clavuianic acid pathway genes in batch culture. A gene of the methylenomycin 
cluster was also found to be down-regulated at D = 0.02h'\ which led to look at the 
whole cluster, which seemed to be expressed in both conditions.
No explanation could be found for the up- or down-regulation of some of the genes. 
This could be because the genes were false discoveries, or that some different S. 
ciavuiigerus genes had cross-hybridised on the probes for these genes, or just that 
5. ciavuiigerus metabolism is not yet well understood.
In the next Chapter of this study, transcriptomics results will be compared to the 
fiuxomic results presented in Chapter 4.
Chapter  6  
Co m pa r iso n  of 
TRANSCRIPTOMICS AND 
FLUXOMICS
DNA GENOMICS
RNA TRANSCRIPTOMICS
PROTEINS => PROTEOMICS
FUNCTION => METABOLOMICS, FLUXOMICS
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6.1. Introduction
6.1.1. The 'omics' sciences
Fluxomics provides information on the distribution of carbon fluxes within an organism's 
metabolism, whereas transcriptomics provides with information at the RNA levei. They each 
study an organism at a different levei of the 'information flow' (cf. Figure 6.1.).
DNA GENOMICS
RNA TRANSCRIPTOMICS
PROTEINS => PROTEOMICS
FUNCTION => METABOLOMICS, FLUXOMICS
Figure 6.1.: Relationships between the 'omics' sciences: the information flow
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The above model suggests that the Information flow Is hierarchical, I.e. dominated by 
regulation of gene expression. For Instance, In transcrlptomic studies. It Is assumed that the 
mRNA level Is a quantitative predictor for function. However, ter Kulle and Westerhoff (2001) 
showed that this does not always reflect reality, at least in protlsts. For Instance, the rate of 
an enzymatic reaction also depends on metabolic properties such as substrate or product 
concentratlon(ter Kulle and Westerhoff, 2001). Therefore, It Is essential to take Into 
consideration not only the transcrlptome or the proteome, but also the end product of the 
Information flow: the metabolite (ter Kulle and Westerhoff, 2001).
Each method has Its own advantages and drawbacks. For Instance, a weakness of 
transcriptomics Is that an Increase In gene expression does not necessarily mean that the 
flux of the metabolic pathway linked to this gene will Increase as well, because of 
translational or post-translational regulation. But on the other hand, fluxomics only gives 
estimation of fluxes, based on a metabolic network that Is not always at genome-scale, and 
relies on some questionable assumptions.
Therefore, It seems sensible to associate these two methods together In order to alleviate 
their respective limitations. Their association can also yield some Information that would not 
be possible to get by using one method or the other.
Gonzalez et al. (2002) studied the distribution of fluxes and the gene expression in two 
strains of E coif with two different carbon substrates. They discovered that the 
reproducibility of expression measurements was as good as that of enzyme activity assays 
(coefficient of variation of 12% for the genes above a certain minimum level of expression). 
They also found that the changes In the expression of genes encoding glycolysis were In very 
good agreement with the fluxes of this pathway. In contrast, expression of genes of the 
Pentose-Phosphate Pathway (PPP) remained constant during fermentation although the 
metabolic fluxes through this pathway varied greatly. The use of the two methods also 
enabled them to gather some Information about pathways regulation. Gonzalez et ai. (2002) 
showed that the use of one method Is not enough to get a good understanding of an 
organism's metabolism and physiology, and therefore to perform metabolic engineering. 
Phelps e t ai. (2002) also observed that the Integration of transcriptomics and fluxomics 
might give substantial clues about genes function and relationship to phenotype.
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6.1.2. Aims and objectives
In this Chapter, fluxomic and transcrlptomic analyses will be compared both In batch and 
chemostat cultures. The results of this comparison, as well as possible Improvements, will be 
discussed.
6.2. Comparison of fiuxomics and transcriptomics in batch cultures
6.2.1. Comparison of reievant genes to their corresponding fluxes
The first way to compare fluxomic and transcrlptomic data Is to examine the fluxes 
corresponding to the genes whose expression was found to be either positively or negatively 
correlated to clavulanic acid specific production rate.
6.2.I.I. InTS l and TS2
In TSl and TS2, only two genes correlated to clavulanic add specific production rate had an 
equivalent reaction In the metabolic network (cf. Table 6.1.). The other genes either did not 
encode enzymes or encoded putative enzymes that were not part of the network. The 
expression of the first gene, SCO5470, was positively correlated to clavulanic add specific 
production rate, while the equivalent metabolic flux showed a slightly negative correlation to 
clavulanic add production. The flux corresponding to the second gene, SCO4890, which 
expression was also positively correlated to clavulanic add specific production rate, was null 
In our simulations.
Pathway Reaction Gene
Piux 
correlation 
in all TS
Gene 
expression 
correlation 
In TSl-2
Glycine utilisation THF + SER = GLY + METTHF SCO5470 -0.324 0.721
Pyrimidines biosynthesis THY + DRIP = DT + PI SCO4890 0.000 0.757
Table 6.1.: Genes correlated to clavulanic acid specific production rate and the correlation of their corresponding
fluxes with clavulanic acid flux In T S l and TS2
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6.2.I.2. InTS3
In TS3, eleven genes correlated to clavulanic acid specific production rate had an equivalent 
reaction In the metabolic network (cf. Table 6.2.). Four of them corresponded to genes of 
the clavulanic add pathway {cas2, b!s2, ceas2, and cat). These four genes are the only ones 
that also correspond to a reaction with a flux highly correlated to clavulanic add production. 
The fluxes of the reactions corresponding to the seven other genes do not significantly 
correlate with clavulanic add production. In fact, two of these reactions, corresponding to 
the genes SC01393 and SCO 1174, were Inactive In our simulations.
Pathway Reaction Gene
Gene 
expression 
correlation In 
TS3
Flux 
correlation 
In all TS
Energy metabolism NADH +  MK = NAD +  MKH2 SC04572 -0.770 0.201
Pentose phosphate pathway RL5P =  X5P SCO 1464 -0.709 -0.144
Pyrimidines biosynthesis DOROA +  0 2  = H 202 +  OROA SCO 1482 0.714 -0.155
Leucine utilisation ACTAC +  ATP +  COA = AACCOA +  AMP +  PPI SCO 1393 0.726 0.000
Arginine biosynthesis NAORN +  GLU = ORN +  NAGLU SC01579 0.731 0.140
Clavulanic acid biosynthesis 3 reactions of the clavulanic acid pathwav cas2 0.753 1.000
Glycolysis/gluconeogenesis 2PG = PEP SCO3096 0.767 0.067
Clavulanic acid biosynthesis ATP +  CEA = AMP +  PPI +  DGPC b!s2 0.781 1.000
Pyruvate metabolism ACAL +  NAD = NADH +  AC SC01174 0.783 0.000
Clavulanic acid biosynthesis G3P +  ARC =  CEA +  PI œ as2 0.784 1.000
Clavulanic acid biosynthesis CLAVALD +  NADPH =  CA +  NADP car 0.814 1.000
Table 6.2.: Genes correlated to clavulanic acid specific production rate and the correlation of their corresponding
fluxes with clavulanic acid flux in TS3
6.2.2. Comparison of reievant fluxes to their corresponding genes
A second way to compare fluxomics and transcriptomics Is to examine the gene expression 
of the genes corresponding to the reactions In which flux has been found to be either 
positively or negatively correlated to clavulanic add production. 22 reactions In which fluxes 
significantly correlated to clavulanic add production In all time-serles corresponded to a 
specific gene. In TSl and TS2, the expression of the genes corresponding to these correlated 
reactions was not significantly correlated to clavulanic add specific production rate. In TS3, 
the only genes In which expression was significantly correlated to clavulanic add specific 
production rate were again the genes of the clavulanic add pathway (cf. Table 6.3.).
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It seems that, in batch culture, gene expression does not correlate well with FBA 
results. The only real agreement between fluxomics and transcriptomics is with the 
genes and enzymes of the clavulanic acid pathway.
6.3. Comparison of fiuxomics and transcriptomics in chemostat 
cuitures
6.3.1. Comparison of relevant genes to their corresponding fluxes
Only five genes that were found either up- or down-regulated in chemostat cultures 
using the rank product method had a corresponding reaction in the metabolic 
network (cf. Table 6.4.). Only the gene SCO2014, encoding pyruvate kinase, 
exhibited an expression fold change in agreement with the flux difference observed 
between the two growth rates. The four other genes were down-regulated at D = 
0.02h'^ while their corresponding fluxes were up-regulated at that growth rate. Three 
of them were part of the clavulanic add genes.
Pathway Reaction Gene
Gene expression 
foid change 
(0.02hV0.05h*^)
Flux difference 
(0.02h  ^ - 0.05h \  
% )
Clavulanic acid 
biosvnthesis
CLAVALD +  NADPH = CA +  
NADP car 0.506 68.71%
Glycolysis/
qluconeoaenesis PEP +  ADP = PYR +  ATP SCO2014 0.36 -100%
Valine biosynthesis 2 PYR = ACLAC +  C02 SC06584 0.376 8.49%
Clayulanic acid 
biosynthesis GPC = PROCLAM +  UREA pah2 0.663 68.71%
Clayulanic acid 
biosynthesis
3 reactions of the clavulanic 
acid pathway cas2 0.42 68.71%
Table 6.4.: Genes up- or down-regulated in chemostat culture and the difference of their corresponding
fluxes between the two growth rates
6.3.2. Comparison of relevant fluxes to their corresponding genes
Out of the 81 fluxes that changed from D = 0.02h  ^ to D = O.OSh'^  by more than 
30%, 18 had their corresponding gene over 1.5 times up- or down-regulated. 19 did 
not have a corresponding gene, either because the flux corresponded to an artificial 
reaction such as carbohydrate synthesis, or because the reaction had been added to 
the model in order to make it functional, but without finding the annotation for the
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equivalent gene. Finally, the corresponding genes of 44 changing fluxes did not show 
any significant up- or down-regulation. The 18 fluxes with a corresponding gene up- 
or down-regulated are listed in the Table 6.5. below.
Pathway Reaction Gene
Flux difference 
(0 .02h   ^ - 0.05h \
% )
Gene expression 
foid change 
(0.02h Vo.OSh^)
GIvcolvsis/qluconecxjenesis PEP + ADP = PYR + AT? SCO2014 -10 0 .00 % 0.36
Clavulanic acid biosynthesis DGPC + AKG + 02  = GPC +  SUCC + C02 cas2 6 8 .71% 0.42
Clavulanic acid biosynthesis PROCLAM + AKG + 02  = DHCLAM + SUCC + C02 cas2 6 8 .71% 0.42
Clavulanic acid biosynthesis DHCLAM + AKG + 02  = CLAM + SUCC + C02 cas2 6 8 .71% 0.42
Shikimate pathway DOT = DHSK SC01961 -3 1 .4 9 % 0.46
Clavulanic acid biosynthesis CLAVALD + NADPH = CA + car 68 .71% 0.51
One carbon pool by folate METTVIF + FADH2 = MTHF + FAD SCO2103 -3 1 .2 8 % 0.52
Pentose phosphate pathway RL5P = X5P SC01464 -3 6 .9 1 % 0.56
Folate biosynthesis AHTD = DHP + 3 PI SCO0828 -10 0 .00 % 0.64
Valine utilisation HIBUT + NAD = METVIYLMALONATES + NADH SCO0984 100.00% 0.66
Clavulanic acid biosynthesis GPC = PROCLAM + UREA pah 68 .71% 0.66
Shikimate pathway DHSK + NADPH = SME + NADP SC01498 -3 1 .4 9 % 0.66
Sulphate metabolism APS + ATP = ADP +  PAPS SCO6099 -3 1 .4 7 % 0.67
Methionine biosynthesis HCYS + MTHF = THF + MET SC01657 -3 1 .2 8 % 1.52
Shikimate pathway SME3P + PEP = 3PSME +  PI SC05212 -3 1 .4 9 % 1.63
Glycolysis/qluconeoqenesis G6P = F6P SC01942 42 .4 9 % 1.97
Isoleucine utilisation RMMALONYLCOA = SUCCOA SC06833 100.00% 2.78
C5 carbon utilisation UDPG = UDPGAL SC03137 41 .1 2 % 5.37
Table 6.5.: Fluxes with a corresponding gene up- or down-regulated in chemostat
Among the 18 fluxes/genes couples listed, 10 exhibited changes in the same 
direction, and 8 showed changes in opposite directions. Within these 8 fluxes/genes 
couples, 5 belonged to the clavulanic acid pathway/genes cluster, and the gene cas2 
was actually present three times as the enzyme it encodes catalyses three different 
steps of the clavulanic acid pathway. It has already been mentioned in Chapter 5 
that the down-regulation of genes of the clavulanic acid pathway at D = 0.02h'\ 
when the clavulanic acid specific production rate is higher, was surprising. This 
explains why the clavulanic acid fluxes are not in agreement with the clavulanic acid 
genes expression. If the clavulanic acid genes are ignored, 10 out of 13 (77%) 
gene/reaction couples of the above lost list changed in the same direction, while 3 
out of 13 (23%) changed in the opposite direction.
Fluxomics and transcriptomics seem to be in slightly better agreement in chemostat 
cultures. The main source of disagreement between the two genome-scale methods 
comes from the clavulanic acid genes. It was discussed previously how surprising it
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was that the genes of the clavulanic acid pathway were down-regulated at D = 
0.02h"\ This might be explained by a different regulation of ciavulanic acid gene 
expression in batch and chemostat cultures.
6.4. Conclusions and future work
These comparisons have showed the difficulty of correlating gene expression data 
with flux balance analysis data. There could be many explanations to this 
phenomenon. First of all, it is well known that gene expression does not necessarily 
correlate to protein concentration (Gygi et al., 1999), and that enzyme activity does 
not always correspond to metabolic flux (ter Kulle and Westerhoff, 2001). Therefore, 
metabolic flux can obviously not automatically correlate to gene expression (Akesson 
et a!., 2004). The fact that some reactions are reversible can also be a problem as 
the direction of a flux can change while the gene expression remains the same. 
Another issue is the existence of genes encoding enzymes able to catalyse many 
reactions, or enzymes encoded by several genes. When this is the case, it becomes 
very difficult to correlate gene expression with flux value.
An additional obstacle in this study is that both the microarrays and the metabolic 
network were initially based on the genome of another species, Streptomyces 
coeiicoior. This can lead to error both in the gene expression measurement, and in 
the flux balance analysis.
Despite these difficulties, fluxomics and transcriptomics seemed relatively well 
correlated in chemostat culture, except for the clavulanic acid genes, which were 
unexpectedly down-regulated at D = 0.02h'\ However, the fluxes in batch cultures 
did not seem to correlate with the expression of the corresponding genes. This could 
be partly explained by the fact that the samples were never taken at steady-state, 
making the calculation of metabolic fluxes less reliable. The lack of correlation 
between transcriptomics and fluxomics in batch culture could be an indication that 
FBA should only be used in chemostat cultures.
Finally, it would be useful to use the information given by the microarrays on which 
genes are being expressed or not to constrain further the model, a method that has 
been successfully used by Âkesson et ai. (2004) in Saccharomyces cerevisiae. 
However, as it was mentioned earlier, reaction deietion should be conducted with 
care, as the microarrays are not specific to S. davuiigerus.
Chapter  7  
Fin a l  D is c u s s io n  and  
Future W ork
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The production of antibiotics by streptomycetes is a very complex process and its 
regulation is still poorly understood. Traditionally, antibiotic production has been 
studied in batch culture, by varying medium components and/or performing enzyme 
assays to find out the sequences of the enzyme activities involved in the antibiotic 
biosynthetic pathways (Brana et a!., 1985; Chen eta !., 2003; Kwon and Kim, 1998). 
With the sequencing of the model Streptomyces species Streptomyces coeiicoior, it 
has become possible to perform genome-scale analysis of the transcriptome, 
proteome, fluxome or metabolome of these organisms. Many tools have been 
developed in order to obtain and analyse such large data-sets. The development of 
DMA microarrays technology allows global measurements of the level of transcription 
of every gene in a bacteriai genome in one quick hybridisation. Genome-scaie 
metabolic models are also becoming increasingly popular as a method of studying 
the metabolic flux distribution using techniques such as Flux Balance Analysis (FBA). 
Concurrently, chemostat cultures are starting to be used more often as a technique 
for obtaining steady-state data that is statistically more reproducible (Hoskisson and 
Hobbs, 2005).
The objective of this research was to study clavuianic acid production at genome- 
scale. In order to achieve this, custom microarrays containing about 80 S. 
ciavuiigerus-s^ec\f\c probes, as well as a metabolic network with reactions and 
biomass composition specific to 5. davuiigerus, were deveioped. Bioreactors were 
used in order to study the growth and antibiotic production of S. davuiigerus in both 
batch and continuous cultures.
The transition between the growth phase and the production phase was first 
examined in batch cultures. Using the data obtained from these cultures, two dilution 
rates were then chosen to perform continuous cultivation, one supporting high 
antibiotic production, the other supporting low antibiotic production. The chemostat 
cultures proved to be highly reproducible, while the batch cultures showed 
essentially the same trends but with some parameters such as maximum clavulanic 
acid production or length of the lag phase showing relatively large variations. As 
expected, the clavulanic acid production rate increased with decreasing growth rate 
in both types of culture. Moreover, the clavulanic acid production rates obtained in 
chemostat cultures were of the same order as the ones obtained at the 
corresponding growth rate in batch culture. The studies presented here
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demonstrated the reproducibility of the chemostat data and also the utility of 
continuous culture in modelling a specific developmental phase.
In order to model the metabolism of S. davuiigerus more accurately, the 
macromolecular composition of Streptomyces davuiigerus grown in both batch and 
continuous culture was determined. This data was in accordance with the 
composition reported by Roubos (2000) for Streptomyces davuiigerus grown in a 
defined medium (containing glycerol and ammonium) similar to the medium used in 
the present study. Trehalose, which had not been measured by Roubos (2000) was 
found to be present in considerable amounts, especially during stationary phase and 
at the low dilution rate. The monomeric composition of the different biomass 
components was also reconstructed, using data from S. davuiigerus and closely 
related species such as 5. avermitiiis. It was demonstrated here that biomass 
composition significantly influences the flux balance analysis results and therefore 
needs to be measured in order to obtain reliable results. This is In accordance with 
previous observations (Jaques, 2004; Roubos, 2002).
A genome-scale metabolic network for 5. davuiigerus was reconstructed, based on 
the metabolic network developed by Borodina et ai. (2005) for S. coeiicoior. Using 
flux balance analysis, the metabolic network was able to predict with relative 
accuracy the distribution of metabolic fluxes in Streptomyces davuiigerus. A 
disadvantage of flux balance analysis is that regulatory mechanisms can not be taken 
into account. Due to the unavailability of the genome sequence of S. davuiigerus, 
this network was reconstructed using the annotations of the genome of another 
related species {Streptomyces coeiicoioi). The metabolic potential of Streptomyces 
davuiigerus might be different from 5. coeiicoioi^ s. The Flux Balance Analysis 
simulations suggested that using different supplements could potentially increase 
clavulanic acid production. Some of these supplements had already been tested in 
previous studies either with success (threonine) or with poor results (arginine, 
glutamate) (Bushell et ai., 2006). The latter could be explained by phenomena such 
as end-product inhibition or transcription repression. The organic acids malate, 
pyruvate and citrate were also found to increase clavulanic acid production in siiico 
and were therefore suggested as possible supplements, but they were not tested in 
vivo. Further chemostat experiments would validate the use of these supplements.
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The results from batch and chemostat cultures were comparable, when considering 
fluxes associated with clavulanic acid production, supporting the use of chemostat 
culture for modelling a specific phase of batch culture. Important future work would 
include the measurement of additional external fluxes, in order to constrain the 
model further as this would allow the achievement of more reliable flux distributions.
The 5. coeiicoior microarrays used in this study were customised by adding probes 
for various S. davuiigerus genes such as genes of the clavulanic acid and 
cephamycin C cluster, or genes of the arginine pathway. Most of the S. davuiigerus- 
specific probes gave a satisfying hybridisation signal, although a few probes need 
redesigning as the signal level was very low. Microarrays could also be used to 
assess which genes are active or not in certain conditions. However, as the 
microarrays used in this study were designed for S. coeiicoior, if a gene appeared to 
be inactive on these microarrays, it could be because the probe on the microarray is 
specific for a portion of the gene sequence that is different between 5. davuiigerus 
and S. coeiicoior.
The transcriptome from both batch and chemostat cultures was analysed using the 
custom microarrays and the results suggested that glycolysis was down-regulated at 
the lowest growth rate tested in chemostat. A potential explanation for this change is 
that, at that dilution rate, some of the giyceraldehyde-3-phosphate that normally 
goes through glycolysis gets redirected toward clavulanic acid production. It is 
possible that S. davuiigerus uses the Entner-Doudoroff pathway under given 
physiological conditions, as this pathway was showed to be used by Streptomyces 
tenebratius (Borodina et ai., 2005b). That would explain why the gene rpe encoding 
the enzyme ribulose-phosphate 3-epimerase of the pentose phosphate pathway is 
downregulated at low dilution rate and is negatively correlated to clavulanic acid 
specific production rate. However, the use of an alternative pathway from glycerol to 
3-phosphoglycerate through glyceraldehyde is suggested by the transcriptomic 
results obtained in batch culture. It would therefore be interesting to investigate 
further the utilisation of these pathways by either enzyme assays and/or further 
transcriptomic analysis. The microarray data a iso provided evidence that oxidative 
phosphorylation is down-regulated at low dilution rate and negatively correlated to 
clavulanic acid specific production rate. The analysis of the genes positively 
correlated to specific ciavulanic acid production rate also suggested a few
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supplements that might increase clavulanic acid production. Firstiy, giycine seems to 
play a role in clavulanic acid production, possibly because the enzyme GCAS for the 
clavulanic acid pathway requires glycine. Addition of thymidine, which can be 
converted into glyceraldehyde-3-P, could also be tested.
A few genes involved in morphologicai differentiation, such as traBl, the sporulation- 
related protein, or ramC, which is required for production of aerial hyphae in 5. 
coeiicoior, were found to be either up-regulated at low dilution rate or correlated to 
clavulanic acid production rate. It would be interesting to investigate further the 
morphological changes that S. davuiigerus undergo in iiquid culture as some 
streptomycetes are able to sporulate in such conditions (Daza eta i., 1989).
The apparent presence of numerous genes involved in the synthesis of other 
antibiotics in 5. davuiigerus genome revealed by the hybridisation signal on the 
microarrays suggest that this organism produces much more antibiotics than have 
been identified so far. In batch cuiture, the expression of the genes of both the 
cephamycin C and clavuianic acid clusters followed the same trend as the clavulanic 
acid specific production rate. However, in chemostat culture, most of the genes 
involved in clavulanic acid synthesis were found to be down-reguiated at low dilution 
rate, when clavulanic acid production is higher, except for ccaR, the positive 
regulator of the cephamycin C -  clavulanic acid supercluster, and cyp, encoding a 
cytochrome P450 involved in clavulanic acid synthesis. No explanation was found for 
this phenomenon, but it seems that the regulation of clavulanic acid production is 
different in batch and chemostat cultures. This demonstrates the utility of using both 
batch and chemostat cultivations in order to get a better understanding of the 
differences in regulation between the two cultivation techniques.
Finally, the results from both transcriptomic and fluxomic analysis were compared. 
This demonstrated the difficulties in correlating gene expression data with flux 
balance analysis data, as has been previously observed in previous studies in other 
microorganisms (Gonzalez eta i., 2002). The reversibility of many reactions results in 
a change of flux direction whilst the gene expression does not. Some genes also 
encode enzymes catalysing many reactions, and some enzymes are encoded by 
several genes, making it complex to relate gene expression and metabolic flux. 
Another complication was that both the microarrays and the metabolic network used 
in this study were based on the genome of another species, Streptomyces coeiicoior, 
which could have lead to some error both in gene expression measurement and flux
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distribution simulation. Flux and gene expression values seemed to be reasonably 
well correlated in chemostat culture, while very little correlation was observed in 
batch culture. No real steady-state can be obtained in batch culture, which can make 
Flux Balance Analysis less reliable.
Chemostat culture is generaily more suiTable to study metabolism using genome- 
scale tools such as microarrays and FBA because it is highly reproducible and gives 
true steady-states. However, batch culture is also very useful to observe the 
temporal transcription as well as the co-expression of genes. Moreover, the 
expression of some genes seems to be regulated differently from chemostat culture. 
It was also shown that the correlation between transcriptomic and fluxomic data is 
rather poor for various reasons. In order to understand the regulations operating at 
the various leveis between DNA and reaction flux, it would be very interesting to 
analyse and correlate the three following 'omics': transcriptomics, proteomics, and 
fluxomics. Only then can we truly understand the whole cell as a system.
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Gene Product Gene Product
Cephamycin C cluster clavulanic acid cluster
rhsA unknown protein ceas2 carboxyethylarginine synthase
sdU unknown protein bls2 beta-lactam synthetase
bla class A beta-lactamase pah2 proclavaminate amidinohydrolase
pbp74 penicillin-binding protein cas2 clavaminate synthase
cmcT efflux protein oat2 ornithine acetyltransferase
pcd semialdehyde dehydrogenase oppAl oligopeptide-binding protein
cefE deacetoxycephalosporin-C synthetase (DAOCS) daR transcriptional activator
cefD isopenicillin-N epimerase car clavaldehyde dehydrogenase
cmcl cephalosporin hydroxylase cyp cytochrome P450
cmcJ methyltransferase fd ferredoxin
cefF deacetylcephalosporin-Csynthetase orfl2 putative beta-lactamase
cmcH carbamoyl transferase orfl3 export pump
ccaR positive regulator orfl4 acetyltransferase
o rfll unknown protein oppA2 oligopeptide-binding protein
bip putative beta-lactamase inhibitory protein orflS hypothetical protein
lat L-lysine-epsilon aminotransferase orfl7 carboxylase
pcbAB delta-(L-alpha-aminoadipyl)-L- cysteinyl-D- valine synthetase pbpA penicillin-binding protein
pcbC isopenicillin-N synthetase pbpB penicillin-binding protein
pcbR resistance protein (penicillin- binding) orf20 putative cytochrome P450
Clavam cluster Paralogue cluster
cvm3 unknown protein ceasl carboxyethyl arginine synthase
cvm2 unknown protein bisl beta-lactam synthetase
cvml unknown protein pahl proclavaminate amidinohydrolase
casl clavaminate synthase oatl ornithine acetyltransferase
cvm4 putative deacetylcephalosporin-C acetyltransferase
cvm5 putative luciferase
cvm6 putative pyrldoxal phosphate- dependent aminotransferase
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Reaction
number
%
difference Pathway Reaction
r502 -444372% Coenzyme-A biosynthesis ASP = C02 +  bALA
rl79 -8859% Pyruvate metabolism ATP + AC +  GOA = AMP + PPI +  ACCOA
rl8 8 -8859% Pyruvate metabolism AC +  ATP = ACETYLP +  ADP
rl8 9 -8859% Pyruvate metabolism ACETYLP + COA = ACCOA +  PI
r407 -3110% ATP/dATP biosynthesis ATP + AMP = 2 ADP
r241 -1926% Energy metabolism PPI = 2 PI
r274 -1059% Aspartate biosynthesis OA +  GLU = ASP 4- AKG
r97 -100% Aspartate utilisation bALA +  AKG = MALONATES + GLU
r98 -100% Aspartate utilisation MALONATES 4- COA 4- NAD = ACCOA 4- NADH 4- C02
r76 -100% Isoleucine utilisation RMMALONYLCOA = SMMALONYLCOA
r512 -100% Folate biosynthesis AHTD = DHP 4- 3 PI
r482 -100% NAD,NADP biosynthesis NAAD 4- ATP 4- NH3 = NAD 4- AMP 4- PPI
rl6 5 -100% Glycolysis/gluconeogenesis PEP 4- ADP = PYR 4- ATP
rl9 3 -100% Propanoate metabolism SMMALONYLCOA = PROPIONYLCOA 4- C02
r336 -50% Pyrimidines biosynthesis CAP 4- ASP = CAASP 4- PI
r337 -50% Pyrimidines biosynthesis CAASP = DOROA
r340 -50% Pyrimidines biosynthesis OROA 4- PRPP = PPI 4- OMP
r341 -50% Pyrimidines biosynthesis OMP = C02 4- UMP
r344 -49% Pyrimidines biosynthesis UTP 4- GLN 4- ATP = GLU 4- CTP 4- ADP 4- PI
r210 -47% Pentose phosphate pathway R5P 4- X5P = G3P 4- S7P
r212 -47% Pentose phosphate pathway G3P 4- S7P = E4P 4- F6P
r339 -46% Pyrimidines biosynthesis DOROA 4- MK = MKH2 4- OROA
r410 -40% GTP/dGTP biosynthesis IMP 4- NAD = NADH 4- XMP
r411 -40% GTP/dGTP biosynthesis XMP 4- ATP 4- GLN = GLU 4- AMP 4- PPI 4- GMP
r412 -40% GTP/dGTP biosynthesis GMP 4- ATP = GDP 4- ADP
r364 -40% Purines biosynthesis PRPP 4- GLN = PPI 4- GLU + PRAM
r365 -40% Purines biosynthesis PRAM 4- ATP 4- GLY = ADP +  PI 4- GAR
r366 -40% Purines biosynthesis GAR 4- FTHF = THF 4- FGAR
r367 -40% Purines biosynthesis FGAR 4- ATP 4- GLN = GLU +  ADP 4- PI 4- FGAM
r368 -40% Purines biosynthesis FGAM 4- ATP = ADP 4- PI 4- AIR
r369 -40% Purines biosynthesis AIR 4- C02 4- ATP = CAIR 4- ADP 4- PI
r370 -40% Purines biosynthesis CAIR 4- ATP 4- ASP = ADP 4- PI 4- SAICAR
r371 -40% Purines biosynthesis SAICAR = FUM 4- AICAR
r335 -39% Nucleotide biosynthesis R5P 4- ATP = PRPP 4- AMP
r208 -38% Pentose phosphate pathway RL5P = R5P
r232 -38% One carbon pool by folate METTHF 4- NADP = METHF 4- NADPH
r233 -38% One carbon pool by folate METHF = FTHF
r372 -37% Purines biosynthesis AICAR 4- FTHF = THF 4- PRFICA
r373 -37% Purines biosynthesis PRFICA = IMP
r207 -37% Pentose phosphate pathway RL5P = X5P
r l l 3 -37% Glycine utilisation THF 4- SER = GLY 4- METTHF
r342 -36% Pyrimidines biosynthesis ATP 4- UMP = ADP 4- UDP
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r405 -35% ATP/dATP biosynthesis IMP +  GTP + ASP = GDP +  PI +  ASUC
r406 -35% ATP/dATP biosynthesis ASUC = FUM +  AMP
r211 -35% Pentose phosphate pathway X5P +  E4P = F6P +  G3P
r289 -33% Methionine biosynthesis CYS +  OSLHSER = LLCT +  SUCC
r408 -33% ATP/dATP biosynthesis ADP +  RTHIO = DADP +  OTHIOxt
r409 -33% ATP/dATP biosynthesis DADP +  ATP = DATP +  ADP
r380 -33% Purines biosynthesis DUDP + ATP = DUTP + ADP
r382 -33% Purines biosynthesis UDP +  RTHIO = OTHIOxt +  DUDP
r352 -33% Pyrimidines biosynthesis DUTP = PPI +  DUMP
r353 -33% Pyrimidines biosynthesis METTHF +  DUMP + FADH2 = THF +  DTMP + FAD
r354 -33% Pyrimidines biosynthesis DTMP + ATP = DTDP +  ADP
r355 -33% Pyrimidines biosynthesis DTDP + ATP = DTTP +  ADP
r414 -33% GTP/dGTP biosynthesis GDP +  RTHIO = DGDP +  OTHIOxt
r415 -33% GTP/dGTP biosynthesis DGDP +  ATP = DGTP +  ADP
r347 -33% Pyrimidines biosynthesis CDP + RTHIO = DCDP + OTHIOxt
r348 -33% Pyrimidines biosynthesis DCDP + ATP = DCTP +  ADP
r530 -33% DNA synthesis
4.431 ATP + 0.4756 DATP +  1.1475 DCTP +  
1.1475 DGTP + 0.4756 DTTP = 4.431 ADP + 
4.431 PI +  3.246 PPI +  DNA
r294 -33% Serine biosynthesis 3PG +  NAD = NADH +  PHP
r295 -33% Serine biosynthesis PHP + GLU = AKG + 3PSER
r296 -33% Serine biosynthesis 3PSER = PI +  SER
r330 -32% Tyrosine and phenylalanine biosynthesis CHOR = PH EN
r305 -32% Cysteine biosynthesis LLCT = CYS +  NH3 +  OBUT
r309 -32% Histidine biosynthesis PRPP +  ATP = PPI + PRBATP
r310 -32% Histidine biosynthesis PRBATP = PPI +  PRBAMP
r311 -32% Histidine biosynthesis PRBAMP = PRFP
r312 -32% Histidine biosynthesis PRFP = PRLP
r313 -32% Histidine biosynthesis PRLP + GLN = GLU +  AICAR + DIMGP
r314 -32% Histidine biosynthesis DIMGP = IMACP
r315 -32% Histidine biosynthesis IMACP +  GLU = AKG +  HISOLP
r316 -32% Histidine biosynthesis HISOLP = PI +  HISOL
r317 -32% Histidine biosynthesis HISOL +  2 NAD = HIS +  2 NADH
r265 -32% Isoleucine biosynthesis PYR +  OBUT = ABUT + C02
r266 -32% Isoleucine biosynthesis ABUT + NADPH = NADP +  DIHYDROXYMETHYLPENTANOATE
r267 -32% Isoleucine biosynthesis DIHYDROXYMETHYLPENTANOATE =  OXOMETHYLPENTANOATE
r268 -32% Isoleucine biosynthesis OXOMETHYLPENTANOATE + GLU = AKG +  ILE
r333 -32% Tyrosine and phenylalanine biosynthesis PHEN +  NAD = 4HPP + C02 +  NADH
rl3 0 -32% Tyrosine utilisation AKG + TYR = 4HPP + GLU
r275 -32% Asparagine biosynthesis ASP + ATP +  GLN = GLU +  ASN +  AMP +  PPI
r325 -32% Tryptophan biosynthesis CHOR +  GLN =  GLU + PYR + AN
r326 -32% Tryptophan biosynthesis AN + PRPP = PPI +  NPRAN
r327 -32% Tryptophan biosynthesis NPRAN = CPAD5P
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r328 -32% Tryptophan biosynthesis CPAD5P = C02 + IGP
r329 -32% Tryptophan biosynthesis IGP +  SER = G3P +  TRP
r248 -32% Proline biosynthesis GLU +  ATP = ADP + GLUP
r249 -32% Protine biosynthesis GLUP + NADPH = NADP +  PI +  GLUGSAL
r250 -32% Proline biosynthesis GLUGSAL = P5C
r251a -32% Proline biosynthesis P5C +  NADPH =  PRO + NADP
r331 -32% Tyrosine and phenylalanine biosynthesis PHEN = C02 +  PHPYR
r332 -32% Tyrosine and phenylalanine biosynthesis PH PYR + GLU = AKG +  PHE
r532 -32% Protein synthesis
1.255 ALA +  0.747 ARG +  0.169 ASN +  0.555 ASP 
+  40.3879 ATP + 0.076 CYS + 0.266 GLN +  0.524 
GLU + 0.886 GLY + 0.22 HIS + 0.293 ILE + 0.954 
LEU +  0.161 MET + 0.255 PHE +  0.57 PRO +  
0.491 SER +  0.583 THR +  0.144 TRP + 0.198 TYR 
+  0.779 VAL +  0.215 LYS = 40.3879 ADP +  
40.3879 PI +  PROTEIN
r269 -32% Leucine biosynthesis ACCOA + OIVAL = COA +  IPPMAL
r270 -32% Leucine biosynthesis IPPMAL = CBHCAP
r271 -32% Leucine biosynthesis CBHCAP +  NAD =  NADH +  OICAP
T i l l -32% Leucine biosynthesis OICAP = MOP +  C02
r273 -32% Leucine biosynthesis MOP +  GLU = AKG +  LEU
r288 -32% Methionine biosynthesis HSER +  SUCCOA = OSLHSER + COA
r357 -32% Pyrimidines biosynthesis OTHIOxt +  NADPH = RTHIO +  NAD
r489 -32% NAD,NADP biosynthesis NAD +  ATP = NADP + ADP
r235 -32% One carbon pool by folate FAD +  NADH = FADH2 +  NAD
r318 -31% Shikimate pathway E4P +  PEP = PI +  3DDAH7P
r319 -31% Shikimate pathway 3DDAH7P =  DQT +  PI
r320 -31% Shikimate pathway DQT = DHSK
r321 -31% Shikimate pathway DHSK +  NADPH = SME +  NADP
r322 -31% Shikimate pathway SME +  ATP = ADP + SME3P
r323 -31% Shikimate pathway SME3P +  PEP = 3PSME +  PI
r324 -31% Shikimate pathway 3PSME = PI +  CHOR
r244 -31% Energy metabolism 2 FERO +  NADP = 2 FERI +  NADPH
r301 -31% Cysteine biosynthesis OSLHSER +  H2S = HCYS + SUCC
rl3 8 -31% Sulphate metabolism SLF +  ATP =  PPI +  APS
rl3 9 -31% Sulphate metabolism APS +  ATP = ADP +  PAPS
rl4 0 -31% Sulphate metabolism PAPS +  RTHIO =  OTHIOxt + H2S03 + PAP
rl41 -31% Sulphate metabolism H2S03 +  6 FERO = H2S +  6 FERI
r610 -31% Transport reactions SLFxt +  ATP = SLF +  ADP + PI
rl42 -31% Sulphate metabolism PAP = PI +  AMP
r292 -31% Methionine biosynthesis HCYS +  MTHF = THF +  MET
r234 -31% One carbon pool by folate METTHF +  FADH2 = MTHF +  FAD
r304 -30% Cysteine biosynthesis SER +  HCYS = LLCT
r263 34% Valine biosynthesis OIVAL +  GLU =  AKG +  VAL
r416 35% Lipids biosynthesis MALCOA +  ACP =  MALACP +  COA
rl85 35% Pyruvate metabolism ACCOA +  ATP + C02 = MALCOA + ADP + PI
Appendix 2: List of reactions with over 30% flux difference
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r429 39% Lipids biosynthesis PROPIONYLACP + 7 MAU\CP +  14 NADPH = 14 NADP +  C170ACP +  7 C02 +  7 ACP
r427 40% Lipids biosynthesis PROPIONYLCOA + ACP = PROPIONYLACP + COA
r428 40% Lipids biosynthesis PROPIONYLACP + 6 MALACP + 12 NADPH = 12 NADP +  C150ACP +  6 C02 +  6 ACP
r537 41% Carbohydrate synthesis 1.897 UDPNAG + 3.794 UDPGAL = 5.691 UDP +  CARBOHYDRATE
r31 41% C5 carbon utilisation UDPG = UDPGAL
r33 42% C5 carbon utilisation G IP  +  UTP = UDPG + PPI
r l5 4 42% Glycolysis/gluconeogenesis G6P = G IP
rl5 2 42% Glycolysis/gluconeogenesis G6P = F6P
r52 51% Disaccharides utilisation TRE6P = TRE +  PI
r52a 51% Disaccharides utilisation UDPG + G6P = UDP +  TRE6P
r533 54% TAG synthesis
1.244 GL3P + 0.050 C140ACP + 1.677 C150ACP +  
0.421 C160ACP + 1.570 C170ACP + 0.014 
C181ACP = TAG +  3.732 ACP + 1.244 PI
r561 55% Energy maintenance ATP = ADP + PI
r701 69% Clavulanic acid biosynthesis G3P +  ARG = CEA +  PI
r702 69% Clavulanic acid biosynthesis ATP + CEA = AMP +  PPI +  DGPC
r703 69% Clavulanic acid biosynthesis DGPC +  AKG + 0 2  = GPC +  SUCC +  C02
r704 69% Clavulanic acid biosynthesis GPC = PROCLAM + UREA
r705 69% Clavulanic acid biosynthesis PROCLAM +  AKG +  0 2  = DHCLAM +  SUCC + C02
r706 69% Clavulanic acid biosynthesis DHCLAM + AKG +  0 2  =  CLAM +  SUCC + C02
r707 69% Clavulanic acid biosynthesis CLAM + NADPH + 0 2  = CLAVALD +  NH3 + NADP
r708 69% Ciavulanic acid biosynthesis CLAVALD +  NADPH = CA +  NADP
r709 69% Clavulanic acid biosynthesis CA = CAxt
r582 69% Transport reactions UREAxt = UREA
r77 100% Isoleucine utilisation RMMALONYLCOA = SUCCOA
r87 100% Valine utilisation VAL +  NAD = NADH +  NH3 + OMVAL
r88 100% Valine utilisation OMVAL + ÜPO = IBUTLIPO +  C02
r89 100% Valine utilisation COA +  IBUTLIPO = DLIPO +  IBUTCOA
r90 100% Valine utilisation IBUTCOA +  MK = MACRCOA +  MKH2
r91 100% Valine utilisation MACRCOA = HIBUTCOA
r92 100% Valine utilisation HIBUTCOA = HIBUT +  COA
r93 100% Valine utilisation HIBUT +  NAD = METHYLMALONATES +  NADH
r95 100% Valine utilisation METHYLMALONATES + NAD + COA =  PROPIONYLCOA +  NADH +  C02
r513 100% Folate biosynthesis AHTD = DHP + PPI + PI
r483 100% NAD,NADP biosynthesis NAAD + ATP + GLN = NAD +  AMP + PPI +  GLU
Appendix 2: List of reactions with over 30% flux difference
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rl6 6 100% Glycolysis/gluconeogenesis PYR + LIPO = ADLIPO + C02
rl6 7 100% Glycolysis/gluconeogenesis COA + ADLIPO = DLIPO +  ACCOA
rl6 8 100% Glycolysis/gluconeogenesis DLIPO +  NAD = LIPO + NADH
rl8 4 100% Pyruvate metabolism MAL + NAD = C02 + NADH +  PYR
rl7 7 349% TCA cycle MAL +  NAD = NADH + OA
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-3.59 Pyruvate metabolism ATP + AC + COA = AMP + PPI + ACCOA acetyi-CoA synthetase
-3.59 Pyruvate metabolism ACETYLP + ADP = AC + ATP acetate kinase
-3.59 Pyruvate metabolism ACCOA + PI = ACETYLP + COA phosphateacetyltransferase
-3.44 ATP/dATP biosynthesis ATP +  AMP = 2 ADP adenylate kinase
-3.44 Energy metabolism PPI = 2 PI inorganic diphosphatase
-2.44 Energy metabolism ADP + Pl-f- 4 H = ATP ATP synthase
-1.70 Energy metabolism MKH2 + 0.5 02 = MK + 6 H cytochrome bcl-aa3 supercomplex
-1.47 Energy metabolism NADH + MK = NAD + MKH2 NADH dehydrogenase
-0.70 Transport reactions C02 = C02xt C02 transport via diffusion
-0.54 Transport reactions 02xt = 02 oxygen transport via diffusion
-0.46 Citrate cycle AKG + NAD + COA = NADH + C02 + SUCCOA
dihydroiipoyi 
dehydrogenase 4- 
oxoglutarate 
dehydrogenase 4- 
dlhydroiipoyilysine-residue 
succinyitransferase
-0.46 Citrate cycle ADP + PI +  SUCCOA = ATP + SUCC + COA succinate-CoA ligase
-0.39 Nicotinamide nucleotides biosynthesis NADPH + NAD = NADP + NADH NAD(P) transhydrogenase
-0.31 Glutamate family utilisation GLN = GLU + NH3 giutaminase
-0.23 Energy metabolism SUCC + MK 4- 2 H = FUM + MKH2 succinate dehydrogenase
-0.15 Aspartate utilisation bALA 4- AKG = MALONATES 4- GLU
4-aminobutyrate
transaminase
-0.15 Aspartate utilisation MALONATES 4- COA 4- NAD = ACCOA 4- NADH 4- C02
maionate-semialdehyde
dehydrogenase
(acetylating)
-0.15 Citrate cycle MAL 4- NAD = NADH 4- OA ma late dehydrogenase
-0.15 Coenzyme-A biosynthesis ASP = C02 4- bALA aspartate 1-decarboxylase
-0.15 Citrate cycle ACCOA 4- OA = COA 4- CIT citrate synthase
-0.15 Citrate cycle CIT = ICIT aconitate hydratase
-0.15 Citrate cycle ICIT 4- NADP = NADPH 4- AKG + C02
isocitrate dehydrogenase 
(NADP)
-0.15 Citrate cycle FUM = MAL fumarate hydratase
-0.08 Aspartate biosynthesis OA + GLU = ASP 4- AKG aspartate transaminase
-0.08 Glycolysis/giuconeogenesls G3P 4- PI 4- NAD = NADH 4- 13PDG
giyceraldehyde-3- 
phosphate dehydrogenase
-0.08 Giycolysis/giuconeogenesis 13PDG 4- ADP = 3PG 4- ATP phosphogiycerate kinase
-0.08 Anaplerotic reactions PEP 4- C02 4- GDP = OA + GTP phosphoenolpyruvate carboxykinase (GTP)
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-0.08 GTP/dGTP biosynthesis GTP + ADP = GDP + ATP nucieoside-diphosphatekinase
-0.08 Giycolysis/giuconeogenesis 3PG = 2PG phosphogiycerate mutase
-0.08 Giycolysis/giuconeogenesis 2PG = PEP phosphopyruvatehydratase
-0.01 Cysteine synthesis LLCT = CYS + NH3 + OBUT cystathionine gamma- lyase
-0.01 Methionine biosynthesis CYS + OSLHSER = LLCT + SUCC cystathionine gamma- synthase
-0.01 Methionine biosynthesis HSER + SUCCOA = OSLHSER + COA
homoserine 0- 
succinyltransferase
0.00 Glyoxylate shunt ACCOA + GLX = COA + MAL malate synthase
0.00 Folate biosynthesis AHTD = DHP + 3 PI alkaline phosphatase
0.00 Glyoxyiate shunt DGLYCERATE + NAD = TARTRONATE + NADH
2-hydroxy-3- 
oxopropionate reductase
0.00 Glyoxylate shunt 2 GLX = TARTRONATE + C02 tartronate-semialdehydesynthase
0.00 C3 carbon utilisation DGLYCERATE + ATP = 3PG + ADP glycerate kinase
0.00 Folate biosynthesis AHTD = DHP 4- PPI + PI ATP-dependent DNA heilcase
0.01 Threonine biosynthesis HSER 4- ATP = ADP 4- PHSER homoserine kinase
0.01 Threonine biosynthesis PHSER = THR + PI threonine synthase
0.01 Isoleucine biosynthesis THR = OBUT 4- NH3 threonine ammonia-iyase
0.08 Transport reactions UREA = UREAxt urea transport via facilitate diffusion
0.08 Clavulanic acid biosynthesis G3P 4- ARG = CEA 4- PI
0.08 Ciavulanic acid biosynthesis ATP 4- CEA = AMP 4- PPI 4- DGPC
0.08 Ciavulanic acid biosynthesis
DGPC 4- AKG 4- 02 = GPC 4- SUCC 
4- C02
0.08 Clavulanic acid biosynthesis GPC = PROCLAM 4- UREA
0.08 Clavulanic acid biosynthesis
PROCLAM 4- AKG 4- 02 = 
DHCLAM 4- SUCC 4- C02
0.08 Clavulanic acid biosynthesis
DHCLAM 4- AKG 4- 02 = CLAM 4- 
SUCC 4- C02
0.08 Clavulanic acid biosynthesis
CLAM 4- NADPH 4- 02 = CLAVALD 
4- NH3 4- NADP
0.08 Ciavulanic acid biosynthesis CLAVALD 4- NADPH = CA 4- NADP
0.08 Clavulanic acid biosynthesis CA = C/\xt
0.08 Arginine biosynthesis NAGLU 4- ATP = ADP + NAGLUP acetylgiutamate kinase
Appendix 3: List of reactions with a different flux a t  high
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0.08 Arginine biosynthesis NAGLUP + NADPH = NADP + PI + NAGLUS
N-acetyi-gamma-
giutamyl-phosphate
reductase
0.08 Arginine biosynthesis NAGLUS + GLU = AKG + NAORN acetonitriieaminotransferase
0.08 Arginine biosynthesis NAORN + GLU = ORN + NAGLU glutamate N- acetyitransferase
0.08 Arginine biosynthesis GLN + 2 ATP + C02 = GLU + CAP + 2 ADP + PI
carbamoyl-phosphate
synthase
0.08 Arginine biosynthesis CITR + ASP + ATP = AMP + PPI + ARGSUCC
arglnlnosuccinate
synthase
0.08 Arginine biosynthesis ARGSUCC = FUM + ARG arglnlnosuccinate lyase
0.08 Glutamate family utilisation ORN + CAP = CITR + PI
ornithine
carbamoyitransferase
0.23 Giutamate/giutaminebiosynthesis
AKG + NH3 + NADH = GLU + 
NAD
glutamate dehydrogenase 
(NADP)
0.23 Transport reactions NH3xt = NH3 ammonia transport via diffusion
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PRIMER_EXPLAIN_FLAG=0
PRIMER_FILE_FLAG=0
PRIMER_FIRST_BASE_INDEX= 1
PRIMER„GC_CU\MP=1
PRIM ER_MAX_DIFF_TM=3
PRIMER_MAX_END_STABILITY=9
PRIMER_MAX_GC=85
PRIMER_MAX_SIZE=20
PRIMER_MAX_TM=70
PRIMER_MIN_SIZE=16
PRIMER_MIN_TM=60
PRIMER_NUM_RETURN=5
PRIMER_OPT_TM=65
PRIMER_PAIR_WT_COMPL_ANY=0.25
PRIMER_PAIR_WT_COMPL_END=0.5
PRIMER_PAIR_WT_PR0DUCT_TM_GT=1
PRIM ER_PAIR_WT_PR_PEN ALTY= 1
PRIMER_PAIR_WT_TM_DIFF=0.1
PRIMER_PR0DUCT_MAX_TM=91
PRIM ER_PRODUCT_OPT_TM =89
PRIMER_PRODUCT_SIZE_RANGE=150-500
PRIMER_WT_END_STABILITY=0.5
PRIMER_WT_GC„PERCENT_GT=0
PRIMER_WT_GC_PERCENT_LT=0
PRIMER_WT_SIZE_GT=0
PRIMER_WT_SIZE_LT=0
PRIMER_WT_TM„GT=0
PRIMER WT TM LT=0
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S C O /g en e
nam e
Com m on
nam e
S pearm an
co rre la tio n
c o e ffic ien t
P roduct
SC02785 0 .7 conserved hypothetical protein
SC04214 0 .7 putative AbaA-like regulatory protein
SC07178 0 .7 putative transcriptional regulatory protein
SC01833 0 .7 0 3 5 7 1 putative membrane protein
SC03611 0 .7 035 71 putative membrane protein
SCO4620 traB l 0 .7 0 3 5 7 1 putative sporulation-reiated protein
SC06853 0 .7 0 3 5 7 1 hypothetical protein SC7F9.05
SCO7301 0 .7 0 3 5 7 1 conserved hypothetical protein SC5F8.11c.
SCO7150 0 .7 0 7 1 4 3 putative acetyltransferase
SC03619 0 .7 1 0 7 1 4 conserved hypothetical protein
SCO0867 0 .7 1 0 7 1 4 putative integrai-membrane protein.
SCO7505 0 .7 1 0 7 1 4 putative integral membrane binding-protein-dependent transport protein
SC07637 0 .7 1 0 7 1 4 secreted endoglucanase
SC05141 folP 0 .7 1 4 2 8 6 dihydropteroate synthase
SC03553 0 .7 1 7 8 5 7 putative small membrane protein
SCO5470 g!yA2 0 .7 2 1 4 2 9 serine hydroxymethyltransferase
SC02157 0 .7 25 putative aminotransferase
SC02235 0 .7 2 8 5 7 1 conserved hypothetical protein
S C P l.llO 0 .7 2 8 5 7 1 putative ATP/GTP-bindIng protein
SC06823 0 .7 2 8 5 7 1 putative ArsR-family transcriptional regulator.
SC06979 0 .7 2 8 5 7 1 probable solute-binding lipoprotein.
SC01744 0 .7 3 5 7 1 4 putative two-component system sensor kinase
SC04888 0 .7 3 5 7 1 4 putative sugar ABC transporter integral membrane protein
SC06138 0 .7 3 9 2 8 6 putative transmembrane protein
SC07243 0 .7 4 2 8 5 7 putative secreted protein
SC06378 0 .7 4 2 8 5 7 putative membrane protein
SCO7320 0 .7 4 6 4 2 9 conserved hypothetical protein SC5F8.30c
SCO4890 deoA 0 .7 5 3 5 7 1 thymidine phosphorylase
SC07100 0 .7 5 7 1 4 3 putative oxidoreductase
SC01521 0 .7 5 7 1 4 3 conserved hypothetical protein SCL2.11c
SC01112 0 .7 6 0 7 1 4 putative oxidoreductase
SC04146 0 .7 6 7 8 5 7 putative ECF subfamily sigma factor
SC06341 0 .7 7 1 4 2 9 putative exonuclease
SC04653 rpIL 0 .7 75 SOS ribosomal protein L7/L12
SC07471 paaA 0 .7 8 2 1 4 3 putative phenylacetic acid degradation protein PaaA
SCO0775 0 .7 8 2 1 4 3 conserved hypothetical protein
SC04373 0 .7 8 5 7 1 4 putative mut-like protein
SC04793 0 .7 8 9 2 8 6 putative NPL/P60 family secreted protein
SC05375 0 .7 9 2 8 5 7 putative secreted protein
SC02358 0 .7 9 6 4 2 9 putative two-component system response regulator
SC04625 0 .7 9 6 4 2 9 conserved hypothetical protein
SCO7023 0 .8 0 7 1 4 3 hypothetical protein SC1H10.12.
SC05638 0 .8 0 7 1 4 3 integral membrane protein
SCO7706 0 .8 0 7 1 4 3 putative DNA-binding protein
SC06844 0 .8 1 0 7 1 4 putative DNA methylase.
SC06691 0 .8 1 0 7 1 4 putative phospholipase C
SCO3603 0 .8 3 2 1 4 3 putative N a (+ )/H (+ ) antiporter
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SCO/gene
name
Common
name
Spearman
correlation
coefficient
Product
SCO4701 rpsJ -0.87857 30S ribosomal protein SIO
SC04662 tu fl -0.85 elongation factor TU-1
SC03326 -0.84286 putative epimerase
SCO0346 -0.81071 putative 2-hydroxvhepta-2,4-diene-l,7-dioate isomerase
SC06295 -0.80357 putative ABC transporter ATP-binding protein
SCO4705 rplB -0.79286 505 ribosomal protein L2
SC07020 amlB -0.79286 secreted alpha-amylase.
SCO 1103 -0.78929 putative hydrolase
SC02697 -0.76429 putative secreted protein
SC02315 -0.76071 putative membrane protein
SCO0121 -0.75357 ABC transport system ATP-binding protein
SC04712 rpIN -0.74643 505 ribosomal protein L14
SC00028 -0.74286 hypothetical protein
SCO3906 rpsF -0.74286 putative 305 ribosomai protein 56
SCO2320 -0.73571 hypothetical protein
SCO5409 -0.72857 putative membrane protein
SCO0586 cvnC ll -0.725 conserved hypothetical protein 5CF55.10c
SC03221 -0.725 putative oxidoreductase
SC04557 -0.725 hypothetical protein
SCO4660 rspG -0.725 305 ribosomal protein 57
SCO6075 -0.725 conserved hypothetical protein
SC04389 -0.72143 putative acetyltransferase
SCO1056 -0.71071 putative sugar transport sugar binding protein
SC07090 -0.71071 putative Integral membrane protein.
SC02479 -0.71071 putative membrane protein
SCO4707 rpIV -0.71071 505 ribosomal protein L22
SCO0754 -0.70714 putative secreted protein
SC01272 -0.70714 putative acyi carrier protein
SC04562 nuoA -0.70714 NuoA, NADH dehydrogenase subunit
SCO7510 cypH -0.70714 peptidyi-prolyl cis-trans Isomerase
SCO1108 -0.70357 putative regulatory protein
SCO6088 -0.7 putative solute-binding transport protein
APPENDIX 8 : G enes p o s it iv e l y  co rrelated  t o  c la v u la n ic  a c id  s p e c if ic
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SCO/gene
name
Common
name
Spearman
correlation
coefficient
Product
ca2 b!s2 0.781457 beta lactam synthetase
c a ll c a ll 0.788816 putative beta-iactamase
ca8 car 0.813834 clavaldehyde dehydrogenase
ca4 cas2 0.753495 clavaminate synthase or ciavaminic acid synthetase
cal ceas2 0.784401 carboxyethylarginine synthase
cephlO cmcJ 0.727005 methyltransferase
nrdII2 lexA 0.74025 putative SOS regulatory protein
ca6 oppAl 0.71376
cal4 oppA2 0.700515 peptide transport protein
ceph6 pcd 0.721119 semialdehyde dehydrogenase
SCO0464 0.737307 putative integral membrane protein •
SCO0637 0.703459 conserved hypothetical protein SCF56.21
SCO0645 0.735835 putative Zinc-containing dehydrogenase.
SC00710 0.72259
putative branched-chain amino acid transport ATP-binding
protein.
SCO0819 0.728477 putative transmembrane transport protein
SC01090 0.796174 putative phosphodiesterase
SC01136 0.710817 putative two component system response regulator
SC01174 thcA 0.782929 aldehyde dehydrogenase
SC01271 fabH3 0.70493 putative 3-oxoacyi-[acyl-carrier-protein] synthase III
SCO1290 0.738779 putative secreted alkaline phosphatase
SC01356 0.716704 putative iron sulphur protein (putative secreted protein)
SC01393 acsA 0.725534 acetoacetyl-CoA synthetase
SCO 1482 pyrD 0.71376 dihydroorotate dehydrogenase
SC01579 argJ 0.73142 putative glutamate N-acetyltransferase
SC01828 0.734364 hypothetical protein SCI8.13
SC02030 0.712289 hypothetical protein
SC02786 hexA 0.701987 beta-N-acetylhexosaminidase
SCO3017 0.754967 putative secreted protein
SCO3096 eno 0.76674 enolase
SC03134 0.72259 putative two-component system response regulator
SCO3202 hrdD 0.70493 RNA polymerase principal sigma factor
SC03391 0.712289 hypothetical protein
SC03422 0.700515 hypothetical protein
SCO3506 0.735835 putative lacl-family transcriptional regulator
SC03553 0.70493 putative small membrane protein
SC03577 0.71376 putative ion-transporting ATPase
SCQ3637 0.75791 putative membrane protein
SC03699 0.782929 putative transcriptional regulator
SCO4095 0.790287 putative lipoprotein
SCO4097 0.802061 possible amino acid/metaboiite permease
SC04141 pstC 0.74908 phosphate ABC transport system permease protein
SC04228 0.70493 putative phosphate transport system regulator
SC04596 0.784401 putative two-component system response regulator
SC04625 0.760854 conserved hypothetical protein
SCO4680 0.828551 putative DNA-binding protein
SC04864 0.819721 putative ECF sigma factor
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SCO/gene
name
Common
name
Spearman
correlation
coefficient
Product
SC04882 0.725534 hypothetical protein 2SCK8.08
SC04974 0.796174 putative deaminase
SCO5057 0.707874 putative amino acid permease
SC05133 0.710817 conserved hypothetical protein
SCO5701 0.719647 hypothetical protein SC5H4.25c
SC05848 agaZ 0.737307 tagatose 6-phosphate kinase
SC05923 0.797646 ABC-transporter ATP-binding protein
SC06138 0.772627 putative transmembrane protein
SC06194 0.70493 putative response regulator
SC06198 0.890361 putative secreted protein
SC06245 0.716704 hypothetical protein SCAHIO.IO
SC06466 0.796174 putative transferase
SC06567 0.754967 ABC transporter ATP binding protein
SCO7013 0.743194 putative sugar-binding lipoprotein.
SCO7150 0.793231 putative acetyltransferase
APPENDIX 9 : G enes n e g a tiv e ly  cor r ela ted  to  c la v u la n ic  a c id  s p e c if ic
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SCO/gene
name
Common
name
Spearman
correlation
coefficient
Product
SCO0537 -0.72112 putative secreted protein
SC01464 rpe -0.70935 ribulose-phosphate 3-epimerase
SCO1530 -0.71523 conserved hypothetical protein SCL2.20c
SC01566 -0.73289 putative acyltransferase
SC01598 rpIT -0.72848 50S ribosomal protein L20
SCO 1667 -0.72701 putative ion transport protein
SC02643 pepN -0.76968 aminopeptidase N
SC02892 -0.73289 putative secreted protein.
SCO3037 -0.7167 putative oxidoreductase
SCO3058 -0.7535 putative dipeptidase
SCO3560 -0.72406 putative ATP-binding protein
SC03872 -0.70787 putative integral membrane protein
SCO3909 rpH -0.73289 50S ribosomal protein L9
SC04572 nuoK -0.76968 NuoK, NADH dehydrogenase subunit
SC04636 -0.71818 hypothetical protein SCD82.07
SC04649 rIpA -0.73289 505 ribosomal protein LI
SCO4705 rpB -0.71523 50S ribosomai protein 12
SC04713 rplX -0.81678 50S ribosomal protein L24
SC04719 rpsE -0.77999 30S ribosomal protein 55
SCO4720 rpmD -0.79765 50S ribosomai protein L30
SC04721 rpIO -0.77999 505 ribosomal protein L15
SCO4730 rplQ -0.73142 505 ribosomal protein L17
SC05256 -0.72995 hypothetical protein
SC06612 -0.70052 putative hydrolase
SC06758 -0.73436 putative ABC transporter ATP-binding component
SC06881 -0.74761 putative ATP-binding protein
SC07741 -0.77999 putative bifunctional protein
SCP1.119 dnaN -0.70346 putative DNA-polymerase III, beta chain
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SCO/gene
name
Common
name
Percentage 
of false 
positives
Product
ca8 car 0.0% clavaldehyde dehydrogenase or clavulanate-9-aldehyde reductase
SC04514 0.0% putative integral membrane protein
SCP1.202 0.0% hypothetical protein
SCO0358 0.0% possible racemase
SCP1.253 0.0% hypothetical protein
SCO2014 pykl 0.3% pyruvate kinase
SCO7032 0.4% conserved hypothetical protein SCIH 10.21
SC06239 0.4% putative sigma factor
SC06584 0.4% putative TPP-requiring enzyme
SCO2330 0.5% putative isochorismatase
ca3 pah2 0.6% proclavaminate amidinohydrolase
SC04887 0.7% putative sugar ABC transporter integral membrane protein
SCO1092 0.8% conserved hypothetical protein
SC05429 0.8% putative integral membrane transport protein
SC06618 0.8% hypothetical protein SCIF2.15c
ca4 cas2 0.8% clavaminate synthase or ciavaminic acid synthetase
SC03544 1.3% putative membrane protein
SCO4706 rpsS 1.6% 30S ribosomal protein 819
SC01007 1.6% putative oxidoreductase
SC02459 1.9% hypothetical protein SCC24.30c
SC04345 1.9% hypothetical protein SCD12A.28
SCO5210 1.9% putative molecular chaperone
SCO7120 qrcB2 2.0% ubiquinol-cytochrome C reductase cytochrome B subunit
SCP1.228C mmyF 2.0% putative oxidoreductase, MmyF
SCO0263 2.0% putative oxidoreductase
SCP1.271 2.0% hypothetical protein
SC06498 3.1% conserved hypothetical protein SC1E6.07
SCP1.117 3.5% hypothetical protein
SC01941 3.5% putative integral membrane protein
SCO5703 3.5% hypothetical protein SC5H4.27
SC02837 3.6% putative secreted protein.
SCO7808 3.7% hypothetical protein SC8E7.05c.
SC04662 tu fl 3.7% elongation factor TU-1
SC04341 5.0% hypothetical protein SCD12A.24
SCP1.90C 5.1% putative ATP/GTP-binding protein
SC03754 5.4% putative ABC transporter integral membrane subunit
SCP1.164C 5.5% hypothetical protein
SCP1.318 5.9% putative AraC-famiiy transcriptional regulator
SC03716 5.9% putative cation transport system component
SC07838 6.6% conserved hypothetical protein
SC01666 7.2% putative phosphatase
SCP1.148 7.3% putative secreted protein
SC01442 7.4% putative integral membrane protein
SC04050 7.4% putative acetyltransferase
SC04711 rpsQ 7.8% 305 ribosomal protein 517
SC02389 acpP 8.5% acyl carrier protein
SC02577 8.9% conserved hypothetical protein
SC06999 9.0% hypothetical protein SC8F11.25c.
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SCO/gene
name
Common
name
Percentage 
of false 
positives
Product
SCP1.320C 9.0% putative conserved intégrai membrane protein
SCP1.273C 9.1% putative large secreted protein
SC06179 9.1% putative nucleotide-sugar dehydratase
SC04987 9.3% putative D-amino acid deaminase
SC04854 9.4% putative intégrai membrane protein
SC06766 9.5% conserved hypothetical protein
SC03589 9.7% putative two component sensor kinase
SCO 1449 9.9% hypothetical protein
